TNFAIP3 Data Analysis

HGNC Gene Name
TNF alpha induced protein 3
HGNC Gene Symbol
TNFAIP3
Identifiers
hgnc:11896 NCBIGene:7128 uniprot:P21580
Orthologs
mgi:1196377 rgd:1589275
INDRA Statements
deubiquitinations all statements
Pathway Commons
Search for TNFAIP3
Number of Papers
1619 retrieved on 2023-02-19

DepMap Analysis

The Dependency Map (DepMap) is a genome-wide pooled CRISPR-Cas9 knockout proliferation screen conducted in more than 700 cancer cell lines spanning many different tumor lineages. Each cell line in the DepMap contains a unique barcode, and each gene knockout is assigned a “dependency score” on a per cell-line basis which quantifies the rate of CRISPR-Cas9 guide drop. It has been found that proteins with similar DepMap scores across cell lines, a phenomenon known as co-dependent genes, have closely related biological functions. This can include activity in the same or parallel pathways or membership in the same protein complex or the same pathway.

We identified the strongest seven co-dependent genes (“Symbol”) for DUBs and ran GO enrichment analysis. We used Biogrid, IntAct, and Pathway Commons PPIDs, and the NURSA protein-protein interaction databases (PPIDs) to determine whether co-dependent genes interact with one another. The “Evidence” column contains the PPIDs in which the interaction appears as well as whether there is support for the association by an INDRA statement. As another approach to identify potential interactors, we looked at proteomics data from the Broad Institute's Cancer Cell Line Encyclopedia (CCLE) for proteins whose expression across ~375 cell lines strongly correlated with the abundance of each DUB; it has previously been observed that proteins in the same complex are frequently significantly co-expressed. The correlations and associated p-values in the CCLE proteomics dataset are provided. And, we determined whether co-dependent genes yield similar transcriptomic signatures in the Broad Institute's Connectivity Map (CMap). A CMap score greater than 90 is considered significantly similar.

DepMap Correlations

Symbol Name DepMap Correlation Evidence CCLE Correlation CCLE Z-score CCLE p-value (adj) CCLE Significant CMAP Score CMAP Type
TNIP1 TNFAIP3 interacting protein 1 0.353 BioGRID IntAct INDRA (22) Reactome (4) 0.16 0.80 1.59e-02
NFKBIA NFKB inhibitor alpha 0.292 INDRA (9) Reactome (8) -0.05 -0.38 5.63e-01 95.99 oe
CYLD CYLD lysine 63 deubiquitinase 0.272 INDRA (10) Reactome (15) 0.14 0.66 7.05e-02
ATG101 autophagy related 101 0.228 -0.01 -0.13 9.33e-01
PPM1A protein phosphatase, Mg2+/Mn2+ dependent 1A 0.227 Reactome (1) -0.00 -0.10 9.78e-01
IRAK1 interleukin 1 receptor associated kinase 1 -0.218 INDRA (3) Reactome (6) -0.00 -0.10 9.78e-01 -99.89 kd
EPG5 ectopic P-granules 5 autophagy tethering factor 0.216 0.12 0.59 1.04e-01

Dependency GO Term Enrichment

Gene set enrichment analysis was done on the genes correlated with TNFAIP3using the terms from Gene Ontology and gene sets derived from the Gene Ontology Annotations database via MSigDB.

Using the biological processes and other Gene Ontology terms from well characterized DUBs as a positive control, several gene set enrichment analyses were considered. Threshold-less methods like GSEA had relatively poor results. Over-representation analysis with a threshold of of the top 7 highest absolute value Dependency Map correlations yielded the best results and is reported below.

GO Identifier GO Name GO Type p-value p-value (adj.) q-value
GO:1901222 regulation of NIK/NF-kappaB signaling Biological Process 3.83e-08 1.09e-05 4.56e-06
GO:0035872 nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway Biological Process 2.18e-07 6.20e-05 9.94e-06
GO:0038061 NIK/NF-kappaB signaling Biological Process 2.51e-07 7.12e-05 9.94e-06
GO:0002221 pattern recognition receptor signaling pathway Biological Process 3.70e-07 1.05e-04 1.10e-05
GO:0002753 cytoplasmic pattern recognition receptor signaling pathway Biological Process 1.15e-06 3.27e-04 2.50e-05
GO:0007249 I-kappaB kinase/NF-kappaB signaling Biological Process 1.26e-06 3.58e-04 2.50e-05
GO:0002218 activation of innate immune response Biological Process 2.51e-06 7.12e-04 4.26e-05
GO:0032088 negative regulation of NF-kappaB transcription factor activity Biological Process 3.44e-06 9.78e-04 5.12e-05
GO:0045088 regulation of innate immune response Biological Process 9.45e-06 2.68e-03 1.25e-04
GO:0002224 toll-like receptor signaling pathway Biological Process 1.47e-05 4.16e-03 1.74e-04
GO:0043433 negative regulation of DNA-binding transcription factor activity Biological Process 2.41e-05 6.84e-03 2.60e-04
GO:1901223 negative regulation of NIK/NF-kappaB signaling Biological Process 4.71e-05 1.34e-02 4.67e-04
GO:0034142 toll-like receptor 4 signaling pathway Biological Process 6.51e-05 1.85e-02 5.96e-04
GO:0002755 MyD88-dependent toll-like receptor signaling pathway Biological Process 7.31e-05 2.07e-02 6.21e-04
GO:0030522 intracellular receptor signaling pathway Biological Process 1.04e-04 2.96e-02 8.27e-04
GO:0070646 protein modification by small protein removal Biological Process 1.29e-04 3.67e-02 9.13e-04
GO:0043124 negative regulation of I-kappaB kinase/NF-kappaB signaling Biological Process 1.31e-04 3.71e-02 9.13e-04

Transcriptomics

The following table shows the significantly differentially expressed genes after knocking out TNFAIP3 using CRISPR-Cas9.

Knockout Differential Expression

Symbol Name log2-fold-change p-value p-value (adj.)
CSF2 colony stimulating factor 2 1.51e+00 1.50e-22 2.08e-18
C15orf48 chromosome 15 open reading frame 48 1.15e+00 7.38e-20 5.14e-16
CXCL8 C-X-C motif chemokine ligand 8 1.64e+00 2.09e-19 9.69e-16
CXCL1 C-X-C motif chemokine ligand 1 1.46e+00 4.52e-14 1.58e-10
CXCL2 C-X-C motif chemokine ligand 2 1.33e+00 1.63e-11 4.54e-08
AKR1B1 aldo-keto reductase family 1 member B 5.51e-01 1.83e-10 4.26e-07
RPL13 ribosomal protein L13 5.46e-01 6.63e-10 1.32e-06
MMP1 matrix metallopeptidase 1 4.86e-01 1.22e-09 2.13e-06
SOD2 superoxide dismutase 2 6.83e-01 1.66e-09 2.58e-06
BIRC3 baculoviral IAP repeat containing 3 7.64e-01 4.35e-09 6.07e-06
BCL2A1 BCL2 related protein A1 1.05e+00 4.78e-08 6.06e-05
CSF3 colony stimulating factor 3 1.24e+00 1.01e-07 1.17e-04
NSA2 NSA2 ribosome biogenesis factor 7.84e-01 1.16e-07 1.24e-04
CXCL3 C-X-C motif chemokine ligand 3 1.12e+00 3.18e-07 2.96e-04
SAT1 spermidine/spermine N1-acetyltransferase 1 5.59e-01 3.15e-07 2.96e-04
GPX1 glutathione peroxidase 1 6.04e-01 5.78e-07 5.04e-04
PTX3 pentraxin 3 6.69e-01 9.08e-07 7.45e-04
RPS15 ribosomal protein S15 7.66e-01 1.52e-06 1.18e-03
NFKBIA NFKB inhibitor alpha 6.37e-01 2.02e-06 1.49e-03
SAA1 serum amyloid A1 8.55e-01 2.15e-06 1.50e-03
RPL7 ribosomal protein L7 3.93e-01 2.92e-06 1.94e-03
SEC61G SEC61 translocon subunit gamma 3.61e-01 3.37e-06 2.13e-03
RPS10-NUDT3 RPS10-NUDT3 readthrough -5.78e-01 4.28e-06 2.59e-03
ICAM1 intercellular adhesion molecule 1 8.68e-01 6.10e-06 3.54e-03
ZC3H12C zinc finger CCCH-type containing 12C 9.87e-01 9.52e-06 5.31e-03
CTSS cathepsin S 8.41e-01 1.03e-05 5.52e-03
POU2F2 POU class 2 homeobox 2 6.84e-01 1.39e-05 7.18e-03
SAA2 serum amyloid A2 8.64e-01 2.33e-05 1.16e-02
PLAU plasminogen activator, urokinase 4.50e-01 2.59e-05 1.25e-02
PDZK1IP1 PDZK1 interacting protein 1 9.52e-01 4.92e-05 2.28e-02
EPS8 epidermal growth factor receptor pathway substrate 8 7.72e-01 5.90e-05 2.65e-02
TFPI2 tissue factor pathway inhibitor 2 5.18e-01 7.72e-05 3.36e-02
HACD3 3-hydroxyacyl-CoA dehydratase 3 4.66e-01 8.88e-05 3.75e-02
SPRED1 sprouty related EVH1 domain containing 1 7.59e-01 9.22e-05 3.78e-02
IL6 interleukin 6 8.71e-01 9.96e-05 3.97e-02
ZMIZ2 zinc finger MIZ-type containing 2 7.55e-01 1.26e-04 4.88e-02

Gene Set Enrichment Analysis

The GSEA method was applied for all genes whose knockout resulted in at least 20 significantly differentially expressed genes.

ID Name p-value p-value (adj.) log2 Error ES NES
msig:M5890 HALLMARK_TNFA_SIGNALING_VIA_NFKB 8.15e-14 3.19e-10 9.55e-01 6.01e-01 2.63e+00
go:0030545 receptor regulator activity 1.65e-11 3.22e-08 8.63e-01 6.23e-01 2.59e+00
msig:M9809 KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION 1.24e-09 1.61e-06 7.88e-01 6.85e-01 2.52e+00
go:0005126 cytokine receptor binding 6.93e-09 5.41e-06 7.61e-01 5.85e-01 2.40e+00
go:0031012 extracellular matrix 6.12e-09 5.41e-06 7.61e-01 5.30e-01 2.31e+00
go:0019221 cytokine-mediated signaling pathway 1.22e-08 7.94e-06 7.48e-01 3.79e-01 1.91e+00
go:0005125 cytokine activity 1.86e-08 1.04e-05 7.34e-01 7.45e-01 2.59e+00
go:0010469 regulation of signaling receptor activity 2.37e-08 1.16e-05 7.34e-01 5.08e-01 2.24e+00
msig:M5930 HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION 6.54e-08 2.84e-05 7.05e-01 5.41e-01 2.29e+00
go:0005102 signaling receptor binding 7.84e-08 3.06e-05 7.05e-01 3.24e-01 1.69e+00
go:0050900 leukocyte migration 1.69e-07 6.01e-05 6.90e-01 4.76e-01 2.13e+00
go:0034097 response to cytokine 1.85e-07 6.02e-05 6.90e-01 3.17e-01 1.67e+00
go:0009607 response to biotic stimulus 3.33e-07 9.31e-05 6.75e-01 3.54e-01 1.80e+00
go:0009617 response to bacterium 3.31e-07 9.31e-05 6.75e-01 4.46e-01 2.06e+00
go:0008083 growth factor activity 4.64e-07 1.21e-04 6.75e-01 6.70e-01 2.38e+00
go:0097530 granulocyte migration 5.64e-07 1.38e-04 6.59e-01 6.64e-01 2.32e+00
go:0062023 collagen-containing extracellular matrix 6.16e-07 1.42e-04 6.59e-01 5.16e-01 2.18e+00
go:0060326 cell chemotaxis 7.75e-07 1.68e-04 6.59e-01 5.37e-01 2.23e+00
go:0002237 response to molecule of bacterial origin 1.30e-06 2.68e-04 6.44e-01 4.86e-01 2.09e+00
go:0097529 myeloid leukocyte migration 1.89e-06 3.69e-04 6.44e-01 5.90e-01 2.26e+00
reactome:R-HSA-1280215 Cytokine Signaling in Immune system 2.53e-06 4.49e-04 6.27e-01 3.26e-01 1.68e+00
go:0006954 inflammatory response 2.46e-06 4.49e-04 6.27e-01 4.08e-01 1.92e+00
go:0005783 endoplasmic reticulum 4.34e-06 7.37e-04 6.11e-01 2.69e-01 1.49e+00
go:0030595 leukocyte chemotaxis 5.74e-06 9.34e-04 6.11e-01 5.52e-01 2.18e+00
go:1990266 neutrophil migration 6.30e-06 9.47e-04 6.11e-01 6.87e-01 2.30e+00
go:0001816 cytokine production 6.27e-06 9.47e-04 6.11e-01 3.54e-01 1.75e+00
go:0005201 extracellular matrix structural constituent 8.78e-06 1.27e-03 5.93e-01 7.15e-01 2.27e+00
reactome:R-HSA-449147 Signaling by Interleukins 9.91e-06 1.38e-03 5.93e-01 3.50e-01 1.73e+00
go:1990868 response to chemokine 1.41e-05 1.89e-03 5.93e-01 7.65e-01 2.26e+00
msig:M15569 KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY 1.62e-05 2.12e-03 5.76e-01 6.94e-01 2.30e+00
go:0071216 cellular response to biotic stimulus 2.29e-05 2.88e-03 5.76e-01 4.83e-01 1.99e+00
msig:M5913 HALLMARK_INTERFERON_GAMMA_RESPONSE 2.49e-05 3.01e-03 5.76e-01 4.64e-01 1.97e+00
go:0043062 extracellular structure organization 2.54e-05 3.01e-03 5.76e-01 4.27e-01 1.89e+00
msig:M5947 HALLMARK_IL2_STAT5_SIGNALING 3.12e-05 3.48e-03 5.57e-01 4.73e-01 1.98e+00
msig:M5932 HALLMARK_INFLAMMATORY_RESPONSE 3.07e-05 3.48e-03 5.57e-01 4.84e-01 1.98e+00
msig:M4844 KEGG_CHEMOKINE_SIGNALING_PATHWAY 3.71e-05 4.02e-03 5.57e-01 5.43e-01 2.09e+00
go:0071396 cellular response to lipid 4.19e-05 4.42e-03 5.57e-01 3.54e-01 1.73e+00
go:0048585 negative regulation of response to stimulus 4.44e-05 4.45e-03 5.57e-01 2.70e-01 1.46e+00
go:0006952 defense response 4.44e-05 4.45e-03 5.57e-01 2.83e-01 1.50e+00
go:0040017 positive regulation of locomotion 4.64e-05 4.54e-03 5.57e-01 3.45e-01 1.69e+00
go:1901701 cellular response to oxygen-containing compound 5.14e-05 4.78e-03 5.57e-01 2.95e-01 1.54e+00
go:0002684 positive regulation of immune system process 5.07e-05 4.78e-03 5.57e-01 3.07e-01 1.58e+00
msig:M12868 KEGG_PATHWAYS_IN_CANCER 7.14e-05 6.34e-03 5.38e-01 3.93e-01 1.78e+00
reactome:R-HSA-6785807 Interleukin-4 and Interleukin-13 signaling 7.00e-05 6.34e-03 5.38e-01 6.02e-01 2.10e+00
msig:M5925 HALLMARK_E2F_TARGETS 7.70e-05 6.64e-03 5.38e-01 -3.75e-01 -1.75e+00
go:0051240 positive regulation of multicellular organismal process 7.81e-05 6.64e-03 5.38e-01 2.70e-01 1.45e+00
go:0002224 toll-like receptor signaling pathway 8.09e-05 6.65e-03 5.38e-01 5.48e-01 2.08e+00
go:0032103 positive regulation of response to external stimulus 8.17e-05 6.65e-03 5.38e-01 4.64e-01 1.95e+00
go:0071548 response to dexamethasone 9.42e-05 7.51e-03 5.38e-01 7.29e-01 2.11e+00
go:0042127 regulation of cell population proliferation 9.86e-05 7.71e-03 5.38e-01 2.69e-01 1.44e+00
go:0006959 humoral immune response 1.16e-04 8.91e-03 5.38e-01 6.10e-01 2.11e+00
go:0046545 development of primary female sexual characteristics 1.19e-04 8.92e-03 5.38e-01 5.76e-01 2.05e+00
go:0050918 positive chemotaxis 1.56e-04 1.15e-02 5.19e-01 7.05e-01 2.09e+00
go:0050921 positive regulation of chemotaxis 1.86e-04 1.33e-02 5.19e-01 5.34e-01 1.99e+00
go:0097190 apoptotic signaling pathway 2.04e-04 1.42e-02 5.19e-01 3.02e-01 1.53e+00
reactome:R-HSA-375276 Peptide ligand-binding receptors 2.13e-04 1.46e-02 5.19e-01 6.95e-01 2.12e+00
reactome:R-HSA-373076 Class A/1 (Rhodopsin-like receptors) 2.43e-04 1.63e-02 5.19e-01 6.40e-01 2.12e+00
go:1903900 regulation of viral life cycle 2.47e-04 1.63e-02 4.98e-01 4.43e-01 1.87e+00
go:0023057 negative regulation of signaling 2.78e-04 1.75e-02 4.98e-01 2.71e-01 1.45e+00
go:0002682 regulation of immune system process 2.75e-04 1.75e-02 4.98e-01 2.64e-01 1.40e+00
go:0042330 taxis 2.71e-04 1.75e-02 4.98e-01 3.65e-01 1.70e+00
go:0071384 cellular response to corticosteroid stimulus 3.17e-04 1.97e-02 4.98e-01 5.86e-01 2.02e+00
go:0001775 cell activation 3.45e-04 2.07e-02 4.98e-01 2.67e-01 1.41e+00
go:0001664 G protein-coupled receptor binding 3.41e-04 2.07e-02 4.98e-01 5.01e-01 1.97e+00
go:0046660 female sex differentiation 3.71e-04 2.19e-02 4.98e-01 5.43e-01 2.01e+00
go:0048514 blood vessel morphogenesis 4.28e-04 2.46e-02 4.98e-01 3.38e-01 1.61e+00
go:0002690 positive regulation of leukocyte chemotaxis 4.84e-04 2.74e-02 4.98e-01 5.79e-01 2.01e+00
go:0035150 regulation of tube size 5.03e-04 2.80e-02 4.77e-01 5.93e-01 2.03e+00
go:0003682 chromatin binding 5.10e-04 2.80e-02 4.77e-01 -3.17e-01 -1.55e+00
go:1902533 positive regulation of intracellular signal transduction 5.19e-04 2.82e-02 4.77e-01 2.78e-01 1.43e+00
go:0001541 ovarian follicle development 5.29e-04 2.82e-02 4.77e-01 6.50e-01 2.04e+00
go:0032101 regulation of response to external stimulus 5.69e-04 2.92e-02 4.77e-01 3.24e-01 1.59e+00
go:0034121 regulation of toll-like receptor signaling pathway 5.63e-04 2.92e-02 4.77e-01 7.10e-01 2.01e+00
reactome:R-HSA-381426 Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) 5.88e-04 2.98e-02 4.77e-01 5.08e-01 1.94e+00
go:0003018 vascular process in circulatory system 6.15e-04 3.08e-02 4.77e-01 5.43e-01 1.90e+00
go:1903035 negative regulation of response to wounding 6.49e-04 3.21e-02 4.77e-01 6.12e-01 2.03e+00
go:0034612 response to tumor necrosis factor 6.70e-04 3.27e-02 4.77e-01 3.82e-01 1.72e+00
msig:M5921 HALLMARK_COMPLEMENT 6.92e-04 3.29e-02 4.77e-01 4.24e-01 1.79e+00
reactome:R-HSA-1474244 Extracellular matrix organization 6.99e-04 3.29e-02 4.77e-01 4.09e-01 1.73e+00
go:2001243 negative regulation of intrinsic apoptotic signaling pathway 6.85e-04 3.29e-02 4.77e-01 4.79e-01 1.89e+00
go:0050819 negative regulation of coagulation 7.17e-04 3.34e-02 4.77e-01 6.81e-01 1.97e+00
go:2001234 negative regulation of apoptotic signaling pathway 7.30e-04 3.35e-02 4.77e-01 3.76e-01 1.68e+00
go:0005604 basement membrane 7.44e-04 3.38e-02 4.77e-01 6.17e-01 2.00e+00
msig:M19096 KEGG_BLADDER_CANCER 7.54e-04 3.38e-02 4.77e-01 6.17e-01 1.99e+00
go:0050778 positive regulation of immune response 7.82e-04 3.47e-02 4.77e-01 2.96e-01 1.49e+00
go:0055092 sterol homeostasis 7.91e-04 3.47e-02 4.77e-01 6.42e-01 2.01e+00
go:0035239 tube morphogenesis 8.38e-04 3.56e-02 4.77e-01 3.12e-01 1.56e+00
go:0097193 intrinsic apoptotic signaling pathway 8.26e-04 3.56e-02 4.77e-01 3.44e-01 1.60e+00
go:0043407 negative regulation of MAP kinase activity 8.39e-04 3.56e-02 4.77e-01 5.79e-01 1.98e+00
go:0060968 regulation of gene silencing 9.04e-04 3.72e-02 4.77e-01 -4.21e-01 -1.74e+00
go:0097191 extrinsic apoptotic signaling pathway 9.03e-04 3.72e-02 4.77e-01 3.83e-01 1.69e+00
go:0043408 regulation of MAPK cascade 9.35e-04 3.80e-02 4.77e-01 3.05e-01 1.52e+00
go:0040011 locomotion 9.90e-04 3.95e-02 4.55e-01 2.55e-01 1.37e+00
go:1901700 response to oxygen-containing compound 9.84e-04 3.95e-02 4.55e-01 2.48e-01 1.34e+00
go:0098780 response to mitochondrial depolarisation 1.04e-03 4.10e-02 4.55e-01 -6.87e-01 -1.92e+00
go:0006900 vesicle budding from membrane 1.08e-03 4.22e-02 4.55e-01 4.32e-01 1.76e+00
go:1901655 cellular response to ketone 1.09e-03 4.22e-02 4.55e-01 5.26e-01 1.90e+00
reactome:R-HSA-500792 GPCR ligand binding 1.11e-03 4.26e-02 4.55e-01 5.08e-01 1.88e+00
go:0002687 positive regulation of leukocyte migration 1.13e-03 4.29e-02 4.55e-01 4.98e-01 1.86e+00
go:0002685 regulation of leukocyte migration 1.18e-03 4.38e-02 4.55e-01 4.56e-01 1.80e+00
go:0002688 regulation of leukocyte chemotaxis 1.22e-03 4.50e-02 4.55e-01 5.34e-01 1.92e+00
go:0001819 positive regulation of cytokine production 1.25e-03 4.51e-02 4.55e-01 3.54e-01 1.60e+00
go:0000226 microtubule cytoskeleton organization 1.25e-03 4.51e-02 4.55e-01 -2.99e-01 -1.46e+00
go:0070373 negative regulation of ERK1 and ERK2 cascade 1.32e-03 4.75e-02 4.55e-01 5.29e-01 1.84e+00
go:0033993 response to lipid 1.34e-03 4.76e-02 4.55e-01 2.85e-01 1.45e+00
go:0044450 1.37e-03 4.83e-02 4.55e-01 -4.02e-01 -1.68e+00
go:0046903 secretion 1.41e-03 4.92e-02 4.55e-01 2.46e-01 1.33e+00
go:0050684 regulation of mRNA processing 1.42e-03 4.92e-02 4.55e-01 -3.81e-01 -1.63e+00
go:0070972 protein localization to endoplasmic reticulum 1.50e-03 5.15e-02 4.55e-01 3.67e-01 1.64e+00
go:0002526 acute inflammatory response 1.56e-03 5.20e-02 4.55e-01 5.90e-01 1.95e+00
go:1903428 positive regulation of reactive oxygen species biosynthetic process 1.54e-03 5.20e-02 4.55e-01 6.58e-01 1.90e+00
go:0045087 innate immune response 1.55e-03 5.20e-02 4.55e-01 2.79e-01 1.42e+00
go:0034451 centriolar satellite 1.61e-03 5.32e-02 4.55e-01 -6.75e-01 -1.89e+00
go:0035295 tube development 1.66e-03 5.36e-02 4.55e-01 2.81e-01 1.43e+00
go:0010876 lipid localization 1.67e-03 5.36e-02 4.55e-01 3.70e-01 1.64e+00
go:0071622 regulation of granulocyte chemotaxis 1.67e-03 5.36e-02 4.55e-01 6.47e-01 1.92e+00
go:0023056 positive regulation of signaling 1.65e-03 5.36e-02 4.55e-01 2.44e-01 1.33e+00
go:0031401 positive regulation of protein modification process 1.80e-03 5.65e-02 4.55e-01 2.53e-01 1.33e+00
go:0031226 intrinsic component of plasma membrane 1.81e-03 5.65e-02 4.55e-01 2.83e-01 1.43e+00
go:0072599 establishment of protein localization to endoplasmic reticulum 1.88e-03 5.83e-02 4.55e-01 3.80e-01 1.65e+00
go:0050663 cytokine production 1.93e-03 5.94e-02 4.55e-01 4.70e-01 1.79e+00
go:0051247 positive regulation of protein metabolic process 1.95e-03 5.94e-02 4.55e-01 2.42e-01 1.32e+00
go:0005539 glycosaminoglycan binding 2.01e-03 6.05e-02 4.32e-01 4.55e-01 1.75e+00
go:0016050 vesicle organization 2.00e-03 6.05e-02 4.32e-01 3.29e-01 1.56e+00
msig:M5669 KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY 2.06e-03 6.15e-02 4.32e-01 5.10e-01 1.78e+00
go:2001236 regulation of extrinsic apoptotic signaling pathway 2.11e-03 6.16e-02 4.32e-01 4.13e-01 1.71e+00
go:1902883 negative regulation of response to oxidative stress 2.11e-03 6.16e-02 4.32e-01 5.77e-01 1.88e+00
go:0050920 regulation of chemotaxis 2.16e-03 6.25e-02 4.32e-01 4.45e-01 1.77e+00
go:2001233 regulation of apoptotic signaling pathway 2.19e-03 6.30e-02 4.32e-01 3.04e-01 1.48e+00
go:0002221 pattern recognition receptor signaling pathway 2.29e-03 6.45e-02 4.32e-01 4.32e-01 1.76e+00
go:0022602 ovulation cycle process 2.27e-03 6.45e-02 4.32e-01 6.63e-01 1.88e+00
go:1905954 positive regulation of lipid localization 2.30e-03 6.45e-02 4.32e-01 6.38e-01 1.90e+00
go:0070555 response to interleukin-1 2.31e-03 6.45e-02 4.32e-01 3.81e-01 1.65e+00
go:0002253 activation of immune response 2.43e-03 6.72e-02 4.32e-01 3.05e-01 1.50e+00
go:1900117 regulation of execution phase of apoptosis 2.51e-03 6.91e-02 4.32e-01 -6.19e-01 -1.84e+00
go:2001242 regulation of intrinsic apoptotic signaling pathway 2.56e-03 6.98e-02 4.32e-01 3.73e-01 1.61e+00
reactome:R-HSA-1474290 Collagen formation 2.58e-03 6.99e-02 4.32e-01 5.62e-01 1.88e+00
go:0007186 G protein-coupled receptor signaling pathway 2.68e-03 7.21e-02 4.32e-01 3.32e-01 1.54e+00
msig:M5953 HALLMARK_KRAS_SIGNALING_UP 2.70e-03 7.22e-02 4.32e-01 4.40e-01 1.74e+00
go:0002274 myeloid leukocyte activation 2.86e-03 7.54e-02 4.32e-01 2.77e-01 1.40e+00
go:0002764 immune response-regulating signaling pathway 2.89e-03 7.57e-02 4.32e-01 3.00e-01 1.47e+00
go:0043409 negative regulation of MAPK cascade 3.07e-03 7.98e-02 4.32e-01 4.06e-01 1.66e+00
go:0035924 cellular response to vascular endothelial growth factor stimulus 3.14e-03 8.07e-02 4.32e-01 6.27e-01 1.86e+00
go:1903034 regulation of response to wounding 3.16e-03 8.07e-02 4.32e-01 4.67e-01 1.75e+00
go:0001764 neuron migration 3.13e-03 8.07e-02 4.32e-01 -4.58e-01 -1.72e+00
go:0061180 mammary gland epithelium development 3.27e-03 8.30e-02 4.32e-01 5.71e-01 1.85e+00
go:0032612 interleukin-1 production 3.49e-03 8.77e-02 4.32e-01 5.64e-01 1.87e+00
go:0001649 osteoblast differentiation 3.54e-03 8.77e-02 4.32e-01 3.97e-01 1.66e+00
go:0048194 Golgi vesicle budding 3.52e-03 8.77e-02 4.32e-01 4.25e-01 1.66e+00
go:0015918 sterol transport 3.54e-03 8.77e-02 4.32e-01 5.18e-01 1.79e+00
go:0050776 regulation of immune response 3.57e-03 8.77e-02 4.32e-01 2.69e-01 1.38e+00
go:0005814 centriole 3.63e-03 8.86e-02 4.32e-01 -4.08e-01 -1.64e+00
msig:M16848 KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION 3.69e-03 8.94e-02 4.32e-01 4.87e-01 1.73e+00
go:0008201 heparin binding 3.70e-03 8.94e-02 4.32e-01 4.85e-01 1.80e+00
go:0051094 positive regulation of developmental process 3.90e-03 9.34e-02 4.32e-01 2.55e-01 1.34e+00
go:0005788 endoplasmic reticulum lumen 3.95e-03 9.40e-02 4.07e-01 3.61e-01 1.59e+00
reactome:R-HSA-204005 COPII-mediated vesicle transport 4.08e-03 9.66e-02 4.07e-01 4.72e-01 1.76e+00
msig:M5948 HALLMARK_BILE_ACID_METABOLISM 4.12e-03 9.69e-02 4.07e-01 4.80e-01 1.70e+00
go:0032611 interleukin-1 beta production 4.16e-03 9.74e-02 4.07e-01 6.01e-01 1.86e+00

Literature Mining

INDRA was used to automatically assemble known mechanisms related to TNFAIP3 from literature and knowledge bases. The first section shows only DUB activity and the second shows all other results.

Deubiquitinase Activity

psp cbn pc bel_lc signor biogrid tas hprd trrust ctd vhn pe drugbank omnipath conib crog dgi minerva creeds ubibrowser acsn | geneways tees gnbr semrep isi trips rlimsp medscan eidos sparser reach
TNFAIP3 deubiquitinates RIPK1. 5 / 5
1 | 4

reach
However, LMP1 is also known to upregulate TNFAIP3/A20 (TNFa-induced protein 3), which could deubiquitinate RIPK1 (98, 99) .

reach
TNFAIP3 causes inhibition of the canonical NF-kappaB pathway by deubiquitinating RIP1, thus abolishing the recruitment of the TAK1, TAK1 binding protein 2, and NEMO complex.

reach
However, LMP1 is also known to upregulate TNFAIP3/A20 (TNF-α-induced protein 3), which could deubiquitinate RIPK1 (98, 99).

reach
TNFAIP3 (A20) leads to the ubiquitination of TRAF6 and the deubiquitination of RIP to inhibit the activation of the NF-kappaB signaling pathway that is mediated by NOD1 and NOD2.

ubibrowser
The targets of A20-mediated deubiquitination are K63-linked ubiquitinated TRAF6 and RIP1
TNFAIP3 deubiquitinates OCLN. 4 / 4
1 | 3

reach
To determine whether TNFAIP3 can deubiquitinate occludin, we incubated recombinant N-terminal TNFAIP3 with ubiquitinated occludin in vitro.

ubibrowser
We also found that TNFAIP3 deubiquitinates polyubiquitinated occludin.

reach
Thus TNFAIP3 associates with occludin and can deubiquitinate occludin.

reach
We found that TNFAIP3 was able to decrease the total ubiquitination of occludin (XREF_FIG).
TNFAIP3 deubiquitinates RIPK1 on K377. 3 / 3
3 |

biopax:pid
No evidence text available

biopax:pid
No evidence text available

biopax:reactome
No evidence text available
TNFAIP3 deubiquitinates IKBKG. 2 / 2
1 | 1

reach
The overexpression of GIT2 enhanced the deubiquitination activity of TNFAIP3 toward IKBKG, and siRNA targeted at GIT2 abrogated the TNFAIP3 dependent deubiquitination of IKBKG and impaired the ability of TNFAIP3 to inhibit NF-kappaB activation (XREF_FIG).

ubibrowser
Review
TNFAIP3 deubiquitinates TRAF6. 2 / 2
1 1 |

ubibrowser
The targets of A20-mediated deubiquitination are K63-linked ubiquitinated TRAF6 and RIP1

signor
A20 is a deubiquitinating enzyme (dub) for lys63-linked polyubiquitinated signaling mediators such as traf6
TNFAIP3 deubiquitinates MAP3K5. 2 / 2
1 | 1

reach
In screening for proteins that interact with ASK1 in the context of NASH, we identified the deubiquitinase tumor necrosis factor alpha induced protein 3 (TNFAIP3) as a key endogenous suppressor of ASK1 activation, and we found that TNFAIP3 directly interacts with and deubiquitinates ASK1 in hepatocytes.

ubibrowser
we identified the deubiquitinase tumor necrosis factor alpha-induced protein 3 (TNFAIP3) as a key endogenous suppressor of ASK1 activation, and we found that TNFAIP3 directly interacts with and deubiquitinates ASK1 in hepatocytes.
TNFAIP3 deubiquitinates CALCOCO2. 1 / 1
1 |

ubibrowser
NDP52 itself has to be activated by the E3 ligase TRAF6 via the attachment of Lys63-linked polyubiquitin chains. A20 counteracts the function of NDP52 in order to prevent an overactivation.?
TNFAIP3 deubiquitinates BECN1. 1 / 1
1 |

ubibrowser
However, this TRAF6-dependent polyubiquitination of Beclin 1 is antagonized by the deubiquitinase A20
TNFAIP3 deubiquitinates NFKB1. 1 / 1
1 |

ubibrowser
Review
TNFAIP3 deubiquitinates TP53. 1 / 1
1 |

ubibrowser
Review
TNFAIP3 deubiquitinates RIPK2. 1 / 1
1 |

ubibrowser
Activation of RIPK2 depends on its K63 ubiquitination by E3 ligases, whereas the deubiquitinating enzyme A20 counter regulates RIPK2 activity by cleaving K63-polyubiquitin chains from RIPK2.
TNFAIP3 deubiquitinates IRF7. 1 / 1
1 |

ubibrowser
Thus, A20 negatively regulates LMP1-stimulated IRF7 ubiquitination and activity in EBV latency, and its DUB activity is indispensable for this function.
TNFAIP3 deubiquitinates CASP8. 1 / 1
1 |

ubibrowser
Apo2L induces both K48 and K63-linked polyubiquitination of caspase 8.
TNFAIP3 deubiquitinates RIPK2 on K209. 1 / 1
1 |

biopax:reactome
No evidence text available
TNFAIP3 deubiquitinates TRAF2. 1 / 1
1 |

ubibrowser
A tight control in TNF-a led NF-kB activation is exerted byA20 as it targets both RIP1 and TRAF2 through different mechanisms.
TNFAIP3 leads to the deubiquitination of Proteasome. 1 / 1
| 1

reach
TNFAIP3 and TAX1BP1 inhibit the inflammatory signaling pathway by interacting with Ubc13 and UbcH5c and triggering their ubiquitination and proteasome dependent degradation [XREF_BIBR].

Other Statements

psp cbn pc bel_lc signor biogrid tas hprd trrust ctd vhn pe drugbank omnipath conib crog dgi minerva creeds ubibrowser acsn | geneways tees gnbr semrep isi trips rlimsp medscan eidos sparser reach
TNFAIP3 affects NFkappaB
| 29 44 93
TNFAIP3 inhibits NFkappaB.
| 29 35 51
| 29 35 49

sparser
Itch was further shown to regulate the targeting of A20 to substrates, and A20 was unable to inhibit NF-κB in the absence of Itch ( xref ).

sparser
T cell co-stimulation with a 4-1BB agonist antibody triggers K63 ubiquitination of 4-1BB-associated TRAF2, which is crucial for NF-κB activation and induction of antitumor immunity. xref Conversely, the 4-1BB signaling is negatively regulated by two DUBs, CYLD and A20, which physically associate with the 4-1BB/TRAF2 complex. xref Overexpression of either CYLD or A20 inhibits NF-κB activation by the 4-1BB agonist antibody, whereas silencing these DUBs enhances NF-κB activation mediated by 4-1BB costimulation in human CD8 T cells. xref The role of K63 ubiquitination in 4-1BB-mediated CD8 T cell costimulation is further supported by the finding that CD8 effector and memory T cells expressing a dominant-negative mutant of the E3 ligase cIAP2 (cIAP2 H570A ) have attenuated 4-1BB signaling and impaired survival, demonstrated using a viral infection model. xref

sparser
It is likely that CYLD and A20 inhibit NF-κB at different times during an inflammatory response.

sparser
Since TNIP1 is a negative regulator of the NF-κB pathway, so when the TNIP1-TNFAIP3 complex inhibits NF-κB, anti-apoptotic genes are not activated by NF-κB and hence apoptosis happens.

eidos
TNFAIP3 inhibits NF-kappaB activation as well as TNFalpha-mediated apoptosis by binding to TRAF family adaptor proteins ( Heyninck et al ., 1999 ) .

sparser
A20 expression was regulated by NF-κB. In turn, increased A20 expression inhibited TRAF6 and NF-κB to reduce the subsequent inflammatory response.

reach
Some NF-kappaB pathway inhibitors are targeted by biallelic deletions (FAF1) [30] or inactivating alterations (deletion, mutation or hypermethylation) of TNFAIP3 (A20) [30,64].

eidos
Moreover , the negative feedback loop of suppressing NF-kappaB and associated inflammatory signaling by A20 is not functional in aged HSC .

reach
TNFAIP3 can inactivate a number of NF-kappaB signaling molecules, like receptor interacting protein 1/2 (RIP1/2), TRAFF6, and IKKgamma (NEMO).

reach
The results indicate that miR-98-5p interference and 3beta-hydroxycholest-5-en-7-one treatment significantly upregulated the low TNFAIP3 expression induced by LPS stimulation, thereby inhibiting TRAF6, RIP, NF-kappaB, IL-1beta, and TNF-alpha secretion.
TNFAIP3 bound to DEPDC1 and ZNF224 inhibits NFkappaB. 1 / 1
| 1

reach
In the present study, it was determined that the DEPDC1 and ZNF224 complex suppresses A20 expression and thus activates the NF-kappaB signaling pathway, eventually resulting in the inhibition of apoptosis in HepG2 cells.
Mutated TNFAIP3 inhibits NFkappaB. 1 / 1
| 1

reach
Also, loss of function mutations of TNFAIP3 (A20), a negative regulator of NF-kappaB, contributes to NF-kappaB pro survival signaling in ABC-DLBCL tumors [XREF_BIBR, XREF_BIBR].
TNFAIP3 activates NFkappaB.
| 9 40
| 9 39

reach
Accordingly, overexpression of a miR-29b-refractory isoform of TNFAIP3 restored NF-kappaB and extrinsic apoptosis, confirming that TNFAIP3 is a functionally relevant target of miR-29b.

reach
Consistent with our findings in the gut derived lethal infection model, i.p. injection of the PC resulted in downregulation of IRF3 and the upregulation of NF-kB Inhibitor Alpha (NFKBIA), NF-kB Inhibitor Beta (NFKBIB), and TNF Alpha Induced Protein 3 (TNFAIP3), known NF-kappaB pathway inhibitors XREF_BIBR, XREF_BIBR, in the cecum, liver, and spleen, 20h post PC injection in AC-FMT mice.

reach
Up-regulation of the inhibitor of NF-kappaB activation TNFAIP3, also known as A20, in the DM samples, along with its binding partner, TNFAIP3 interacting protein 1 (TNIP1), and RELA suggests a potenti[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

sparser
The C-terminal region (containing the functional zinc finger structures) mediates A20 dimerization and binding to several other proteins that might be involved in the inhibition of NF-kB activation and apoptosis by A20 [ xref ].

reach
Accordingly, overexpression of an miR-29b-refractory isoform of TNFAIP3 restored NF-kappaB and extrinsic apoptosis, confirming that TNFAIP3 is a functionally relevant target of miR-29b.

reach
For example, TNFAIP3 is a transcriptional target of NF-kappaB, serves as a " global " feedback regulator to attenuate NF-kappaB activity by inactivation of NEMO, TRAF6, and RIP1, thus negatively regul[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Conclusion : Down-regulated MiR-128-3p significantly suppressed the inflammation response of RA through suppressing the activity of NF-kappaB pathway, which was mediated by TNFAIP3.

reach
Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma.

reach
By targeting TNFAIP3, miR-125a/b directly inhibits the expression level of TNFAIP3, and induces NF-kappaB activity, which leads to increased aggressiveness in both cell line assays and in primary tumors [XREF_BIBR].

reach
Tnfaip3 OTU and OTU and Tnfaip3 ZF4 and ZF4 cells produced less of the NF-kappaB dependent mRNAs IL-6 and cellular inhibitor of apoptosis protein 2 (cIAP2), and exhibited less NF-kappaB signaling than Tnfaip3 -/- cells, suggesting that neither A20 's C103 motif nor its ZF4 motif are singly responsible for all of A20 's functions during TNF signaling (XREF_SUPPLEMENTARY).
Mutated TNFAIP3 activates NFkappaB. 1 / 1
| 1

reach
TNFAIP3 mutations likely contribute to lymphomagenesis by inducing unregulated prolonged NF-kappaB responses.
TNFAIP3 increases the amount of NFkappaB.
| 1
TNFAIP3 increases the amount of NFkappaB. 1 / 1
| 1

reach
For example, in C. concisus infected cells the protein coding gene TNFAIP3 (which was upregulated 25.7-fold by the infection) adjacent to regulated lncRNAs was shown to inhibit TNF- and IL1 induced NFkappaB gene expression.
TNFAIP3 decreases the amount of NFkappaB.
| 1
TNFAIP3 decreases the amount of NFkappaB. 1 / 1
| 1

reach
TNFAIP3, an important anti-inflammatory factor, can repress the expression of inflammatory NF-kappaB signaling and promote cell survival.
| PMC
TNF affects TNFAIP3
| 1 6 53
TNF activates TNFAIP3.
| 1 5 41
TNF activates TNFAIP3. 10 / 53
| 1 5 40

reach
Two targets of miR-21 : Interleukin I Beta (IL1beta) and tumor necrosis factor, alpha induced protein 3 (TNFAIP3), which is rapidly induced by the TNF were assayed by RT-qPCR on mRNA in another APP infection study in pigs [XREF_BIBR].

reach
In addition, reduced expression was also evident for two IL17 target genes in vertebrates : tumor necrosis factor alpha induced protein 3 (tnfaip3; also known as A20), which encodes a ubiquitin editing enzyme that inhibits NF-kappaB activation, and NF-kappaB inhibitor zeta (nfkbiz), an IL17 target gene in vertebrates that also regulates NF-kappaB activity.

reach
We also found that A20 (also known as tumor necrosis factor alpha induced protein 3, or TNFAIP3) protected against CVB3 induced myocarditis by inhibiting inflammatory response.

reach
TNFalpha induced protein-3 (TNFAIP3; also known as A20) is a ubiquitin editing enzyme that acts as a negative regulator of NFkappaB.

reach
Expression of TNFAIP3 is increased in PBMC from rheumatoid arthritis (RA) patients, consistent with findings that TNFAIP3 is rapidly induced by TNF, the expression of which is known to be markedly elevated in active RA patients.

reach
It was shown that TNFAIP3 is induced by TNF and IL-1 and might therefore be involved in the regulation of NFkappaB dependent genes in diverse bacterial infections.

sparser
On the other hand, both untreated (basal level) and TNF-induced activation of the A20 promoter were severely compromised in E1A/Ras MEFs ( xref ).

reach
Aberrations in TNF signaling were apparent with upregulation of both TNF and TNF receptor superfamily members but universal downregulation of IRF8 bound TNF induced TNFAIP3, a negative regulator of cytokine mediated immune and inflammatory responses.

reach
As expected, TNFalpha treatment rapidly induced NF-kappaB activation, reflected by robust expression of NFKBIA (encoding IkappaBalpha) and TNFAIP3 (XREF_SUPPLEMENTARY), two direct downstream targets of NF-kappaB.

reach
To test this hypothesis, we targeted A20 (tumor necrosis factor alpha induced protein 3 [TNFAIP3]), an anti-inflammatory molecule and primary negative regulator of NF-kappaB activity.
TNF bound to IRF8 activates TNFAIP3. 1 / 1
| 1

reach
Aberrations in TNF signaling were apparent with upregulation of both TNF and TNF receptor superfamily members but universal downregulation of IRF8 bound TNF induced TNFAIP3, a negative regulator of cytokine mediated immune and inflammatory responses.
TNF increases the amount of TNFAIP3.
| 1 10
TNF increases the amount of TNFAIP3. 10 / 16
| 1 10

reach
Thirty‐eight genes involved in the defense response to virus, including bone marrow stromal antigen (BST2)/tetherin and MX Dynamin Like GTPase 2/myxovirus resistance protein 2 (MX2) and tumor necrosis factor‐alpha‐induced protein 3 (TNFAIP3) were overexpressed in VKC (Table 1 and Figure 1).

reach
TNF induces TNFAIP3 expression in all tissues including mouse and human intestinal epithelial cells XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR.

reach
The expression of TNFAIP3 is induced by TNF and is involved in the signaling pathway by GPCR.

reach
These results suggest that TNF induces the expression of NFKBIA and TNFAIP3 independently of c-Rel in Jurkat T cells or that the induction of these genes in response to TNF is mediated by c-Rel that is not GlcNAcylated.

reach
To our knowledge, our study indicates for the first time the up-regulation of TNFAIP3 and A20 gene expression by TNF-alpha through NF-kappaB.

reach
In primary human airway smooth muscle cells, TNFAIP3 expression was induced by TNF.

reach
To confirm our speculation, we pre-treated the BMDMs with TNFalpha, which could increase the levels of endogenous A20 and TNFAIP3.

sparser
As biphasic necroptosis kinetics had indicated that the RelA‐dependent survival mechanism only protected a fraction of cells from premature necroptosis, we asked whether cell‐to‐cell heterogeneity in TNF‐induced A20 expression may be responsible.

reach
TNFalpha increased the expression of IL6, ICAM1, and TNFAIP3 in both cell lines (XREF_FIG).

reach
Additionally, GFPT2 expression was not required for TNF induced BIRC3 and cIAP -2 and TNFAIP3 and A20 mRNA expression, indicating that GFPT2 was not required to potentiate NF-kappaB transcription (Additional file 1 : Figure S4B).
TNF inhibits TNFAIP3.
| 2
TNF inhibits TNFAIP3. 2 / 2
| 2

reach
Homozygous deletions of the chromosomal band 6q23, involving the tumor necrosis factor alpha induced protein 3 (TNFAIP3, A20) gene, a negative regulator of NF-kappa B, had already been described in ocular adnexal MZL.

reach
TNF stimulation of Rela +/- splenocytes resulted in significantly impaired up-regulation of Il6, Tnfaip3, and Traf1; all which depend on NF-kappaB activation (XREF_FIG).
| 4 17 28
| 2 17 10
| 2 17 10

sparser
TNF alpha induced protein 3 (TNFAIP3, A20) is a tumor enhancer in glioma [ xref ] and inhibits apoptosis in glioblastoma [ xref ].

sparser
A20 inhibits TNF-induced apoptosis in fibroblasts, blocks necroptosis in fibroblasts and T cells, and paradoxically promotes Fas-dependent death in activated B cells ( xref ; xref ; xref ).

eidos
One critical finding from this study is that A20 not only completely blocked the transcription of other NF-kappaB target genes known to antagonize JNK signaling , but also effectively suppressed TNF-induced JNK activation and apoptotic cell death in NF-kappaB activation-deficient MEFs ( Figure 2 ) .

reach
Consistently, IEC specific deletion of TNFAIP3 (encoding A20), a gene mutated in Crohn 's disease that encodes an E3 ligase editing enzyme involved in dampening NF-kappaB signaling and TNF induced apoptosis, leads to massive IEC apoptosis and increased susceptibility to experimental colitis.

reach
In contrast, ATRA induces the expression of BIRC3 and TNFAIP3, which inhibit Fas and TNFalpha mediated apoptosis signaling pathway by the interaction with TRAF2, and thus may prevent apoptosis.

reach
We found that overexpression of miR-19b-3p or knockout of TNFAIP3 decreased apoptosis rates of NPC cell lines after irradiation.

sparser
In contrast, A20 inhibits apoptosis, at least partially, by binding to TXBP151, which inhibits TNF-α-induced apoptosis.

sparser
A20 can inhibit TNF-induced apoptosis in many cell types.

sparser
In pancreatic islets, A20 inhibited both apoptosis and NF-κB activation induced by cytokines, suggesting that NF-κB may actually mediate apoptosis [58] .

eidos
Additionally , the same group has reported that TNFAIP3 can endogenously suppress ASK1 and reduce apoptosis , lipid accumulation , and inflammation [ 116 ] .
| 2 18

reach
However, it is unclear how the transfected TNFAIP3 triggers apoptosis in the lymphoma cells.

reach
The deletions or mutations of TNFAIP3 are found in about 30% of patients with diffuse large B-cell lymphoma, while reinforced TNFAIP3 induces apoptosis and cell growth arrest XREF_BIBR, suggesting TNFAIP3 is a tumor suppressor.

reach
Moreover, TNFAIP3 induces cell growth arrest and apoptosis, accompanied by down-regulation of nuclear factor-kappa B (NF-kB) activation [XREF_BIBR, XREF_BIBR].

reach
In KRAS (G12V)-transduced bronchial epithelial (BEAS-2B) cells, introduction of anti-miR-29b constructs increased the sensitivity to apoptosis by targeting TNFAIP3 and A20, a negative regulator of nuclear factor (NF)-kappaB signaling.

reach
Results demonstrated that TNFAIP3 knockdown contributed to the proliferation, migration, invasion, and inflammation and suppressed the apoptosis in HAND2-AS1-overexpressed MH7A cells.

reach
TNFAIP3 and A20 as a Gateway Gene to Drug Induced Extrinsic Apoptosis.

reach
miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus related hepatocellular carcinoma.

reach
TNFAIP3, that was found to be up-regulated by TRAIL in our study, is an inhibitor of the NFKB pathway [XREF_BIBR] and may thereby promote apoptosis but, on the other hand, it was shown to decrease TNF mediated apoptosis and necrosis [XREF_BIBR], leaving its specific influence unclear.

reach
In addition, exosomes generated from lipopolysaccharide (LPS)-activated microglia promote neuron apoptosis, which can reversed by the knockdown of TNF inducible protein 3 (TNFAIP3) [XREF_BIBR].

reach
Accordingly, overexpression of a miR-29b-refractory isoform of TNFAIP3 restored NF-kappaB and extrinsic apoptosis, confirming that TNFAIP3 is a functionally relevant target of miR-29b.
| 9 5 20
| 6 5 15

eidos
Numerous researchers have identified that A20 is a susceptibility gene for inflammatory diseases , and that A20 inhibits inflammation by regulating the NF-kappaB pathway.17-21 Interestingly , when NF-kappaB translocates into the nucleus and binds to the kappaB binding site in the A20 gene promoter structure , it can promote the expression of the A20 gene , and A20 acts as an ubiquitinating enzyme to modify the upstream molecules of the NF-kappaB pathway , leading to a negative feedback loop between A20 and the NF-kappaB .

eidos
Similarly , deficiency in CYLD or A20 , a master regulator of NFkappaB , lead to overt pathway activation and inflammation ( 132 ) .

sparser
Taken together, A20 inhibited FFAs-induced inflammatory response via attenuating NF-κB activation in four cell lines we generated.

reach
axis likely plays a role in SARS-CoV-2 infection as well, with TNFAIP3 inhibiting NF-κB-mediated antiviral responses at the site of local infection yet promoting a systemic inflammatory response in the periphery.
| DOI

reach
TNFAIP3 is primarily responsible for attenuation of NFkappaB signaling and thereby inhibits inflammation and tumorigenesis and TNF mediated mediated apoptosis [XREF_BIBR].

eidos
Results demonstrated that TNFAIP3 knockdown contributed to the proliferation ( Fig. 5b ) , migration ( Fig. 5d ) , invasion ( Fig. 5e ) , and inflammation ( Fig. 5f ) and suppressed the apoptosis ( Fig. 5c ) in HAND2-AS1-overexpressed MH7A cells .

reach
Additionally, the same group has reported that TNFAIP3 can endogenously suppress ASK1 and reduce apoptosis, lipid accumulation, and inflammation [XREF_BIBR].

eidos
One mechanism by which A20 inhibits inflammation is through negative regulation of NLRP3 and caspase-1 activation , suppressing interleukin production and pyroptosis ( 167 , 168 ) .

reach
Tnfaip3 expression is necessary for prevention of chronic inflammation and autoimmune pathology according to studies on mice with full or conditional gene deletion [XREF_BIBR].

reach
A variant of TNFAIP 3, which encodes an ubiquitin editing enzyme inhibiting NF-kappaB-dependent signaling and prevents inflammation, and polymorphic haplotypes of the human T-lymphotropic virus-1-related endogenous sequence (HRES) 1 long terminal repeat (LTR) have been associated with SLE [XREF_BIBR, XREF_BIBR].
TNFAIP3 bound to TNIP1 inhibits inflammatory response. 1 / 1
| 1

reach
XREF_BIBR TNIP1 may interact with TNFAIP3 and inhibit TNFalpha induced NFkappaB inflammation pathway.
| PMC
| 3 5

reach
These findings show that neutrophilic airway inflammation induced by activated TNFAIP3 and A20 deficient myeloid cells can develop in the absence of IL-17RA-signalling.

eidos
353 [ 4 ] Hsu ACY , Dua K , Starkey MR , Haw TJ , Nair PM , Nichol K , et al. MicroRNA-125a 354 and - b inhibit A20 and MAVS to promote inflammation and impair antiviral response 355 in COPD .
| PMC

reach
Hepatocyte specific ablation of Tnfaip3 exacerbated nonalcoholic fatty liver disease- and NASH related phenotypes in mice, including glucose metabolism disorders, lipid accumulation and enhanced inflammation, in an ASK1 dependent manner.

eidos
3beta-Hydroxycholest-5-en-7-one alleviates inflammation by downregulating miR-98-5p and upregulating TNFAIP3 , thereby blocking NF-kappaB pathway activation .

eidos
According with this view , we can assume that the A20 upregulation observed in sciatic nerve of 4 months old SOD1-G93A mice can be ascribed to an activation of the non-canonical pathway , fitting with the idea that A20 ( 62 ) , when aberrantly activated , in different cell types , can promote autoimmunity and inflammation .

reach
Cluster 2 contained IL8, IL1A, PTGS2, DTR, TNFAIP3, and CXCL3 that were up-regulated and linked primarily to inflammatory response and cell proliferation.

reach
Tnfaip3 -/- Myd88 -/- double-mutant mice are rescued from lethal inflammation, suggesting that TLR signals drive the spontaneous inflammation in the absence of A20 [XREF_BIBR].

reach
Taken together, decreased expression of TNFAIP3 and its partners contribute to inflammation and up-regulation of apoptosis inhibitors that may create microenvironment for colorectal cancer.
NFkappaB affects TNFAIP3
| 1 12 22
NFkappaB activates TNFAIP3.
| 1 10 15
| 1 10 15

reach
TNFAIP3 (also known as A20) expression is up-regulated by NF-kB activation, as confirmed in our study, and it acts in a negative feedback loop to control NF-kB-dependent gene expression.

sparser
A20 is a protein with dual enzymatic activity (DUB/E3 ligase) encoded by the NF-kB induced gene TNF alpha induced protein 3 (TNFAIP3). xref A20 stops NF-κB activation by (1) deubiquitinating RIPK-1 and (2) polyubiquitinating RIP-1 to target it for degradation (proteolysis).

reach
A co-occupied intronic TNFAIP3 regulatory element mediated cooperative enhancement of transcription by GR and NF-kappaB that required the presence of a functional GR binding site (GBS).

reach
As A20 ZF4 proteins are recruited poorly to TNFR signaling complexes, the presence of normal NF-kappaB signaling in Tnfaip3 OTU and ZF4 cells also raises the interesting possibility that A20 OTU proteins may dimerize with A20 ZF4 proteins and recruit the latter to TNFR signaling complexes in Tnfaip3 OTU and ZF4 cells.

sparser
Overexpression of A20 resulted in suppression of cytokine-triggered NF-kappaB activation and knockdown of A20 by RNA interference significantly attenuated induction of anergy by ER stress.

reach
XREF_BIBR, XREF_BIBR Both miR-125b 37 and TNFAIP3 38 are induced by NF-kappaB activity.

reach
Thus, we suggest the ability of COUP-TFII to inhibit NFkappaB stimulated TNFAIP3 may play a role in the observed ability of COUP-TFII to resensitize LCC9 cells to 4-OHT.

eidos
In addition , Kadiyala et al. reported that GR and NF-kappaB cooperatively bound to the enhancer of the A20 locus and induced A20 expression ( 35 ) .
| PMC

reach
Tnfaip3 is induced by NF-kappaB signaling as an early response gene and encodes the A20 protein, a ubiquitin modifier that inhibits formation of linear and K63 linked ubiquitin chains on key proteins in the NF-kappaB signaling pathway to provide a negative feedback that terminates further activation of NF-kappaB.

sparser
TCR specific signalling protein MALT1 (through the CARD11-BCL10-MALT1 complex) was recently reported to be required for optimal NF-κB activation through proteolysis of the NF-κB inhibitor TNFAIP3 [ xref , xref ].
NFkappaB increases the amount of TNFAIP3.
| 5
NFkappaB increases the amount of TNFAIP3. 5 / 5
| 5

reach
TNFAIP3 expression is induced by NFkappaB 31.

reach
NF-kappaB signaling also induces TNFAIP3 expression, thus providing a further feedback loop that modifies inflammation.

reach
NF-kappaB signaling induces transcription of the TNFAIP3 gene, encoding a ubiquitin modifying enzyme (also known as A20) that negatively regulates the NF-kappaB signaling pathway [XREF_BIBR - XREF_BIBR].

reach
In our work, we found that NF-kappaB induced the expression of CXCL1, ICAM1 and TNFAIP3 after doxorubicin treatment only in a subset of tumors, suggesting that differences in responses may exist among tumor subtypes.

reach
Furthermore, persistent endothelial NF-kappaB activation by vFLIP induces expression of the NF-kappaB regulator A20 and TNFAIP3, which represses vFLIP induced NF-kappaB activation and augments IKK1 protein expression [XREF_BIBR].
NFkappaB decreases the amount of TNFAIP3.
| 2
NFkappaB decreases the amount of TNFAIP3. 2 / 3
| 2

reach
This inhibition led to downregulation of TNFalpha induced NFkappaB target gene expression of IL6, ICAM1, and TNFAIP3, which had reduced basal and/or TNFalpha induced expression upon COUP-TFII overexpression.

reach
These results suggested that SFE suppressed ESCC progression through inactivating the NFkappaB pathway which lowered TNFAIP3 and PLAU expression.
NFkappaB inhibits TNFAIP3.
| 2
| 2

sparser
Numerous lines of evidence, from human disease linkage analyses to mouse experimental models, attest to critical roles for the NFκB inhibiting partner proteins A20 and ABIN1 in systemic and cutaneous inflammatory disease.

sparser
Moreover, Tax requires CADM1 for its K63-linked polyubiquitination, NF-κB activation, and inactivation of the NF-κB negative regulatory A20 complex.
| 5 26 1
TNFAIP3 inhibits IKK_complex.
| 5 25 1
| 5 25 1

eidos
TNF-induced expression of IkappaB attenuates NFkappaB , whereas A20 inhibits IKK and RIPK3 .

sparser
Our results suggest a non-catalytic mechanism of IKK inhibition by A20 and a means by which polyubiquitin chains can specify a signaling outcome.

sparser
These results provide direct evidence that A20 inhibits IKK by preventing the phosphorylation of IKK by TAK1.

sparser
It has been found that A20 inhibits the IKK complex by non-catalytic functions, mediated by recruitment of A20 to the C-terminal domain of IKKα [31,32] .

reach
In addition to TNFAIP3 modulating ubiquitin others have found that TNFAIP3 can also inhibit IKK complex activity through a mechanism that is independent of ubiquitin.

sparser
The model simulations ( xref ) confirmed the experimental findings that RC3H1 reduces A20 mRNA and subsequently A20 protein expression, and, due to the attenuated IKK inhibition by A20, leads to an increased IKK activity.

sparser
Indeed, we present multiple lines of evidence that A20 inhibits IKK through a non-catalytic mechanism.

sparser
However, direct evidence of IKK inhibition by A20 is lacking, and the inhibitory mechanism remains poorly understood.

sparser
We found evidence that A20 can inhibit IKK through a mechanism that cannot be accounted for by reducing the interaction of polyubiquitin chains with NEMO.

sparser
A20 inhibition of IKK was dependent on A20 binding to NEMO which was induced by K63-linked polyubiquitin chains. xref The binding of A20 with NEMO occurred rapidly upon IL-1 stimulation (2–5 min) in HeLa cells. xref Therefore, the polyubiquitin chains that serve to activate IKK also serve a dual function in its negative regulation by the recruitment of A20 to NEMO.
TNFAIP3 activates IKK_complex.
| 1
| 1

sparser
Direct, Non-Catalytic Impairment of IKK Activation by A20.
TNFAIP3 affects TNF
| 1 5 19
TNFAIP3 inhibits TNF.
| 1 5 10
| 1 5 10

reach
The results indicate that miR-98-5p interference and 3beta-hydroxycholest-5-en-7-one treatment significantly upregulated the low TNFAIP3 expression induced by LPS stimulation, thereby inhibiting TRAF6, RIP, NF-kappaB, IL-1beta, and TNF-alpha secretion.

reach
The feedback regulator TNFAIP3 (A20) which negatively regulates TNF-alpha and IL-1beta signalling is up-regulated in two datasets and is down-regulated in one dataset.

reach
Thus, the heterologous expression of TNFAIP3 in IECs can prevent TNF induced decreases in barrier function in these cells.

sparser
Recently, it has been shown by gene knock-out studies that A20, a protein interacting with IKKγ, can also specifically inhibit TNF- but not IL-1-induced NF-κB activation [34] .

eidos
While A20 restricts TNF signaling in vitro , elimination of TNF does not prevent spontaneous disease in A20 - / - mice or A20Flox LysM-Cre mice 10 , 34 .

sparser
We thus propose a model in which A20 inhibits TNF- and LUBAC-induced NF-κB signalling by binding to linear polyubiquitin chains via its seventh zinc finger, which prevents the TNF-induced interaction between LUBAC and NEMO.

sparser
A20 also inhibits TNF and IL-1 induced activation of NF-κB, suggesting that it may act as a general inhibitor of NF-κB activation xref – xref .

reach
For example, the expression of tumor necrosis factor-alpha inducing protein (TNFAIP3) that inhibits NF-kappaB activation and negatively regulates TNF-alpha signaling exhibited individual variability among our human donors.

reach
TNFAIP3 also perturbs caspase activation of TNF receptor 1 (TNFR1) which is coupled to apoptotic caspases 8 and 10 [XREF_BIBR, XREF_BIBR].

sparser
Furthermore, A20 inhibits TNF- and IL-1-induced NF-κB activation in 293 cells [ xref ], and deregulated Toll-like receptor signaling in response to commensal bacteria was shown to be responsible for the multiorgan inflammation and premature death of A20-knockout mice [ xref ].
TNFAIP3 activates TNF.
| 6
TNFAIP3 activates TNF. 6 / 6
| 6

reach
TNFAIP3 protein as a zinc finger protein and ubiquitin shearing enzyme can suppress activated NF-kappaB signal pathway and induce apoptosis of TNF by activating ubiquitin ligase and ubiquitinase.

reach
TNFAIP3, a negative regulator of inflammation that inhibits NF-kB (nuclear factor kappa-B) and TNF (tumor necrosis factor)-mediated pathways, has been linked to several immune mediated diseases like T1D, systemic lupus erythematosus, and rheumatoid arthritis [XREF_BIBR, XREF_BIBR].

reach
It has not been determined whether TNFAIP3 -/- mucosal immune cells cause decreased IEC barrier function, but TNFAIP3 -/- immune cells produce higher amounts of TNF XREF_BIBR.

reach
In addition to IFN pathway genes, the higher anti-viral activity of hub genes related to TNF signaling and NAD metabolisms such as TNFAIP3, PARP9, and DTX3L would be able to characterize patients with a high viral load, indicating a clear association of their expression to the presence of the virus and the phase of the disease.

reach
The negative expression of TNFAIP3 inhibits TNF, and the unspecified expression of TNFAIP3 affects the catalysis of TNF.

reach
This inhibition led to downregulation of TNFalpha induced NFkappaB target gene expression of IL6, ICAM1, and TNFAIP3, which had reduced basal and/or TNFalpha induced expression upon COUP-TFII overexpression.
TNFAIP3 increases the amount of TNF.
| 1
TNFAIP3 increases the amount of TNF. 1 / 2
| 1

reach
Although dexamethasone mediated activation of the glucocorticoid receptor (GR) potently repressed expression of IL1beta, IL8, and several other pro inflammatory TNF targets, the expression of anti-inflammatory TNF targets such as TNFAIP3 (A20) and NFKBIA was selectively spared or augmented by dexamethasone treatment.
TNFAIP3 decreases the amount of TNF.
| 2
TNFAIP3 decreases the amount of TNF. 2 / 2
| 2

reach
TNFAIP3 knockdown enhanced TNF expression in the presence of TNF, TNF plus budesonide, and TNF plus budesonide-formoterol combination and confirms feedback inhibition.

reach
The finding does not preclude the observation increased TNF-α signaling in the bloodstream of severe patients [33] , as TNFAIP3 depletion has been shown to cause increased TNF-α expression [56] .
| DOI

reach
In addition, TNFAIP3 re-expression can inhibit proliferation, decrease expression of target genes in NF-kappaB signaling pathway, increase cytotoxicity and induce apoptosis in cells lacking TNFAIP3.

sparser
However, there are no reports on whether A20 can inhibit vascular smooth muscle cell proliferation in vivo.

eidos
A20 Like CYLD , A20 suppresses cell proliferation and promotes apoptosis as a negative regulator of the NF-kappaB pathway , and it is well known to play an important role in inflammation and immunity ( Dixit et al. 1990 ; Hoesel and Schmid 2013 ) .

reach
The phenotype of this patient characterized by autoinflammation might be explained by increased cell proliferation and cell death caused by reduced TNFAIP3 (A20) expression.

sparser
With a combination of loss-of-function and gain-of-function approaches, we further showed that A20 inhibited NPC cell proliferation, induced NPC cell apoptosis, and reduced the growth of NPC xenograft tumors.

sparser
A20 inhibits SMC proliferation via increased expression of cyclin-dependent kinase inhibitors p21waf1 and p27kip1.

sparser
Here, we report that miR-125b is upregulated, whereas A20 is downregulated in NPC tissues relative to normal nasopharyngeal mucosa (NNM); miR-125b promotes NPC cell proliferation and inhibits NPC cell apoptosis by targeting A20/NF-κB signaling pathway; A20 inhibits NPC cell proliferation, induces NPC cell apoptosis, and reduces the growth of NPC xenograft tumors.

reach
Results demonstrated that TNFAIP3 knockdown contributed to the proliferation, migration, invasion, and inflammation and suppressed the apoptosis in HAND2-AS1-overexpressed MH7A cells.

reach
Importantly, TNFAIP3 knockout not only inhibited the AP20187 induced proliferation and tumor growth of DCIS-iFGFR1 cells, but also further reduced baseline proliferation and tumor growth of DCIS-iFGFR1 cells without AP20187 treatment.

sparser
A20 could also promote liver regeneration [ xref ] and inhibit HCC proliferation, metastasis and microvascular invasions [ xref , xref ].

reach
Importantly, TNFAIP3 knockout not only inhibited the AP20187 induced proliferation and tumor growth of DCIS-iFGFR1 cells, but also further reduced baseline proliferation and tumor growth of DCIS-iFGFR1 cells without AP20187 treatment.

reach
However, when overexpressing TNFAIP3 and PLAU or upon activation of the NFkappaB pathway, all the inhibitory effects of SFE were reversed (XREF_FIG A-D), suggesting that SFE blocked the p65 promotion of TNFAIP3 and PLAU expression to inhibit ESCC cell proliferation and metastasis.

reach
Both Emu- BCL10 and Emu- API2-MALT1 mice develop splenic marginal zone hyperplasia but not lymphoma [86,113], while TNFAIP3 (A20) deficiency in B-cells enhances B-cell proliferation with an excessive [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus related hepatocellular carcinoma.

reach
TNFAIP3 deficient B-cells are hyper-reactive to antigen stimulation, leading to enhanced proliferation and survival.

reach
Cluster 2 contained IL8, IL1A, PTGS2, DTR, TNFAIP3, and CXCL3 that were up-regulated and linked primarily to inflammatory response and cell proliferation.

reach
In addition, the knockdown of TNFAIP3 restores the significant decrease in invasion and proliferation in miR-605-5p-inhibitor-transfected lung cancer cells.
11 | 11
Lipopolysaccharide increases the amount of TNFAIP3.
8 | 5
Lipopolysaccharide increases the amount of TNFAIP3. 10 / 13
8 | 5

ctd
No evidence text available

reach
In the TREM2 + ScMglia population, expression of IL-1beta, CCL2, and TNFAIP3 were all significantly induced by LPS stimulation compared with untreated controls (XREF_FIG).

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

reach
We have proposed a working model based on these results (XREF_FIG) and suggest that Tnfaip3 might be expressed through transcriptional regulation of both p65 and the p38-downstream transcription factor C/EBPbeta in response to LPS.

reach
In this study, LJF significantly inhibited the LPS stimulated downregulation of CXCL2, CXCL1, CXCL6, NFKBIA, IFNG, IL6, IL17A, IL17F, IL17C, MMP9, and TNFAIP3 mRNA expression in lung tissue homogenates according to RNA-Seq and qRT-PCR, which indicates that the IL-17 signalling pathway is critical for treatment by LJF of LPS induced ALI.
| PMC

reach
The results indicate that miR-98-5p interference and 3beta-hydroxycholest-5-en-7-one treatment significantly upregulated the low TNFAIP3 expression induced by LPS stimulation, thereby inhibiting TRAF6, RIP, NF-kappaB, IL-1beta, and TNF-alpha secretion.

ctd
No evidence text available

reach
Ex vivo farm dust or LPS stimulation restored TNFAIP3 expression to healthy levels in asthmatics and shifted NF-kappaB signaling associated gene expression towards an anti-inflammatory state (p < 0.001).
1 | 6

reach
The LPS induced immune markers, specifically TLR4, TNF alpha induced protein 3 (TNFAIP3) and interleukin-1 receptor associated kinase like 2 (IRAK2), were identified among the strongest variables of the PC1, along with the increase in expression of genes related to mitochondrial metabolism (e.g. NADH dehydrogenase (ubiquinone) 1 beta sub-complex 5; NDUFB5).

reach
While LPS upregulated both IL-12p40 and TNFAIP3 and A20 production, adding DEHP to cultures dramatically reduced IL-12p40 and TNFAIP3 and A20 levels.

reach
We thus utilized anti-G-G antibody assisted mass spectrometry to find potential ubiquitinated IL-1beta peptides from LPS stimulated Tnfaip3 -/- BMDMs.

reach
To test whether Tnfaip3 -/- cells might release such ligands, we stimulated LPS primed control BMDMs with supernatants from LPS stimulated Tnfaip3 -/- cells and assayed for additional IL-1beta production by control cells.

reach
These results showed that TNFAIP3 induced by LPS is insufficient for persistently inflammatory stimulation, and TNFAIP3 may be important for the metabolism in nucleus pulposus cells, providing a new research idea for the treatment and prevention of degenerative diseases.

ctd
No evidence text available

reach
Secondly, in parallel to what was observed in cambinol treated cells, we also observed a significant upregulation of such LPS induced genes as ADORA2A, RUNX3, TNFAIP3 and SLC1A2 in MACs treated with DAC following LPS stimulation.
Lipopolysaccharide decreases the amount of TNFAIP3.
2 |
Lipopolysaccharide decreases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
TNFAIP3 affects autophagy
| 1 1 15
TNFAIP3 activates autophagy.
| 1 12
| 1 12

reach
TNFAIP3 and DEPTOR together rapidly promoted autophagy after LPS treatment to prevent NLRP3 inflammasome formation.

reach
TNFAIP3 promotes autophagy in LPS stimulated human NPCs.

reach
The above results suggested that TNFAIP3 induces autophagy through inhibiting mTOR signaling.

reach
It has been reported that Zinc finger protein A20 and TNFAIP3 (A20) can inhibit the activity of the NF-kappaB pathway and promote autophagy.

reach
TNFAIP3 promotes autophagy by inhibiting mTOR signaling in inflammatory human NPCs.

reach
These results demonstrated that TNFAIP3 may induce autophagy in the LPS stimulated human NPCs.

reach
In normal monocytes, TNFAIP3 induced autophagy, which restricted inflammasome activation to the early stage of LPS stimulation.

reach
Moreover, autophagy triggered by TNFAIP3 can ameliorate the degeneration of inflammatory human NPCs, providing a potential and an attractive therapeutic strategy for degenerative disease.

reach
In summary, overexpressed TNFAIP3 can promote autophagy and reduce inflammation in LPS induced human NPCs.

eidos
It has been reported that Zinc finger protein A20 / TNFAIP3 ( A20 ) can inhibit the activity of the NF-kappaB pathway and promote autophagy .
TNFAIP3 inhibits autophagy.
| 1 3
| 1 3

reach
Simultaneously, TNFAIP3 also decreased the secretion of inflammatory corpuscles by promoting autophagy in Ankylosing spondylitis [XREF_BIBR].

sparser
TRAF6 K63-linked ubiquitination of Beclin 1 was shown to induce autophagy [ xref ]; suggesting a possible feedback loop, the authors also demonstrated that A20 inhibits autophagy by deubiquitinating Beclin 1, thereby inhibiting the autophagy-activating ubiquitination by TRAF6.

reach
XREF_BIBR In contrast, the deubiquitinase TNFAIP3 and A20 reduces TLR4 triggered autophagy by decreasing K63 ubiquitination of BECN1.

reach
The results of this study showed that TNFAIP3 significantly reduces inflammatory response and ameliorates the degradation of the extracellular matrix by promoting autophagy in LPS-induced-inflammatory human NPCs that mimics IVDD.
TNFAIP3 affects HSPB3
| 11
TNFAIP3 activates HSPB3.
| 10
| 10

reach
At least 36 different loci have been identified as susceptibility loci of psoriasis by GWAS [XREF_BIBR], including the TNIP1 gene, which encodes TNF-alpha-induced protein 3 interacting protein 1 (TNIP1), as well as the tumor necrosis factor alpha induced protein 3 (TNFAIP3) gene, which encodes protein A20 [XREF_BIBR, XREF_BIBR].

reach
When younger brother also developed recurrent oral ulcers, genetic studies were performed in the index patent and targeted panel revealed a novel variant in Tumor necrosis factor alpha induced protein 3 (TNFAIP3) gene (XREF_TABLE).

reach
A20, a protein encoded by the tumor necrosis factor alpha induced protein 3 gene (TNFAIP3), plays a vital role in the negative regulation of inflammation and immunity.

reach
The variant proximal to NFkappaB1 controls signaling responses by altering the expression of NFkappaB itself, with the GG risk genotype expressing 20-fold more p50 NFkappaB and diminished expression of the negative regulators of the NFkappaB pathway : TNFalpha induced protein 3 (TNFAIP3), B cell leukemia 3 (BCL3), and cellular inhibitor of apoptosis 1 (CIAP1).

reach
A20 (TNFAIP3, tumor necrosis factor, alpha induced protein 3) is an endogenous negative regulator of the NF-kappaB pathway and is rapidly and transiently induced in response to bacterial and viral sti[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Other potential hubs includes TRAF6 (TNF receptor associated factor 6), PIN1 (Peptidyl-prolyl cis-trans isomerase NIMA interacting 1), FOS (FBJ murine osteosarcoma viral oncogene homolog), CTNNB1 (Catenin (cadherin associated protein) beta 1), CDKN1A (Cyclin dependent kinase inhibitor 1A (P21, Cip1)-A), TNFAIP3 (Tumor necrosis factor, alpha induced protein 3), SIRT1 (Sirtuin 1), ESR1 (Estrogen receptor 1) and HDAC5 (Histone deacetylase 5).

reach
Two groups identified a strong association between systemic lupus erythematosus (SLE) and haplotypes that contain variants in the protein coding region of the gene tumour necrosis factor alpha induced protein 3 (TNFAIP3) XREF_BIBR, XREF_BIBR.

reach
TNFAIP3 codes for tumor necrosis factor alpha induced protein-3 and has been identified as a risk factor in SSc [XREF_BIBR, XREF_BIBR] particularly with dcSSc, ILD (fibrosing alveolitis) and PAH as well as in individuals with SSc and other autoimmune diseases [XREF_BIBR].

reach
A20 is a cytoplasmic zinc finger protein encoded by the gene TNF-alpha induced protein 3 TNFAIP3.

reach
A GWA study reported a new association of the tumor necrosis factor alpha induced protein 3 (TNFAIP3) gene with SLE XREF_BIBR.
TNFAIP3 inhibits HSPB3.
| 1
| 1

reach
Furthermore, miR-125b target genes (histone methyltransferase Suv39h1 and the NF-kappaB negative regulator TNFAIP3 [tumor necrosis factor alpha induced protein 3]) were downregulated, which resulted in increased proinflammatory cytokine expression, aortic macrophage recruitment, MMP (matrix metalloproteinase)-2/9 activity, elastin fragmentation, and vascular smooth muscle cell loss in ATP7A mut/+ / ApoE -/- mice and reversed by locked nucleic acid-anti-miR-125b infusion.
TNFAIP3 affects MTOR
| 10
TNFAIP3 inhibits MTOR.
| 9
TNFAIP3 inhibits MTOR. 9 / 9
| 9

reach
As mTOR is a major negative regulator of autophagy, we hypothesized that TNFAIP3 could inhibit mTOR signaling for the introduction of autophagy.

reach
Taken together, our findings illustrate that TNFAIP3 restricts MTOR signaling and promotes autophagy, providing new insight into the manner in which MTOR and autophagy regulate survival in CD4 T cells.

reach
Thus, TNFAIP3 inhibits mTOR signaling in this cell model.

reach
TNFAIP3 promotes autophagy by inhibiting mTOR signaling in inflammatory human NPCs.

reach
A recent study has identified that TNF-alpha-induced protein 3 (TNFAIP3) restricts mTOR activity and promotes macroautophagy and survival in CD4 + T-cells [XREF_BIBR].

reach
These findings revealed the relationship between degeneration process, inflammatory response, and autophagy in human NPCs, in which TNFAIP3 inhibits the mTOR signaling to ameliorate IVDD.

reach
TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.

reach
TNFAIP3 inhibits mTOR signaling in the inflammatory human NPCs.

reach
Yu Matsuzawa et al. also found that TNFAIP3 promoted the survival of CD4 T cells by restricting mTOR and promoting autophagy [XREF_BIBR].
TNFAIP3 decreases the amount of MTOR.
| 1
TNFAIP3 decreases the amount of MTOR. 1 / 1
| 1

reach
Thus, we infer that TNFAIP3 may decrease phosphorylation level of mTOR after LPS stimulation in human NPCs.
RELA affects TNFAIP3
2 2 | 5
RELA increases the amount of TNFAIP3.
2 2 | 4
RELA increases the amount of TNFAIP3. 7 / 8
2 2 | 3

reach
However, when overexpressing TNFAIP3 and PLAU or upon activation of the NFkappaB pathway, all the inhibitory effects of SFE were reversed (XREF_FIG A-D), suggesting that SFE blocked the p65 promotion of TNFAIP3 and PLAU expression to inhibit ESCC cell proliferation and metastasis.

reach
RelA also enhanced Tnfaip3 expression following TNFalpha treatment, but significant differences were not detected between wild-type and Thr 435 mutants (XREF_FIG C).

reach
Together these data indicate that NF-kappaB p65 and C/EBPbeta were mediators of LPS induced Tnfaip3 expression in macrophages.

trrust
No evidence text available

biopax:pid
No evidence text available

trrust
No evidence text available

biopax:pid
No evidence text available
Modified RELA increases the amount of TNFAIP3. 1 / 1
| 1

reach
This finding is consistent with the hypothesis that elevated expression of RelA enhances transcription of the TNFAIP3, PIGR and TNF genes through the classical NF-kappaB signaling pathway.
RELA activates TNFAIP3.
| 1
RELA activates TNFAIP3. 1 / 1
| 1

reach
Real-time ChIP-PCR showed that the occupancy of the TNFAIP3 promoter by p65 was decreased in MDA-MB-231 cells in response to CTCF overexpression.
| 1 5 3
TNFAIP3 inhibits cell death.
| 1 5 2
| 1 5 2

sparser
Therefore, A20 inhibits RIP3-dependent necroptotic cell death. xref This finding sheds new light on the importance of RIP3 ubiquitination in the process of necroptosis ( xref ).

sparser
Although most studies have focused on the role of A20 in the inhibition of NF-κB and inflammatory signaling, little is known about how A20 inhibits cell death.

sparser
In future studies, determining the precise role and mechanisms by which A20 inhibits cell death promises to be an exciting avenue of research.

reach
The phenotype of this patient characterized by autoinflammation might be explained by increased cell proliferation and cell death caused by reduced TNFAIP3 (A20) expression.

sparser
We considered two major hypotheses, how the increased NF-κB activation of A20-deficient pathogen-specific CD8 + T cells might cause reduced numbers of T EM and T CM : (i) A20 regulates the development of SLEC and MPEC CD8 + T cells, and (ii) A20 inhibits cell death and enables persistence of CD8 + T cells.

sparser
Given that A20 inhibits T effector cell death in CD4 + T cells, unleashing T effector cell–mediated inflammatory activity, our data complement the picture of A20 as a potent regulator of T cell–mediated inflammation, inducing T effector cell survival while reducing T reg cell generation.

eidos
While the cell biological mechanisms by which A20 restricts cell death remain incompletely understood , some clues are provided by the observations that several death signaling proteins undergo physiological ubiquitination , and ubiquitinated death signaling complexes are dependent upon A20 .

reach
Upon searching the microarray for candidate genes involved in apoptosis downstream of PGC-1alpha4, we identified Birc2 (Ciap1) and Tnfaip3 (also known as A20), two anti-apoptotic proteins that prevent cell death downstream of inflammatory signaling.
TNFAIP3 activates cell death.
| 1
| 1

reach
Reconstitution of wild type TNFAIP3 in the TNFAIP3 mutated lymphoma cells induces cell death.
TNFAIP3 affects RIPK1
| 6 3
TNFAIP3 inhibits RIPK1.
| 5 1
| 5 1

sparser
Second, TNFAIP3 inactivates RIPK1, which regulates IκB kinase (IKK) [ xref ].

reach
The results indicate that miR-98-5p interference and 3beta-hydroxycholest-5-en-7-one treatment significantly upregulated the low TNFAIP3 expression induced by LPS stimulation, thereby inhibiting TRAF6, RIP, NF-kappaB, IL-1beta, and TNF-alpha secretion.

sparser
Together, our results indicated that following TNF‐induced, RelA‐responsive A20 expression in a subset of cells, A20 binds to and subsequently inhibits RIPK1‐RIPK3 complexes, thereby transiently protecting these cells from necroptosis.

sparser
Therefore, A20 inactivates RIP1 via sequential deubiquitinase and E3 ligase activities ( xref ).

sparser
Downstream to Toll-like receptor 4 (TLR4) and tumor necrosis factor receptor 1 (TNFR1) the A20 complex inactivates TRAF6 and RIP1, repressing the NF- κ B signaling pathway [ xref , xref ].

sparser
A20 inhibits pro-necroptotic RIPK1-RIPK3 complexes.
TNFAIP3 activates RIPK1.
| 1 2
TNFAIP3 activates RIPK1. 3 / 3
| 1 2

reach
However, molecules that negatively regulate Ripk1 and Jnk signaling, such as Tnfaip3 (A20) and GADD45beta respectively XREF_BIBR, are decreased in gammadelta T cells isolated from obese db/db mice.

sparser
The signaling pathway also has several levels of autoregulation, one of which includes the activation and association of the RIP1 and IκB kinases by the A20 ubiquitin-editing protein complex [ xref ].

reach
A20 (TNFAIP3), TNF alpha inducible protein 3; IkappaBalpha, inhibitor of kappaB alpha subunit; IKK, IkappaB kinase; IKKK, IKK kinase; IRAK1 interleukin-1 receptor associated kinase 1; MEKK3, mitogen activated protein kinase kinase kinase 3; NF-kappaB, nuclear factor-kappaB; RIP, receptor interacting protein; TAK1, transforming growth factor-beta-activated kinase 1; TNFalpha, tumor necrosis factor alpha; TNFR, TNF receptor; TRAF2, tumor necrosis factor receptor associated factor 2.
TNFAIP3 affects IL6
| 2 7
TNFAIP3 activates IL6.
| 6
TNFAIP3 activates IL6. 6 / 6
| 6

reach
At this time, very little information is available regarding the interaction of TNFAIP3 and STAT3 activation, and what is there appears disease and tissue dependent : in liver, TNFAIP3 activity results in increased STAT3 phosphorylation and IL-6 induction via inhibition of suppressor of cytokine signaling 3.

reach
Rather, these mice express increased quantities of splenic IL-4 mRNA (data not shown), and Tnfaip3 fl/fl CD19-Cre B cells produced more IL-6 and expressed higher amounts of co-stimulatory molecules upon stimulation.

reach
Thirdly, Tnfaip3 fl/fl CD19-Cre B cells produced more IL-6 than Tnfaip3 fl/+ CD19-Cre and Tnfaip3 +/+ CD19-Cre cells after treatment with LPS and CpG (XREF_FIG).

reach
Both Tnfaip3 OTU and OTU and Tnfaip3 ZF4 and ZF4 cells produced elevated amounts of the NF-kappaB dependent IL-6 and A20 mRNAs within one hour of TNF stimulation, consistent with increased NF-kappaB signaling in these cells (XREF_FIG).

reach
Tnfaip3 OTU and OTU and Tnfaip3 ZF4 and ZF4 cells produced less of the NF-kappaB dependent mRNAs IL-6 and cellular inhibitor of apoptosis protein 2 (cIAP2), and exhibited less NF-kappaB signaling than Tnfaip3 -/- cells, suggesting that neither A20 's C103 motif nor its ZF4 motif are singly responsible for all of A20 's functions during TNF signaling (XREF_SUPPLEMENTARY).

reach
Moreover, TNFAIP3 has been reported to control NF-kappa B activity and promote liver regeneration by activating the inflammatory IL-6/STAT3 signaling pathway.
| PMC
TNFAIP3 inhibits IL6.
| 2 1
TNFAIP3 inhibits IL6. 3 / 3
| 2 1

sparser
This agrees with A20 inhibiting interleukin-6 and promoting transforming growth factor-β production by medial SMC and in SMC cultures exposed to cytokines, which favors differentiation of regulatory over pathogenic T cells.

sparser
This agrees with A20 inhibiting IL-6 and promoting TGFβ production by medial SMC and in SMC cultures exposed to cytokines, thereby favoring differentiation of regulatory over pathogenic T cells.

reach
Furthermore, when compared with TNFAIP3 non knockdown and UBE2L3 knockdown in human HeLa cells, TNFAIP3 knockdown and UBE2L3 non knockdown synergistically increase three cytokines, CCL2, CXCL8 (IL8), and IL6, all regulated by NF-kappaB in the human TNFR signaling pathway.
TNFAIP3 affects TRAF6
1 | 1 5 1
1 | 1 5 1

sparser
Downstream to Toll-like receptor 4 (TLR4) and tumor necrosis factor receptor 1 (TNFR1) the A20 complex inactivates TRAF6 and RIP1, repressing the NF- κ B signaling pathway [ xref , xref ].

reach
The results indicate that miR-98-5p interference and 3beta-hydroxycholest-5-en-7-one treatment significantly upregulated the low TNFAIP3 expression induced by LPS stimulation, thereby inhibiting TRAF6, RIP, NF-kappaB, IL-1beta, and TNF-alpha secretion.

eidos
TRAF6 are inhibited by A20 , CYLD and OTUB2 that specially remove TRAF6 K63-linked ubiquitination .

sparser
TRAF6 are inhibited by A20, CYLD and OTUB2 that specially remove TRAF6 K63‐linked ubiquitination.

sparser
A20 inhibits TRAF6, a molecule required for IL-17 induced NFκB and MAPK signaling ( xref ).

signor
A20 is a deubiquitinating enzyme (dub) for lys63-linked polyubiquitinated signaling mediators such as traf6

sparser
A20 expression was regulated by NF-κB. In turn, increased A20 expression inhibited TRAF6 and NF-κB to reduce the subsequent inflammatory response.

sparser
Some of the proteins induced include SOCS3 – which inhibits JAKs, A20- which inhibits TRAF6, ABIN-3 which inhibits NFκB, and the transcriptional regulators, Hes1 and STAT3, that suppress the synthesis of inflammatory cytokines ( xref ).
| 2 2 4
| 2 2 2

sparser
We noted that A20 significantly inhibited poly(I:C)-induced cytokine production, and this effect was related to the inhibition of NF-κB signaling.

eidos
Downstream of TLR activation , Quercetin supplement decreased cytokine production by regulating NF-kappaB activation and possibly modulating A20 expression , in response to oral bacteria and TLR agonist challenge .
| PMC

eidos
Downstream of TLR activation , Quercetin supplement decreased cytokine production by regulating NF-kB activation and possibly modulating A20 expression , in response to oral bacteria and TLR agonist challenge .
| PMC

reach
Given the relationship we observed between elevated TNFAIP3 and decreased TNF-alpha, the lower levels of TNFAIP3 in AxSpA subjects may contribute to excessive cytokine production in response to PRR agonists.

reach
We hypothesized that lower levels of TNFAIP3 contributes to excessive cytokine production in response to inflammatory stimuli in axial spondyloarthritis (AxSpA).

sparser
Porphyromonas gingivalis (P. gingivalis) , one of the keystone periodontal bacteria, can activate NF-κB signaling in macrophages and induce A20 expression in vivo when injected intraperitoneal cavity of mice and therefore it is included as a model oral bacteria in in vitro assays. ( xref ) Our results revealed that A20 inhibits pro-inflammatory cytokine production both in human and mouse macrophages infected with P. gingivalis through its effect on NF-κB signaling.
| 2

reach
Although multiple factors converge to regulate inflammatory cytokine production, we hypothesized that low TNFAIP3 may contribute to excessive cytokine production in spondyloarthritis.

reach
Compared with control siRNA, Tnfaip3 and Socs1 siRNAs increased both IL-13 and IL-5 cytokine production and mRNA expression in ILC2s (XREF_FIG).
7 |
Benzo[a]pyrene increases the amount of TNFAIP3.
4 |
Benzo[a]pyrene increases the amount of TNFAIP3. 4 / 4
4 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
Benzo[a]pyrene decreases the amount of TNFAIP3.
3 |
Benzo[a]pyrene decreases the amount of TNFAIP3. 3 / 3
3 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
TNFAIP3 affects MAP3K5
| 5 2
TNFAIP3 inhibits MAP3K5.
| 5 1
| 5 1

eidos
The results from this study reveal a novel anti-apoptotic mechanism of A20 in TNF signaling pathway : A20 binds to apoptosis signal-regulating kinase1 ( ASK1 ) and mediates ASK1 degradation , leading to suppression of JNK activation and eventually blockage of apoptosis .

eidos
Taken together , the results from this study reveal a novel anti-apoptotic mechanism of A20 in TNF signaling pathway : A20 binds to ASK1 and mediates ASK1 degradation , leading to suppression of JNK activation and eventually blockage of apoptosis .

eidos
A20 signaling in APAP necrosis is through the MAPK cascade Since A20 is known to degrade ASK1 , thus abrogating JNK activation ( 26 ) , we examined JNK expression in A20HepCKO mice after APAP .

reach
Additionally, the same group has reported that TNFAIP3 can endogenously suppress ASK1 and reduce apoptosis, lipid accumulation, and inflammation [XREF_BIBR].

eidos
Additionally , the same group has reported that TNFAIP3 can endogenously suppress ASK1 and reduce apoptosis , lipid accumulation , and inflammation [ 116 ] .

eidos
A20 reduces the stability and promotes the degradation of ASK1 through the ubiquitination process A20 restricts TNF-induced NF-kappaB signaling through its ubiquitin editing activity on RIP1 ,14,15 it is thus of interest to test whether A20 would be affecting the stability of ASK1 through a similar mechanism .
TNFAIP3 activates MAP3K5.
| 1
| 1

reach
The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis.
Particulate Matter increases the amount of TNFAIP3.
6 |
Particulate Matter increases the amount of TNFAIP3. 6 / 6
6 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
Particulate Matter decreases the amount of TNFAIP3.
1 |
Particulate Matter decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
MALT1 affects TNFAIP3
| 1 5 1
MALT1 inhibits TNFAIP3.
| 1 5
| 1 5

sparser
Although MALT1 inactivates A20 by protease activity-mediated cleavage, it seems to be dispensable for initial IKK/NF-κB activation by TCR stimulation ( Coornaert et al., 2008 ).

sparser
Firstly, Malt1 directly cleaves and inactivates A20, a negative regulator of the antigen receptor-to-NF-kappaB pathway.

sparser
MALT1 proteolytically cleaves and inactivates A20 as well as CYLD, two negative regulators of NF-κB signaling ( xref , xref ).

eidos
For example , following TCR stimulation , A20 is degraded by paracaspase MALT1 [ 79 , 80 ] .
| PMC

sparser
Firstly, Malt1 directly cleaves and inactivates A20, a negative regulator of the antigen receptor-to-NF-κB pathway.

sparser
However, MALT1 inactivates A20 by cleavage after arginine 439 to disrupt its inhibitory effect on NF-κB ( xref ) ( xref ).
MALT1 activates TNFAIP3.
| 1
MALT1 activates TNFAIP3. 1 / 1
| 1

reach
In turn, MALT1 mediates rapid proteolytic cleavage and inactivation of TNFAIP3 after TCR stimulation, thus fine tuning TCR activation 21.
| 7
Infections increases the amount of TNFAIP3.
| 5
Infections increases the amount of TNFAIP3. 5 / 5
| 5

reach
FIG 5: Deltacoronavirus infection synchronously activates endogenous circTNFAIP3 and TNFAIP3 expression.

reach
Therefore, we performed experiments using cell lines A549 and THP1, and observed that IAV infection remarkably upregulated the expression of Tnfaip3 (Supplementary Figures 6C, D).

reach
Both OSU and NCDV NSP1 interact with β-TrCP, indicating that an association between NSP1 and target is likely necessary to induce turnover, as is true for NSP1 proteins that mediate IRF3 degradation.Recently, microarray analysis of host gene expression in HT-29 (human colorectal adenocarcinoma) cells has demonstrated that infection with SA11-4F, Wa, or bovine A5-13 RVA upregulates transcription of the tumor necrosis factor (TNF)-α-induced protein 3 (TNFAIP3) gene (Bagchi et al., 2012).

reach
Deltacoronavirus infection synchronously activates endogenous circTNFAIP3 and TNFAIP3 expression.

reach
(A) Expression of TNFAIP3 pre-mRNA, mRNA, and circRNA induced by PDCoV infection.
Infections activates TNFAIP3.
| 2
| 2

reach
We speculated that NFKBIA and TNFAIP3 were significantly induced by ALV-J infection in MDM to down-regulate cytokines in macrophages, resulting in viral persistence in the host.

reach
EPs 7630 treatment post-SARS-CoV-2 infection resulted in a significant reduction of IL1B gene expression and strong upregulation of anti-inflammatory TNFAIP3.
6 |
Silicon dioxide increases the amount of TNFAIP3. 6 / 6
6 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
U90/U89 affects TNFAIP3
| 6
| 6

sparser
The results of similar transfection assays showed that IE1 activated the wild-type A20 promoter by 32-fold but upregulated the NF-κB mutant version by only 6-fold, whereas IE2 did not significantly affect IE1 activity (Figure  xref C).

sparser
Although A20 has been shown to be induced during HCMV entry, we also found that IE1 activates the A20 promoter through the upstream NF-κB sites.

sparser
We also found that the viral IE1 protein activates the A20 promoter through the upstream NF-κB biding sites, suggesting a role of IE1 in the initial A20 activation.

sparser
The direct activation of A20 promoter by IE1 is not surprising, since IE1 induces NF-κB activity and the A20 promoter contains two NF-κB binding sites.

sparser
These results indicate that IE1 activates the A20 promoter through the NF-κB sites in reporter assays.

sparser
We also found that IE1 activates the A20 promoter.
IL1 affects TNFAIP3
| 3 3
IL1 activates TNFAIP3. 6 / 6
| 3 3

reach
IL-1 induced six of these genes (ATF3, DUSP1, TNFAIP3, KLF6, PPP1R15A, and EGR1) indicating that HCoV-229E shares pathways with this cytokine but activates additional specific sets of genes (Fig 2A).

reach
It was shown that TNFAIP3 is induced by TNF and IL-1 and might therefore be involved in the regulation of NFkappaB dependent genes in diverse bacterial infections.

sparser
This result was also substantiated by studies of the role of IKKα and IKKβ on either IL-1 or TNFα activation of the A20 gene.

sparser
Furthermore, TAK1 siRNA reduced IL-1-induced activation of the A20 gene to 3.2-fold ().

sparser
The relatively small effect of the individual IKKα and IKKβ siRNAs on inhibiting IL-1-induced activation of A20 was seen in three separate experiments.

reach
IL-8, TNFAIP3 and A20 and IL-6 (Early genes in response to TNF) were also rapidly induced by IL-1, peaking 1 h after stimulation.
IE1 affects TNFAIP3
| 6
IE1 activates TNFAIP3. 6 / 6
| 6

sparser
We also found that IE1 activates the A20 promoter.

sparser
The direct activation of A20 promoter by IE1 is not surprising, since IE1 induces NF-κB activity and the A20 promoter contains two NF-κB binding sites.

sparser
Although A20 has been shown to be induced during HCMV entry, we also found that IE1 activates the A20 promoter through the upstream NF-κB sites.

sparser
These results indicate that IE1 activates the A20 promoter through the NF-κB sites in reporter assays.

sparser
The results of similar transfection assays showed that IE1 activated the wild-type A20 promoter by 32-fold but upregulated the NF-κB mutant version by only 6-fold, whereas IE2 did not significantly affect IE1 activity (Figure  xref C).

sparser
We also found that the viral IE1 protein activates the A20 promoter through the upstream NF-κB biding sites, suggesting a role of IE1 in the initial A20 activation.
Zinc atom affects TNFAIP3
4 | 2
Zinc atom increases the amount of TNFAIP3.
3 | 2
Zinc atom increases the amount of TNFAIP3. 5 / 5
3 | 2

sparser
Silencing of the zinc-sensing receptor G protein-coupled receptor 39 (GPR39) was shown to abolish zinc-induced TNFAIP3 expression and the effects of zinc on high glucose-induced osteogenic marker expression.

ctd
No evidence text available

sparser
Silencing of the zinc-sensing receptor G protein-coupled receptor 39 (GPR39) was shown to abolish zinc-induced TNFAIP3 expression and the effects of zinc on high glucose-induced osteogenic marker expression.
| PMC

ctd
No evidence text available

ctd
No evidence text available
Zinc atom activates TNFAIP3.
1 |
1 |

ctd
No evidence text available
TNFAIP3 affects TLR
| 1 5
TNFAIP3 inhibits TLR.
| 1 2
TNFAIP3 inhibits TLR. 3 / 3
| 1 2

reach
On the other hand, TNFAIP3 can inhibit TLR induced activity of NFkappaB by de-ubiquitination of TRAF6.

reach
As TNFAIP3 normally restricts inflammatory TLR signals and its expression is induced in a variety of tissue types XREF_BIBR, XREF_BIBR, XREF_BIBR, the increased gut permeability in TNFAIP3 -/- mice might reflect an indirect effect of ongoing inflammation in these mice, a direct role for TNFAIP3 in IEC TJ stability, or a combination of these two effects.

sparser
As mentioned earlier, Tnfaip3 −/− mice develop spontaneous multi-organ inflammation that leads to premature lethality. xref Tnfaip3 −/− mice on a Rag1 −/− background still developed spontaneous inflammation, indicating that adaptive lymphocytes were not essential for the uncontrolled inflammatory response, xref although hematopoietic cells were clearly involved. xref Signals from TNF were similarly dispensable for the inflammation in Tnfaip3 −/− mice, and A20 potently inhibited TLR signaling in macrophages. xref Consistent with these observations, homeostatic TLR signaling dependent on the Myd88 adaptor was dysregulated in A20-deficient mice. xref The homeostatic Myd88-dependent signals were derived from commensal intestinal bacteria since treatment of Tnfaip3 −/− mice with broad spectrum antibiotics reduced systemic inflammation and prevented cachexia. xref A20 is therefore a critical regulator of immune homeostasis and TLR signaling in vivo .
TNFAIP3 activates TLR.
| 3
TNFAIP3 activates TLR. 3 / 3
| 3

reach
However, polymorphisms genes encoding proteins and transcription factors downstream of TLR activation, including TNFAIP3, TNIP1 and IRF5, correlate with lupus risk [XREF_BIBR, XREF_BIBR].

reach
83 In ABC DLBCL, biallelic inactivation of TNFAIP3 (by mutations, deletions or both) occurs in 30% of cases and can coexist with mutations in both MYD88 and CD79B, suggesting that inactivation of TNFAIP3 can enhance both BCR and TLR signalling pathways.

reach
Mice adoptively transferred with TNFAIP3 -/- x Myd88 -/- hematopoietic stem cells display decreased inflammatory activation in the intestine demonstrating that the control of immune cell TLR signaling by TNFAIP3 is also required for intestinal homeostasis XREF_BIBR.
TNFAIP3 affects RIPK3
| 2 2 2
TNFAIP3 inhibits RIPK3.
| 2 2
| 2 2

sparser
A20 inhibits pro-necroptotic RIPK1-RIPK3 complexes.

eidos
In addition , A20 integrates into the downstream necrosome and restricts RIPK3 activation to limit necroptosis ( Onizawa et al , 2015 ) .

sparser
Together, our results indicated that following TNF‐induced, RelA‐responsive A20 expression in a subset of cells, A20 binds to and subsequently inhibits RIPK1‐RIPK3 complexes, thereby transiently protecting these cells from necroptosis.

eidos
TNF-induced expression of IkappaB attenuates NFkappaB , whereas A20 inhibits IKK and RIPK3 .
TNFAIP3 activates RIPK3.
| 2
TNFAIP3 activates RIPK3. 2 / 2
| 2

reach
TNFAIP3-upregulated RIP3 exacerbates acute pancreatitis via activating NLRP3 inflammasome.

reach
Collectively, overexpressed TNFAIP3 could contribute to the progression of AP by activating RIP3/NLRP3 axis, providing a potential therapeutic target for AP treatment.
| 1 4

reach
Functional studies indicated that TNFAIP3 knockdown promoted migration and invasion, whereas TNFAIP3 overexpression alleviated these functions.

reach
Our data suggested that TNFAIP3 inhibited migration and invasion by suppressing epithelial mesenchymal transition in NPC.

reach
Furthermore, Huang et al reported that overexpression of TNFAIP3 inhibited migration and invasion in nasopharyngeal carcinoma XREF_BIBR.

reach
TNFAIP3 inhibits migration and invasion in nasopharyngeal carcinoma by suppressing epithelial mesenchymal transition.

eidos
Results demonstrated that TNFAIP3 knockdown contributed to the proliferation ( Fig. 5b ) , migration ( Fig. 5d ) , invasion ( Fig. 5e ) , and inflammation ( Fig. 5f ) and suppressed the apoptosis ( Fig. 5c ) in HAND2-AS1-overexpressed MH7A cells .

reach
In addition, the knockdown of TNFAIP3 restores the significant decrease in invasion and proliferation in miR-605-5p-inhibitor-transfected lung cancer cells.
IL17A affects TNFAIP3
| 1 3
IL17A increases the amount of TNFAIP3.
| 2
IL17A increases the amount of TNFAIP3. 2 / 3
| 2

reach
IL-17 induces expression of Tnfaip3 mRNA and A20 protein levels, which triggers deubiquitination of TRAF6 and downregulation of NF-kappaB and MAPK activation (particularly JNK).

reach
We demonstrated that IL-17 stimulates TNFAIP3 expression.
IL17A activates TNFAIP3.
| 1 1
IL17A activates TNFAIP3. 2 / 3
| 1 1

eidos
A20 ( Tnfaip3 ) , a deubiquitinase associated with susceptibility to autoimmune syndromes including psoriasis , is upregulated by IL-17A through NF-kappaB .

reach
IL-17 increased the abundance of TNFAIP3 mRNA and the subsequent production of A20 protein, which inhibited IL-17-mediated activation of TRAF6, NF-kappaB, and MAPKs, as well as downstream gene expression.
TNFAIP3 affects IL17A
| 4 1 1
TNFAIP3 inhibits IL17A.
| 3 1
| 3 1

eidos
A20 can block IL-17 production by interrupting the MAPK signaling pathway through abrogating K63 ubiquitination of TNF receptor associated factor 6 ( TRAF6 ) and preventing the prolonged phosphorylation of c-Jun-N-terminal-kinase ( JNK ) , which are both important for MAPK activation [ 46 ] .
| PMC

eidos
A20 can block IL-17 production and IL-17-mediated inflammatory aggravation during anti-TNF treatment by preventing the prolonged phosphorylation of JNK and inhibiting p38 MARK and PKC activity , which is dependent on the ZnF7 motif of A20 .
| PMC

sparser
Using RNA-silencing and A20 −/− cells, we showed that the expression of various IL-17 target genes was inhibited by A20 ( xref to xref ).

eidos
Both ABIN1 and A20 appear to independently inhibit IL-17 signaling .
TNFAIP3 decreases the amount of IL17A.
| 1
TNFAIP3 decreases the amount of IL17A. 1 / 1
| 1

reach
Functional blockage of TNFAIP3 in normal CD4 + T cells using small interfering RNA increased the expression of IFN-gamma and IL-17, but not IL-2, IL-4 and IL-5.
TNFAIP3 activates IL17A.
| 1
TNFAIP3 activates IL17A. 1 / 1
| 1

eidos
A20 was previously shown to modulate IL-17 signaling , but was proposed to bind directly to IL-17RA ( Garg et al , 2013 ) .
MTX1 affects TNFAIP3
| 6
MTX1 activates TNFAIP3.
| 4
MTX1 activates TNFAIP3. 4 / 4
| 4

reach
TNFAIP3 induction by MTX was inhibited by the simultaneous addition of FA, indicating that MTX triggered TNFAIP3 induction relies on blocking one-carbon metabolism (XREF_FIG).

reach
By contrast, TNFAIP3 induction by MTX was observed in all donors examined.

reach
XREF_BIBR Assessment of the underlying mechanism revealed that MTX triggered TNFAIP3 induction in GM-MO was significantly diminished (40%) after TS silencing with two different small interfering RNA (XREF_FIG), thus indicating that MTX triggered TNFAIP3 upregulation is partly dependent on TS expression.

reach
MTX induces upregulation of the TNFAIP3 gene, which encodes for the protein A20, a negative regulator of NFkappaB signaling.
MTX1 inhibits TNFAIP3.
| 1
MTX1 inhibits TNFAIP3. 1 / 1
| 1

reach
XREF_BIBR Assessment of the underlying mechanism revealed that MTX triggered TNFAIP3 induction in GM-MO was significantly diminished (40%) after TS silencing with two different small interfering RNA (XREF_FIG), thus indicating that MTX triggered TNFAIP3 upregulation is partly dependent on TS expression.
MTX1 increases the amount of TNFAIP3.
| 1
MTX1 increases the amount of TNFAIP3. 1 / 1
| 1

reach
Therefore, MTX induces a tolerant state in macrophages by upregulating the expression of TNFAIP3 in a TS/p53 dependent pathway.
Tax affects TNFAIP3
| 5
Tax inhibits TNFAIP3. 5 / 5
| 5

sparser
HTLV-1 Tax might also provide a bridge to the proteasome by disrupting the interaction between an E3 ubiquitin ligase and its substrate, illustrated by the inactivation by Tax of the A20-Itch E3 ligase complex, potentially leading to a permanent activation of tumor necrosis factor (TNF) receptor (TNFR) signaling [ xref ].

sparser
CADM1 is required for Tax to inactivate the A20 complex.

sparser
The inhibition of A20 by Tax may contribute to the constitutive activation of NF-κB in HTLV-1 infected cells.

sparser
Tax inactivation of A20 alleviates the negative feedback control of NF-κB and facilitates persistent NF-κB signaling that drives cell transformation.

sparser
The exact mechanism by which Tax inactivates A20 has remained elusive.
5 |
Cyclosporin A increases the amount of TNFAIP3.
3 |
Cyclosporin A increases the amount of TNFAIP3. 3 / 3
3 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
Cyclosporin A decreases the amount of TNFAIP3.
2 |
Cyclosporin A decreases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
| 3

reach
TNFAIP3 reduces pro inflammatory cytokines expression in LPS stimulated human NPCs.

reach
However, TNFAIP3 overexpression in IECs attenuates LPS induced barrier loss in vivo and TNF induced decreases in TER in vitro.

reach
siRNA mediated TNFAIP3 knockdown in MTX treated GM-MO significantly restored IL-6 secretion in response to LPS, as macrophages with lower A20 expression yielded significantly higher levels of LPS induced IL-6 (XREF_FIG).
| 2

reach
In addition, we also found TNFAIP3 up-regulation in LPS induced human NPCs, but the expression of inflammatory cytokines was higher than that of the control group.

reach
CD11c specific TNFAIP3 deficient mice produce excess IL-2, IL-10, IL-12, IFN-gamma, and TNF-alpha in response to LPS.
TNFAIP3 affects Ubiquitin
| 5
TNFAIP3 activates Ubiquitin.
| 3
| 3

reach
In addition to TNFAIP3 modulating ubiquitin others have found that TNFAIP3 can also inhibit IKK complex activity through a mechanism that is independent of ubiquitin.

reach
TNFAIP3 protein as a zinc finger protein and ubiquitin shearing enzyme can suppress activated NF-kappaB signal pathway and induce apoptosis of TNF by activating ubiquitin ligase and ubiquitinase.

reach
Therefore, it is plausible that TNFAIP3 mediated ubiquitin editing contributes to the modification of tight junction proteins.
TNFAIP3 inhibits Ubiquitin.
| 2
| 2

reach
TNFAIP3 inhibits NF-kappaB activation by exerting dual ubiquitin editing functions [XREF_BIBR].

reach
CYLD and TNFAIP3 and A20 negatively regulate the NFkappaB pathway by removing ubiquitin chains from multiple signaling molecules including TRAFs and RIP.
TNFAIP3 affects TRAF2
| 3 2
| 3 1

sparser
Since TRAF2 overexpression activates these signaling events via distinct downstream components [ xref ], a simple explanation of these observations is that A20 may directly inhibit TRAF2 to terminate these signals.

sparser
Moreover we demonstrated that A20 could inhibit RIP- and TRAF2- but not NIK-induced NF-κB–dependent reporter gene activation, suggesting that A20 interferes with NF-κB activation upstream of NIK.

reach
WT TNFAIP3 induces the degradation of TRAF2 in a dose dependent manner; whereas, the catalytic mutant C103A fails to do so (XREF_FIG).

sparser
The mechanism of A20-dependent TRAF2 inhibition is still unknown.
Mutated TNFAIP3 inhibits TRAF2. 1 / 1
| 1

reach
The ability of these TNFAIP3 mutants to induce the degradation of TRAF2 was tested to evaluate the functional consequence of nonsynonymous coding variants in TNFAIP3.
Phorbol 13-acetate 12-myristate increases the amount of TNFAIP3.
3 |
3 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
Phorbol 13-acetate 12-myristate decreases the amount of TNFAIP3.
1 |
1 |

ctd
No evidence text available

ctd
No evidence text available
TNFAIP3 affects TNFAIP3
| 1 4
TNFAIP3 inhibits TNFAIP3.
| 1 1
| 1 1

sparser
A20 potently inhibited growth of A20 transfectant ACC-2-A20 compared with control vector transfected groups and the ACC-2 empty control group (P < 0.05).

reach
Mutant TNFAIP3 (A20)-transfected cells showed increased TRAF6 polyubiquitination, suggesting the loss of function of TNFAIP3 (A20) deubiquitination activity in the mutant protein (Fig 6).
TNFAIP3 decreases the amount of TNFAIP3.
| 2
TNFAIP3 decreases the amount of TNFAIP3. 2 / 2
| 2

reach
Firstly, we confirmed that transfection of si-TNFAIP3 markedly reduced the level of TNFAIP3 in MH7A cells.

reach
TNFAIP3 siRNA decreased TNFAIP3 levels compared with LPS stimulated NPCs (XREF_FIG - XREF_FIG).
TNFAIP3 increases the amount of TNFAIP3.
| 1
Modified TNFAIP3 increases the amount of TNFAIP3. 1 / 1
| 1

reach
As shown in XREF_FIG, along with the significant reduction of AGO2, the expression of TNFAIP3 was up-regulated remarkably, indicating that miRNAs modulate the expression of TNFAIP3.
4 |
Nickel sulfate increases the amount of TNFAIP3. 4 / 4
4 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
4 |
Carbon nanotube increases the amount of TNFAIP3. 4 / 4
4 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
NFKB1 affects TNFAIP3
2 2 |
NFKB1 increases the amount of TNFAIP3. 4 / 4
2 2 |

trrust
No evidence text available

trrust
No evidence text available

biopax:pid
No evidence text available

biopax:pid
No evidence text available
MTOR affects TNFAIP3
| 4
MTOR inhibits TNFAIP3. 4 / 4
| 4

reach
Moreover, inhibition of mTOR signaling reversed TNFAIP3 inhibition on both IL-1beta and TNF-alpha production (XREF_FIG, XREF_FIG).

reach
The induction of autophagy in naive CD4 T cells following TCR stimulation is dependent on mTOR inhibition downstream of the ubiquitin editing enzyme TNFAIP3 (A20) 114.

reach
Further, pharmacological inhibition of mTOR signaling can significantly reverse the effects of TNFAIP3 knockdown, including inhibition of autophagy and extracellular matrix production, as well as the promotion of inflammatory response.

reach
The induction of autophagy in naïve CD4 T cells following TCR stimulation is dependent on mTOR inhibition downstream of the ubiquitin editing enzyme TNFAIP3 (A20) 114 .
(+)-JQ1 compound decreases the amount of TNFAIP3. 4 / 4
4 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
Cisplatin affects TNFAIP3
4 |
Cisplatin increases the amount of TNFAIP3.
3 |
Cisplatin increases the amount of TNFAIP3. 3 / 3
3 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
Cisplatin decreases the amount of TNFAIP3.
1 |
Cisplatin decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
TNFAIP3 affects IL1B
| 4
TNFAIP3 inhibits IL1B.
| 2
TNFAIP3 inhibits IL1B. 2 / 2
| 2

reach
The feedback regulator TNFAIP3 (A20) which negatively regulates TNF-alpha and IL-1beta signalling is up-regulated in two datasets and is down-regulated in one dataset.

reach
The results indicate that miR-98-5p interference and 3beta-hydroxycholest-5-en-7-one treatment significantly upregulated the low TNFAIP3 expression induced by LPS stimulation, thereby inhibiting TRAF6, RIP, NF-kappaB, IL-1beta, and TNF-alpha secretion.
TNFAIP3 activates IL1B.
| 2
TNFAIP3 activates IL1B. 2 / 2
| 2

reach
We found that Tnfaip3 -/- BMDMderived supernatant failed to stimulate additional IL-1beta secretion from Tnfaip3 +/+ cells (XREF_FIG).

reach
We therefore assessed the contribution of MyD88 to the spontaneous IL-1beta secretion induced by these ligands in Tnfaip3 -/- cells.

reach
Our data indicated that TNFAIP3 gene rs10499194 and rs13207033 polymorphisms decreased the risk of RA.

reach
In conclusion, this meta-analysis indicates that TNFAIP3 gene rs10499194, rs13207033 polymorphisms decrease the risk of RA, especially among Caucasian populations.

reach
In this meta-analysis, our data found that TNFAIP3 gene rs6920220, rs2230926, and rs5029937 polymorphisms increased the risk of RA.

reach
Finally, the heterogeneity of genetic models in this meta-analysis is high, we should interpret the data with caution.In summary, this meta-analysis provides evidence that TNFAIP3 gene rs2230926 and r[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
TLR affects TNFAIP3
| 4
TLR activates TNFAIP3.
| 3
TLR activates TNFAIP3. 3 / 3
| 3

reach
Consistent with these observations, treatment of A20 deficient mice with broad-spectrum antibiotics rescues the severe inflammation and lethality, indicating that a dysregulated response to commensal intestinal flora is responsible for the constitutive TLR signaling in Tnfaip3 -/- mice [XREF_BIBR].

reach
We noted the amounts of pro-IL-1beta expressed in wt and Tnfaip3 -/- cells induced by various TLR ligands correlated poorly with the amounts of secreted mature IL-1beta (XREF_FIG).

reach
To determine whether the secreted IL-1beta was proteolytically mature, we immunoprecipitated (IP 'd) IL-1beta from the supernatants of TLR stimulated Tnfaip3 -/- cells and assessed the molecular weight of the secreted IL-1beta by immunoblotting (IB).
TLR inhibits TNFAIP3.
| 1
TLR inhibits TNFAIP3. 1 / 1
| 1

reach
We demonstrate that Ash1l inhibits TLR triggered innate inflammatory response in macrophages by directly targeting Tnfaip3 promoter region to induce its expression.

reach
A co-occupied intronic TNFAIP3 regulatory element mediated cooperative enhancement of transcription by GR and NF-kappaB that required the presence of a functional GR binding site (GBS).

reach
Multiple downstream components of TNF signaling have been associated in autoimmunity, most notably the tumor necrosis factor inducible protein A20 (TNFAIP3), which terminates TNF- and pattern recognition receptor induced responses of the transcription factor NF-kappaB.

reach
TNFAIP3 mutations may lead to a reduced transcription and instability of mutant proteins.

sparser
A20 inhibits NF-kappa B-dependent transcription without a concomitant decrease in nuclear NF-kappa B DNA binding activity or nuclear translocation of p65.
TNFAIP3 affects SOCS3
| 4
TNFAIP3 decreases the amount of SOCS3.
| 2
TNFAIP3 decreases the amount of SOCS3. 2 / 2
| 2

reach
Interestingly, TNFAIP3 is reported to suppress SOCS3 expression to enhance STAT3 proliferative signals.

reach
These findings suggested that STAT3 could also be activated by increased Tnf and Tnfaip3 signals that further led to reduced Socs3 level in Vldlr -/- retinas.
TNFAIP3 inhibits SOCS3.
| 1
| 1

reach
IL-6 activated the STAT3 and vascular endothelial growth factor A (VEGFA) pathway directly, and elevated TNFAIP3 suppressed SOCS3 (suppressor of cytokine signaling 3)-activated STAT3 and VEGFA indirectly.
TNFAIP3 activates SOCS3.
| 1
TNFAIP3 activates SOCS3. 1 / 1
| 1

reach
IL-6 activated the STAT3 and vascular endothelial growth factor A (VEGFA) pathway directly, and elevated TNFAIP3 suppressed SOCS3 (suppressor of cytokine signaling 3)-activated STAT3 and VEGFA indirectly.
3 |
Valproic acid increases the amount of TNFAIP3. 3 / 3
3 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
Bis(2-chloroethyl) sulfide increases the amount of TNFAIP3. 3 / 3
3 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
Bacterial infection affects TNFAIP3
3 |
Bacterial infection increases the amount of TNFAIP3. 3 / 3
3 |

bel
TABLE 2. Genes differentially expressed in human neutrophils following 4 h of A. phagocytophilum infection # Anaplasma phagocytophilum is a gram-negative bacterial pathogen

bel
Understanding the response of innate immune cells to pathogens may provide insights to host defenses and the tactics used by pathogens to circumvent these defenses. We used DNA microarrays to explore the responses of human macrophages to a variety of bacteria. Macrophages responded to a broad range of bacteria with a robust, shared pattern of gene expression. The shared response includes genes encoding receptors, signal transduction molecules, and transcription factors. This shared activation program transforms the macrophage into a cell primed to interact with its environment and to mount an immune response. Further study revealed that the activation program is induced by bacterial components that are Toll-like receptor agonists, including lipopolysaccharide, lipoteichoic acid, muramyl dipeptide, and heat shock proteins. Pathogen-specific responses were also apparent in the macrophage expression profiles. Analysis of Mycobacterium tuberculosis-specific responses revealed inhibition of interleukin-12 production, suggesting one means by which this organism survives host defenses. These results improve our understanding of macrophage defenses, provide insights into mechanisms of pathogenesis, and suggest targets for therapeutic intervention.

bel
Early infection was characterized by an upregulation of anti-apoptotic genes and a downregulation of pro-apoptotic genes. This correlated with a necrotic, rather than apoptotic cell death.
3 |
Aflatoxin B1 increases the amount of TNFAIP3. 3 / 3
3 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
TNFAIP3 affects IRF3
| 1 2
TNFAIP3 inhibits IRF3. 3 / 3
| 1 2

reach
TNFAIP3 downregulates the activity of IRF-3, a key transcription factor for the induction of IFN-gamma [XREF_BIBR].
| PMC

reach
XREF_BIBR Also, IRF3 dependent signaling is negatively regulated by TAX1BP1 and TNFAIP3.

eidos
TNFAIP3 downregulates the activity of IRF-3 , a key transcription factor for the induction of IFN-gamma [ 36 ] .
| PMC
TNFAIP3 affects IKBKB
| 1 2
| 1 2

reach
TNF alpha induced protein 3 (A20, also known as TNFAIP3) is also induced upon NF-kappaB activation and negatively regulates IKKbeta activity.

sparser
A20, a deubiquitinating enzyme, inactivates IKKβ by removing regulatory K63-linked polyubiquitin chains from IKKγ.

reach
Also, TNFAIP3 acts to deactivate IKK1 and IKK2.
TNFAIP3 affects Disease
| 3
| 3

eidos
Therefore , A20 directly preserves immune homeostasis and prevents disease .

eidos
As inflammasomes are implicated in a number of experimental and clinical disease models , restricting inflammasome activation is another mechanism by which A20 can prevent disease .

eidos
In this study , we have used six distinct gene-targeted lines of Tnfaip3 knock-in mice to dissect how A20 prevents disease .
TNFAIP3 affects Death
| 3
| 3

reach
Intestinal epithelial cell (IEC) expression of TNFAIP3 improves barrier function and tight junction integrity and prevents dextran sulfate sodium (DSS)-induced IEC death and colitis.

reach
As TNFAIP3 inhibits NF-kappaB activation and IEC death, expression of TNFAIP3 in IEC may provide an avenue to inhibit IEC NF-kappaB activation without inducing IEC death and inflammation.

reach
These results indicate that TNFAIP3 expression in IEC prevents colitis involving DSS induced IEC death, but not colitis driven by T cell mediated inflammation.
| 1 2
| 1 2

eidos
TNFAIP3 , an important anti-inflammatory factor , can repress the expression of inflammatory NF-kappaB signaling and promote cell survival ( Catrysse et al ., 2014 ) .
| PMC

reach
This signature of EGFR TKI induced NF-kappaB output consisted of 36 NF-kappaB target genes, including established regulators of NF-kappaB signaling and cell survival such as TNFAIP3, BIRC3, and IL6 (XREF_FIG and XREF_SUPPLEMENTARY).

reach
Activation of canonical NF-κB in response to EGFR oncogene inhibition in mutant EGFR-bearing human and mouse lung cancer cells, drives tumour cell survival and residual disease in lung cancer via several established regulators of canonical NF-κB signalling and cell survival such as TNFAIP3 (TNFα-induced protein 3), BIRC3 (c-IAP2, TNFR2-TRAF signalling complex protein) and IL-6 [16].
TNFAIP3 affects CD4
| 1 2
TNFAIP3 activates CD4. 3 / 3
| 1 2

eidos
A20 also promotes CD4 + T cell survival via restriction of mTOR activity and increased autophagy [ 52 ] ) .

reach
Yu Matsuzawa et al. also found that TNFAIP3 promoted the survival of CD4 T cells by restricting mTOR and promoting autophagy [XREF_BIBR].

reach
TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.
TNFAIP3 affects Arthritis
| 3
| 3

eidos
Additionally , domain-specific mutant mice can be generated by mutating OTU ( C103A ) , ZnF4 ( C609A and C612A ) , or ZnF7 ( C764A and C767A ) and other specific sites The inflammatory features of arthritis and the anti-inflammatory function of A20 suggest that A20 can suppress arthritis by restricting inflammation , which has been verified by a growing number of studies .
| PMC

eidos
A20 prevents arthritis by inhibiting macrophage necroptosis and restricting spontaneous immune activation through its ZnF7 Necroptosis is a modified form of necrosis in which dead cells break up and release intracellular components , triggering an innate immune response that includes IL-1beta release and NLRP3 inflammasome activation [ 29 , 57 ] .
| PMC

eidos
More recently , it has been shown that A20 restricts Th17 cell expansion and arthritis through its ZnF7 motif [ 28 ] .
| PMC
SPP1 affects TNFAIP3
| 1
SPP1 activates TNFAIP3. 1 / 3
| 1

reach
We further show that activation of NF-kappaB by OPN occurs through a unique mechanism in which intracellular OPN (iOPN) causes transcriptional downregulation of the NF-kappaB inhibitors, A20 and TNFAIP3 and ABIN1 and TNIP1, and secretory OPN (sOPN) promotes receptor mediated activation of NF-kappaB.
RNF31 affects TNFAIP3
| 3
| 3

eidos
Actinomycin tracing and proteasome inhibition experiments showed that RNF31 degrades A20 through the proteasome pathway .

eidos
Mechanistic studies revealed that RNF31 was able to degrade A20 , which affected the inflammatory response and hepatocyte apoptosis mediated by the toll like receptor 4 ( TLR4 ) / myeloid differentiation factor88 ( MyD88 ) / nuclear transcription factor-kappaB ( NF-kappaB ) signaling pathway .

eidos
In conclusion , RNF31 degrades A20 by ubiquitination and activates the TLR4 / MyD88 / NF-kappaB signaling pathway to aggravate acute liver injury .
All-trans-retinoic acid increases the amount of TNFAIP3.
| 2
All-trans-retinoic acid increases the amount of TNFAIP3. 2 / 2
| 2

reach
In contrast, ATRA induces the expression of BIRC3 and TNFAIP3, which inhibit Fas and TNFalpha mediated apoptosis signaling pathway by the interaction with TRAF2, and thus may prevent apoptosis.

reach
However, fenretinide specifically induced Fas and TNFalpha mediated apoptosis by increasing the expression of pro apoptotic genes i.e., DEDD2, CASP8, CASP4, and HSPA1A/B; whereas, ATRA induced the expression of BIRC3 and TNFAIP3, which inhibit apoptosis by interacting with TRAF2.

reach
In contrast, ATRA up-regulated two anti-apoptotic genes (BIRC3 and TNFAIP3), which have negative regulatory effects in the Fas and TNFalpha-mediate death receptor signaling pathway.
TNIP1 affects TNFAIP3
| 1 2
TNIP1 inhibits TNFAIP3.
| 1 1
| 1 1

reach
ABIN1 attenuated inflammatory responses and colitis by regulating A20 and TNFAIP3 activities.

sparser
ABIN-1 inhibits IL-17R signaling independently of A20.
TNIP1 activates TNFAIP3.
| 1
TNIP1 activates TNFAIP3. 1 / 1
| 1

reach
Previous studies have demonstrated that ABIN1 mediated anti-inflammatory mechanisms are A20 and TNFAIP3 dependent.
| 1 2
TNFAIP3 inhibits cell growth.
| 1 1
| 1 1

reach
The deletions or mutations of TNFAIP3 are found in about 30% of patients with diffuse large B-cell lymphoma, while reinforced TNFAIP3 induces apoptosis and cell growth arrest XREF_BIBR, suggesting TNFAIP3 is a tumor suppressor.

sparser
A20 inhibits in vivo NPC cell growth.
TNFAIP3 activates cell growth.
| 1
| 1

reach
Moreover, TNFAIP3 induces cell growth arrest and apoptosis, accompanied by down-regulation of nuclear factor-kappa B (NF-kB) activation [XREF_BIBR, XREF_BIBR].
TNFAIP3 affects NLRP3
| 1 2
TNFAIP3 activates NLRP3.
| 1 1
TNFAIP3 activates NLRP3. 2 / 2
| 1 1

sparser
For example, Walle et al. showed that the negative regulation of NLRP3 inflammasome activation induced by A20 markedly protects against the onset of RA-associated inflammation and cartilage destruction, highlighting the contribution of the NLRP3 inflammasome to the pathology of RA [ xref ].

reach
Collectively, overexpressed TNFAIP3 could contribute to the progression of AP by activating RIP3/NLRP3 axis, providing a potential therapeutic target for AP treatment.
TNFAIP3 inhibits NLRP3.
| 1
| 1

reach
In murine models, A20 and Tnfaip3 was shown to downregulate the activity of NLRP3 inflammasome.
TNFAIP3 affects MYD88
| 3
TNFAIP3 activates MYD88.
| 2
TNFAIP3 activates MYD88-L265P. 2 / 2
| 2

reach
The lack of any measurable effect of CD79B in these assays contrasts with our previous findings, in which loss-of-function mutations in Tnfaip3 (A20) blocked MYD88 L265P -induced down-regulation of CD23, CD25, CD86, and CD95.

reach
Overall, these results suggest that MYD88 L265P signaling can be enhanced by a second genetic alteration in TNFAIP3 and highlights a potential opportunity for therapeutic targeting.
TNFAIP3 inhibits MYD88.
| 1
| 1

reach
Loss of TNFAIP3 enhances MYD88
TNFAIP3 affects IRF7
1 | 1 1
TNFAIP3 inhibits IRF7.
| 1 1
TNFAIP3 inhibits IRF7. 2 / 2
| 1 1

eidos
As described in a previous section , A20 induction by EBV LMP1 was shown to inhibit IRF7 , which consequently prevents IRF7dependent IFN induction ( Ning and Pagano , 2010 ) .

reach
Recently TNFAIP3 and A20 has been shown to interact with and negatively regulate IRF7, thus potentially explaining its molecular involvement in SLE [XREF_BIBR].
TNFAIP3 decreases the amount of IRF7.
1 |
TNFAIP3 decreases the amount of IRF7. 1 / 1
1 |

trrust
No evidence text available
NR3C1 affects TNFAIP3
| 1 2
NR3C1 activates TNFAIP3. 2 / 2
| 1 1

eidos
In addition , Kadiyala et al. reported that GR and NF-kappaB cooperatively bound to the enhancer of the A20 locus and induced A20 expression ( 35 ) .
| PMC

reach
A co-occupied intronic TNFAIP3 regulatory element mediated cooperative enhancement of transcription by GR and NF-kappaB that required the presence of a functional GR binding site (GBS).
NR3C1 activates mutated TNFAIP3. 1 / 1
| 1

reach
Supporting this notion, a selective GR ligand with only weak agonist activity for induction of FKBP5 enabled robust GR/NF-kappaB cooperative induction of a mutant TNFAIP3 reporter harboring the FKBP5 GBS.
3 |
Air Pollutants increases the amount of TNFAIP3.
2 |
Air Pollutants increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Air Pollutants decreases the amount of TNFAIP3.
1 |
Air Pollutants decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
17beta-estradiol increases the amount of TNFAIP3.
2 |
17beta-estradiol increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
17beta-estradiol decreases the amount of TNFAIP3.
1 |
17beta-estradiol decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
TNFAIP3 affects VIM
| 3
TNFAIP3 decreases the amount of VIM.
| 2
Modified TNFAIP3 decreases the amount of VIM. 1 / 1
| 1

reach
Western blot analysis was used to examine protein changes from TNFAIP3 overexpression and knockdown, in which TNFAIP3 promoted the protein expression of E-cadherin and suppressed vimentin expression.
TNFAIP3 decreases the amount of VIM. 1 / 1
| 1

reach
Western blot analysis was used to examine protein changes from TNFAIP3 overexpression and knockdown, in which TNFAIP3 promoted the protein expression of E-cadherin and suppressed vimentin expression.
TNFAIP3 increases the amount of VIM.
| 1
Modified TNFAIP3 increases the amount of VIM. 1 / 1
| 1

reach
Western blot analysis was used to examine protein changes from TNFAIP3 overexpression and knockdown, in which TNFAIP3 promoted the protein expression of E-cadherin and suppressed vimentin expression.
2 |
Trovafloxacin increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Toluene affects TNFAIP3
2 |
Toluene increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Titanium dioxide increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Tetrachloromethane increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Sodium dodecyl sulfate increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available

sparser
Inhibition of TNFα signaling led to reduced TNFAIP3 expression, which, by using siRNA inhibition of TNFAIP3 , appeared causally linked to increased IL-17A expression in eff Treg.

sparser
Inhibition of A20 by siRNA alone did not affect HCC cell viability indicating that TNF stimulation and subsequent activation of the downstream pathways was necessary to uncover the biological effects of A20 (Figure xref ).
Rotenone affects TNFAIP3
2 |
Rotenone increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
2 |
Resveratrol increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available

eidos
Our model simulation revealed that NFkB activation increased with the ROS level , which consequently increased the production of A20 .

eidos
Reactive oxygen species promoted A20 expression via increased H3K4me3 modification of histones on the A20 promoter domain [ 84 ] .
| PMC
| 2
Precursor mRNA increases the amount of TNFAIP3. 2 / 2
| 2

sparser
FIG 5: Deltacoronavirus infection synchronously activates endogenous circTNFAIP3 and TNFAIP3 expression. (A) Expression of TNFAIP3 pre-mRNA, mRNA, and circRNA induced by PDCoV infection.

sparser
Deltacoronavirus infection synchronously activates endogenous circTNFAIP3 and TNFAIP3 expression. (A) Expression of TNFAIP3 pre-mRNA, mRNA, and circRNA induced by PDCoV infection.
Phenethyl isothiocyanate increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
| 2
Messenger RNA increases the amount of TNFAIP3. 2 / 2
| 2

sparser
Deltacoronavirus infection synchronously activates endogenous circTNFAIP3 and TNFAIP3 expression. (A) Expression of TNFAIP3 pre-mRNA, mRNA, and circRNA induced by PDCoV infection.

sparser
FIG 5: Deltacoronavirus infection synchronously activates endogenous circTNFAIP3 and TNFAIP3 expression. (A) Expression of TNFAIP3 pre-mRNA, mRNA, and circRNA induced by PDCoV infection.
Magnetite nanoparticle increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
2 |
Hsa-miR-19b-3p decreases the amount of TNFAIP3. 2 / 2
2 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
2 |
Hsa-miR-19a-3p decreases the amount of TNFAIP3. 2 / 2
2 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
2 |
Hsa-miR-125b-5p decreases the amount of TNFAIP3. 2 / 2
2 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
2 |
Hsa-miR-125a-5p decreases the amount of TNFAIP3. 2 / 2
2 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
Diarsenic trioxide increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
2 |

ctd
No evidence text available

ctd
No evidence text available
Crocidolite asbestos increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
2 |
Cadmium atom increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Atrazine affects TNFAIP3
2 |
Atrazine decreases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Zinc affects TNFAIP3
| 2
Zinc activates TNFAIP3. 2 / 2
| 2

eidos
We also showed previously that in the human promyelocytic leukemia cell line ( HL-60 ) , which differentiates to the monocyte and macrophage phenotype in response to PMA , zinc upregulates the expression of A20 and the binding of A20 transactivating factor to DNA , which results in the inhibition of NF-kB activation ( 44 , 45 ) .

eidos
We have also shown previously that in the promyelocytic leukemia cell line HL-60 , which differentiates to a monocyte and macrophage phenotype in response to phorbol-12-myristate-13-acetate PHA , zinc upregulated the expression of A20 , and the binding of A20 transactivating factor to DNA , which resulted in the inhibition of NF-kappaB activation ( Bao et al ., 2010 ; Prasad et al ., 1993 Prasad et al ., , 2007 .
| PMC
| 2

reach
Moreover, virus infection-induced TNFAIP3 can block the phosphorylation and dimerization of IRF3 and inhibit the TLR3-induced activation of NF-k B and IFN-b (72, 73) .

reach
Moreover, virus infection-induced TNFAIP3 can block the phosphorylation and dimerization of IRF3 and inhibit the TLR3-induced activation of NF-κB and IFN-β (72, 73).
Tobacco Smoke Pollution increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
TNFSF10 affects TNFAIP3
| 2
| 2

reach
TNFAIP3, that was found to be up-regulated by TRAIL in our study, is an inhibitor of the NFKB pathway [XREF_BIBR] and may thereby promote apoptosis but, on the other hand, it was shown to decrease TNF mediated apoptosis and necrosis [XREF_BIBR], leaving its specific influence unclear.

reach
TNFAIP3 and NFkappaBIA, which is found to be up-regulated by TRAIL, are inhibitors of the NF-kappaB pathway [XREF_BIBR, XREF_BIBR].
| 2
| 2

eidos
A20 also has the ability to inhibit pyroptosis in a mechanism that is dependent on active Casp1 , thereby restoring the IL-1beta production process Therefore , in the TNF-alpha inflammatory pathway , which is upstream of the inflammatory response , A20 can target RIPK1 for proteasomal degradation , thus protecting cells from NF-kappaB activation and the subsequent production of pro-inflammatory factors .
| PMC

eidos
A20 has the ability to inhibit pyroptosis through a mechanism that is dependent on Casp1 , thereby preventing the maturation of pro-IL-1beta , but the exact mechanism remains unknown [ 20 ] ( Fig. 3d ) .
| PMC
| 2

reach
The deletion of TNFAIP3 in macrophages reversed daphnetin elicited inhibition of the immune response.
| PMC

reach
Accordingly, the deletion of TNFAIP3 in primary macrophages reversed daphnetin elicited inhibition of immune response, and the beneficial effect of daphnetin in the pathogenesis of ALI was, partially at least, abrogated by TNFAIP3 knockdown.

reach
TNFAIP3 deficient DCs induced HDM specific T H 17cell differentiation through increased expression of the T H 17 instructing cytokines IL-1beta, IL-6, and IL-23, whereas HDM specific T H 2 cell differentiation was hampered by increased IL-12 and IL-6 production.

reach
The deficiency of TNFAIP3 in MSCs can induce immune thrombocytopenia and influence megakaryocytic differentiation through terminating the NF-kappaB pathway that suggests TNFAIP3 play a critical role in the process of MSCs alleviate s autoimmune disease [XREF_BIBR].
TNFAIP3 affects TLR4
| 2
TNFAIP3 inhibits TLR4. 2 / 2
| 2

sparser
In a scenario where A20 inhibits TLR-4 at or downstream of MEKK-1, one would predict that the C-terminal region of A20 should also regulate MEKK-1 in a manner similar to its modulation of TLR-4.

sparser
Thus the inhibitory effects of A20 on MEKK-1 activation of NF-κB and AP-1 and induction of IL-8 mimicked its effects on TLR-4 suggesting that A20 inhibits TLR-4 at or downstream of MEKK-1.
TNFAIP3 affects TLR3
| 1 1
TNFAIP3 inhibits TLR3. 2 / 2
| 1 1

eidos
41 In addition , A20 interacts with TRIF and inhibits TLR3 - and Sendai virus-induced activation of IFN-sensitive response element and IFN-beta promoter , suggesting that A20 is a virus-inducible protein that blocks both inflammatory and cellular antiviral responses .

sparser
A20 can inhibit TLR3 signals and can bind TRAF6, Nef-associated kinase/TANK-binding kinase 1, and IκB kinase ε ( xref – xref ).
TNFAIP3 affects TICAM2
| 2
| 2

sparser
Taken together, these observations suggest that A20 inhibits a TRIF- and RIPK3-dependent step in NLRP3 inflammasome activation that is distinct from TLR-triggered transcription.

sparser
A20 also inhibited TRIF-, but not its downstream signaling components TBK1-, IKKbeta-, and IKKepsilon-mediated activation of ISRE and NF-kappaB and IFN-beta promoter.
TNFAIP3 affects TICAM1
| 2
| 2

sparser
Taken together, these observations suggest that A20 inhibits a TRIF- and RIPK3-dependent step in NLRP3 inflammasome activation that is distinct from TLR-triggered transcription.

sparser
A20 also inhibited TRIF-, but not its downstream signaling components TBK1-, IKKbeta-, and IKKepsilon-mediated activation of ISRE and NF-kappaB and IFN-beta promoter.
TNFAIP3 affects STAT3
| 2
TNFAIP3 activates STAT3. 2 / 2
| 2

reach
IL-6 activated the STAT3 and vascular endothelial growth factor A (VEGFA) pathway directly, and elevated TNFAIP3 suppressed SOCS3 (suppressor of cytokine signaling 3)-activated STAT3 and VEGFA indirectly.

reach
Moreover, TNFAIP3 has been reported to control NF-kappa B activity and promote liver regeneration by activating the inflammatory IL-6/STAT3 signaling pathway.
| PMC
TNFAIP3 affects NPC
| 2
TNFAIP3 inhibits NPC. 2 / 2
| 2

sparser
The purpose of this study was to investigate whether A20 could inhibit TNF-α-induced senescence of NPCs, and further reveal its biological mechanism to guide clinical treatment.

sparser
Since TNF-α is a critical inflammatory factor in the degenerated discs, xref , xref these results indicated that A20 could inhibit the senescence of NPCs in the TNF-α inflammatory microenvironment.
TNFAIP3 affects NFKB1
1 | 1
TNFAIP3 decreases the amount of NFKB1. 2 / 2
1 | 1

reach
The protein product of TNFAIP3 (TNF-alpha- induced protein 3) inhibits TNF-alpha-induced NFkB dependent gene expression by interfering with transactivation signals.

trrust
No evidence text available
TNFAIP3 affects Melanoma
| 2
| 2

eidos
Taken together , we demonstrated that up-regulated A20 promoted melanoma progression via the activation of Akt pathway , and that A20 could be exploited as a potential therapeutic target for melanoma treatment .

eidos
A20 promotes melanoma progression via the activation of Akt pathway .
TNFAIP3 affects MALT1
| 1 1
| 1 1

reach
Activation of NFkappabeta through the canonical pathway related to TCR activation requires MALT1 signaling, which is suppressed by TNFAIP3 through deubiquitination 37.

sparser
The fact that MALT-1 ubiquitination by TRAF6 is essential for TCR- and BCR-induced activation of NF-κB and evidence that MALT-1 plays an important role in the pathogenesis of several autoimmune diseases (e.g., Multiple Sclerosis; Brüstle et al., xref ; Mc Guire et al., xref ) and lymphomas (e.g., Marginal B zone lymphoma and ABC-DLBCL; Ngo et al., xref ; Vega et al., xref ) suggest that MALT-1 inhibition by A20 plays an important role in the prevention of autoimmunity and lymphomas (Figure xref ).
TNFAIP3 affects JNK
| 1 1
TNFAIP3 activates JNK. 2 / 2
| 1 1

reach
However, molecules that negatively regulate Ripk1 and Jnk signaling, such as Tnfaip3 (A20) and GADD45beta respectively XREF_BIBR, are decreased in gammadelta T cells isolated from obese db/db mice.

sparser
However, unexpectedly, the extent and duration of TNF-induced TRAF2 recruitment into complex I was not affected by A20 overexpression ( xref , second row), indicating that suppression of TNF-induced JNK activation by A20 is independent of TRAF2 recruitment into complex I. This conjecture also seems to be consistent with the earlier observation that A20 is capable of protecting TRAF2/5 DKO MEFs against TNF-induced cell death ( xref ).

reach
Tumor necrosis factor alpha induced protein 3 (TNFAIP3) mutations cause infantile-onset IBD.

reach
IL10/R, TTC7A and IKBKG are known to cause severe colitis in early infancy, whereas XIAP deficiency, IBD with Hermansky-Pudlak Syndrome, and IBD caused by mutation in TNFAIP3 can occur in a wide range of ages from infancy to adulthood.
TNFAIP3 affects IL1
| 1
TNFAIP3 inhibits IL1. 1 / 2
| 1

sparser
A20 also inhibits TNF and IL-1 induced activation of NF-κB, suggesting that it may act as a general inhibitor of NF-κB activation xref – xref .
| 1 1

eidos
Integrative genomic analysis identified that KMT2D-targeted genes included TNFAIP3 , TNFRSF14 , and SOCS3 , which suppress tumorigenesis , and genes involved in cell signaling pathways such as JAK-STAT and BCR .

sparser
Silencing of A20 inhibited tumorigenesis and metastasis via subcutaneous tumor formation and liver metastasis experiments in nude mice.
TNFAIP3 affects BAX
| 2
TNFAIP3 increases the amount of BAX. 2 / 2
| 2

reach
For example, genetic ablation of CCL2 decreases the levels of neutrophil recruitment 96, and knockdown of TNF-alpha-induced-protein 3 inhibits Bax expression and mitochondrial apoptosis 97.

reach
Knockdown of TNF-alpha-induced-protein 3 (A20) restored mitochondrial apoptosis, Bax expression, and liver damage.
Soot affects TNFAIP3
2 |
Soot increases the amount of TNFAIP3. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
SUPT5H affects TNFAIP3
| 2
| 2

sparser
Upon NF-kappaB activation, inhibition of the A20 gene by DSIF persists, but now NF-kappaB and the core promoter regulate DSIF instead of ELIE.

sparser
Prior to NF-kappaB stimulation, the A20 gene is occupied by polymerase II, and elongation is inhibited by DSIF.
OLR1 affects TNFAIP3
| 2
OLR1 activates TNFAIP3. 2 / 2
| 2

reach
Overexpression of LOX1 activates an NF-kappaB-dependent antiapoptotic pathway (BCL2, BCL2A1, and TNFAIP3).

reach
Overexpression of LOX1 activated an NF-kappaB-dependent anti-apoptosis pathway (BCL2, BCL2A1, and TNFAIP3) as well as lipogenesis in MCF10A normal mammary epithelial cells and HCC1143 breast cancer cells, suggesting that LOX-1 acts as an oncogene promoting tumorigenesis.
NR2F2 affects TNFAIP3
| 2
NR2F2 decreases the amount of TNFAIP3. 2 / 2
| 2

reach
The suppression of IL6, ICAM1, and TNFAIP3 expression by COUP-TFII is in agreement with the data from the NFkappaB PCR array.RELB expression was decreased by COUP-TFII overexpression in the NFkappaB p[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
The suppression of IL6, ICAM1, and TNFAIP3 expression by COUP-TFII is in agreement with the data from the NFkappaB PCR array.
MME affects TNFAIP3
| 2
MME decreases the amount of TNFAIP3. 2 / 2
| 2

reach
SFE Suppresses TNFAIP3 and PLAU Expression by Inactivating the NFkappaB Pathway to Inhibit ESCC Cell Progression.

reach
In summary, we identified that SFE inactivated the NFkappaB pathway and down-regulated TNFAIP3 and PLAU expression to suppress ESCC cell proliferation and metastasis, providing new insights into the anticarcinogenic activity of SFE and confirming SFE as a potential chemotherapeutic agent.
MAST3 affects TNFAIP3
| 2
MAST3 increases the amount of TNFAIP3. 2 / 2
| 2

reach
MAST3 positively regulates TNFAIP3 expression through the NFkappaB pathway in vitro 36.

reach
In vitro over expression of MAST3 up-regulates TNFAIP3 expression indicating that it 's expression is modulated by MAST3.
LMP1 affects TNFAIP3
| 1 1
LMP1 activates TNFAIP3. 2 / 2
| 1 1

sparser
A second possibility is A20, which is activated by both LMP1 ( Laherty et al. 1992 ) and CD40 ( Sarma et al. 1995 ).

eidos
As described in a previous section , A20 induction by EBV LMP1 was shown to inhibit IRF7 , which consequently prevents IRF7dependent IFN induction ( Ning and Pagano , 2010 ) .
ITCH affects TNFAIP3
1 | 1
ITCH activates TNFAIP3. 2 / 2
1 | 1

reach
ITCH mediates binding of TNFAIP3 and Tax1BP1 with substrates 17.

signor
Here we demonstrate that the regulatory molecule tax1bp1 recruited the e3 ligase itch to a20 via two 'ppxy' motifs. Itch was essential for the termination of tumor necrosis factor receptor signaling by controlling a20-mediated recruitment and inactivation of rip1. (abstract)
HBX affects TNFAIP3
| 2
HBX inhibits TNFAIP3. 2 / 2
| 2

sparser
A20 is inhibited by HBx in hepatocytes.

sparser
A20 is inhibited by HBx in hepatocytes.
ADIPOQ affects TNFAIP3
| 1 1
| 1 1

eidos
Adiponectin can augment the expression of A20 rapidly and observably by stimulating glucose synthase kinase 3beta ( GSK3beta ) activity , resulting in macrophage quiescence and initiating an A20-mediated anti-inflammatory program [ 65 ] .
| PMC

reach
A systematic search for adiponectin inducible genes with established anti-inflammatory properties revealed that adiponectin augmented the expression of A20, suppressor of cytokine signaling (SOCS) 3, B-cell CLL and lymphoma (BCL) 3, TNF receptor associated factor (TRAF) 1, and TNFAIP3 interacting protein (TNIP) 3.
4-hydroxyphenyl retinamide increases the amount of TNFAIP3. 2 / 2
1 | 1

ctd
No evidence text available

reach
For example, six and one hr after ATRA treatment, the expression of anti-apoptotic genes BIRC3 and TNFAIP3 was induced, respectively; whereas fenretinide only modestly induced the expression of TNFAIP3 at 12 hrs.
2 |
Sodium arsenite increases the amount of TNFAIP3.
1 |
Sodium arsenite increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Sodium arsenite decreases the amount of TNFAIP3.
1 |
Sodium arsenite decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
2 |
Pirinixic acid increases the amount of TNFAIP3.
1 |
Pirinixic acid increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Pirinixic acid decreases the amount of TNFAIP3.
1 |
Pirinixic acid decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
2 |
Phenobarbital increases the amount of TNFAIP3.
1 |
Phenobarbital increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Phenobarbital decreases the amount of TNFAIP3.
1 |
Phenobarbital decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
2 |
Ochratoxin A increases the amount of TNFAIP3.
1 |
Ochratoxin A increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Ochratoxin A decreases the amount of TNFAIP3.
1 |
Ochratoxin A decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
2 |
Homocysteine increases the amount of TNFAIP3.
1 |
Homocysteine increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Homocysteine decreases the amount of TNFAIP3.
1 |
Homocysteine decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Gamma-aminobutyric acid increases the amount of TNFAIP3.
| 1
Gamma-aminobutyric acid increases the amount of TNFAIP3. 1 / 1
| 1

reach
Mechanistically, GABA treatment significantly induced the sustained expression of TNFAIP3.

reach
Gamma-Aminobutyric Acid Promotes Osteogenic Differentiation of Mesenchymal Stem Cells by Inducing TNFAIP3.
1 | 1
Doxorubicin decreases the amount of TNFAIP3.
1 |
Doxorubicin decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Doxorubicin activates TNFAIP3.
| 1
| 1

reach
Unexpectedly, no differences were detected in ICAM-1 and TNFAIP3 mRNA levels between CT and p53 knocked down cells when treated with doxorubicin.
1 | 1
Dexamethasone increases the amount of TNFAIP3.
| 1
Dexamethasone increases the amount of TNFAIP3. 1 / 1
| 1

reach
While stimulation with MOG antigen failed to induce TNFAIP3, dexamethasone stimulation, a potent glucocorticoid, partially rescued the expression of TNFAIP3 protein and transcriptome levels in the relapse sample thereby suggesting that the induction of TNFAIP3 by glucocorticoids can improve relapses in MOG-AAD patients.
Dexamethasone decreases the amount of TNFAIP3.
1 |
Dexamethasone decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
2 |
Bisphenol A increases the amount of TNFAIP3.
1 |
Bisphenol A increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Bisphenol A decreases the amount of TNFAIP3.
1 |
Bisphenol A decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Benzene affects TNFAIP3
2 |
Benzene increases the amount of TNFAIP3.
1 |
Benzene increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Benzene decreases the amount of TNFAIP3.
1 |
Benzene decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Adenosine affects TNFAIP3
2 |
Adenosine increases the amount of TNFAIP3.
1 |
Adenosine increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Adenosine decreases the amount of TNFAIP3.
1 |
Adenosine decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
ZNF224 affects TNFAIP3
| 2
ZNF224 inhibits TNFAIP3.
| 1
| 1

eidos
In bladder carcinogenesis , ZNF224 , interacting with the transcriptional co-repressor DEPDC1 , downregulates the expression of A20 , a negative regulator of the NF-kB pathway [ 29 ] , whereas , in breast cancer , ZNF224 acts as an oncogenic transcriptional activator .
| PMC
ZNF224 activates TNFAIP3.
| 1
| 1

eidos
In more detail , chromatin immunoprecipitation and luciferase reporter assays showed that DEPDC1 is recruited on the promoter of A20 by ZNF224 and functions as a ZNF224 transcriptional co-repressor .
| PMC
Thr-Thr affects TNFAIP3
| 2
Thr-Thr inhibits TNFAIP3.
| 1
| 1

reach
Mutations in the TT> A enhancer reduces the ability of TNFAIP3 to attenuate the activation of NF-kappaB signaling.
Thr-Thr increases the amount of TNFAIP3.
| 1
Thr-Thr increases the amount of TNFAIP3. 1 / 1
| 1

reach
Given that disruptions in the TT> A enhancer disrupts TNFAIP3 expression, we next evaluated whether the disruption in TNFAIP3 alters receptor mediated NF-kappaB signaling and, more importantly, A20 mediated NF-kappaB signaling attenuation.
TRAF2 affects TNFAIP3
| 2
TRAF2 inhibits TNFAIP3-A125V. 1 / 1
| 1

reach
However, the A125V and F127C mutant may have a more profound functional defect (compare levels of TRAF2 degradation of A125V and F127C TNFAIP3 in XREF_FIG with A125V TNFAIP3 in XREF_FIG).
TRAF2 inhibits TNFAIP3-F127C. 1 / 1
| 1

reach
However, the A125V and F127C mutant may have a more profound functional defect (compare levels of TRAF2 degradation of A125V and F127C TNFAIP3 in XREF_FIG with A125V TNFAIP3 in XREF_FIG).

sparser
The TNFR1 associated inhibitor A20 has been reported to induce RIP poly-ubiquitination and inhibit TRADD downstream signal transduction in T cells ( xref , xref ).
| 1

reach
Moreover, TNFAIP3 has been reported to control NF-kappa B activity and promote liver regeneration by activating the inflammatory IL-6/STAT3 signaling pathway.
| PMC

reach
TNFAIP3 gene rs10499194, rs13207033 polymorphisms decrease the risk of rheumatoid arthritis.
| 1

reach
Three single nucleotide polymorphisms of TNFAIP3 gene increase the risk of rheumatoid arthritis.

reach
In this respect, it has been shown that up-regulation of TNFAIP3 and A20 down-regulates the NF-kappaB-mediated innate immune response.

reach
The loci that were associated with the largest number of ADs include IL23R, TNFAIP3, and IL2RA, supporting an important role for T cell and innate immune response pathways in autoimmunity.
TNFAIP3 affects PCBD1
| 2
TNFAIP3 inhibits PCBD1.
| 1
| 1

reach
Enterocyte specific deletion of Tnfaip3 (Tnfaip3 Flox Vil1-Cre) causes hypersensitivity to dextran sodium sulfate (DSS)-induced colitis, which is associated with hypersensitivity of enterocytes to TNF induced PCD and is partially rescued by TNFR1 deficiency.
TNFAIP3 activates PCBD1.
| 1
TNFAIP3 activates PCBD1. 1 / 1
| 1

reach
Remarkably, Tnfaip3 fl/fl CD19-Cre and Tnfaip3 fl/+ CD19-Cre B cells were resistant to Fas mediated PCD when compared to control Tnfaip3 +/+ CD19-Cre cells -- even though Tnfaip3 fl/fl CD19-Cre and Tnfaip3 fl/+ CD19-Cre B cells expressed greater amounts of Fas (XREF_FIG).
TNFAIP3 affects OCLN
| 1 1
TNFAIP3 inhibits OCLN.
| 1
TNFAIP3 inhibits OCLN. 1 / 1
| 1

reach
This indicates that TNFAIP3 may limit the endocytosis of occludin caused by cytokine exposure and mediated by polyubiquitination XREF_BIBR.
TNFAIP3 activates OCLN.
| 1
TNFAIP3 activates OCLN. 1 / 1
| 1

eidos
Blocking A20 resulted in a significantly increased production of IL-6 , IL-8 , and MCP-1 and reduced tight junction protein ZO-1 and occludin expression by hRPE cells ( Figures 4E , I ) .

reach
In summary, we identified that SFE inactivated the NFkappaB pathway and down-regulated TNFAIP3 and PLAU expression to suppress ESCC cell proliferation and metastasis, providing new insights into the anticarcinogenic activity of SFE and confirming SFE as a potential chemotherapeutic agent.
| 1

reach
However, when overexpressing TNFAIP3 and PLAU or upon activation of the NFkappaB pathway, all the inhibitory effects of SFE were reversed (XREF_FIG A-D), suggesting that SFE blocked the p65 promotion of TNFAIP3 and PLAU expression to inhibit ESCC cell proliferation and metastasis.
TNFAIP3 affects IKBKG
| 1 1
TNFAIP3 inhibits IKBKG.
| 1
| 1

eidos
These results align with prior studies suggesting that A20 can inhibit IKKgamma activity without affecting RIP1 ubiquitination 17 .
TNFAIP3 activates IKBKG.
| 1
TNFAIP3 activates IKBKG. 1 / 1
| 1

reach
The products of the TNFAIP3 and TNIP1 genes (A20 and ABIN1 and Naf1alpha, respectively), physically interact with each other to influence the ubiquitin mediated destruction of IKKgamma / NEMO, a central nexus of NF-kappaB signaling XREF_BIBR.
TNFAIP3 affects IFNG
| 2
TNFAIP3 increases the amount of IFNG.
| 1
TNFAIP3 increases the amount of IFNG. 1 / 1
| 1

reach
XREF_BIBR Reductions in TNFAIP3, a regulator of IRF transcription might underlie the increased IFN-gamma levels.
TNFAIP3 decreases the amount of IFNG.
| 1
TNFAIP3 decreases the amount of IFNG. 1 / 1
| 1

reach
Functional blockage of TNFAIP3 in normal CD4 + T cells using small interfering RNA increased the expression of IFN-gamma and IL-17, but not IL-2, IL-4 and IL-5.
| 1 1
| 1

eidos
Conclusions : Following stimulation of the renin angiotensin system , A20 suppresses DC activation and thereby mitigates T cell-dependent blood pressure elevation .
| 1

reach
These observations suggested that the proinflammatory DC phenotype was induced by the caerin gel.Caerin gel treatment significantly upregulated the expression of Tnfaip3 in NK cells.
| PMC
TNFAIP3 affects Caspase
| 2
TNFAIP3 inhibits Caspase.
| 1
| 1

reach
TNFAIP3 also perturbs caspase activation of TNF receptor 1 (TNFR1) which is coupled to apoptotic caspases 8 and 10 [XREF_BIBR, XREF_BIBR].
TNFAIP3 activates Caspase.
| 1
| 1

reach
Various viruses develop different strategies to limit or utilize apoptosis for benefitting their replication and persistent infection (44, 45) , PDCoV has CircRNA TNFAIP3 and Deltacoronavirus Replication ® been reported to induce caspase-dependent apoptosis during replication (46) .
TNFAIP3 affects BMPR2
| 2
TNFAIP3 activates mutated BMPR2. 1 / 1
| 1

reach
Thirdly, PH symptoms in Tnfaip3 DNGR1-KO mice were not enhanced by concomitant mutation of bone morphogenetic protein receptor type 2 (Bmpr2), which is the most affected gene in PAH patients.
TNFAIP3 activates BMPR2. 1 / 1
| 1

reach
Thirdly, PH symptoms in Tnfaip3 DNGR1-KO mice were not enhanced by concomitant mutation of bone morphogenetic protein receptor type 2 (Bmpr2), which is the most affected gene in PAH patients.
OCA2 affects TNFAIP3
| 1 1
OCA2 increases the amount of TNFAIP3.
| 1
OCA2 increases the amount of TNFAIP3. 1 / 1
| 1

reach
During MeV infection, viral P protein activates the expression of the ubiquitin modifier TNFAIP3, which interacts with TRAF6 binding protein, TAX1BP1, forming a complex that acts as TRAF6 inhibitor by preventing E3 ligase TRAF6 polyubiquitination [XREF_BIBR], thus blocking the TLR4 mediated proinflammatory signaling [XREF_BIBR].
| PMC
OCA2 activates TNFAIP3.
| 1
OCA2 activates TNFAIP3. 1 / 1
| 1

eidos
The expression of measles virus phosphoprotein ( P protein ) is necessary and sufficient to induce upregulation of A20 , leading to the suppression of Toll-like receptor signaling ( Yokota et al ., 2008 ) .
NFKBIA affects TNFAIP3
| 1 1
NFKBIA inhibits TNFAIP3.
| 1
| 1

reach
This was attributable at least partially to the NIK induced overexpression of some canonical pathway inhibitors like Nfkbia, Nfkbie, and Tnfaip3 (A20) (XREF_FIG).
NFKBIA activates TNFAIP3.
| 1
| 1

sparser
Endogenous MALT1 activity was evaluated by western blotting for A20, BCL10, and CYLD, and NF-κB activation by phospho-IκB-α and total IκB-α ( xref ).
LGALS1 affects TNFAIP3
| 2
LGALS1 inhibits TNFAIP3.
| 1
Modified LGALS1 inhibits TNFAIP3. 1 / 1
| 1

reach
Moreover, at 6 hours post-PHx, loss of Gal1 caused a decreased expression of Ltbr and an increased induction of the genes Tnfaip3 and Zfp36 both of which encode potent inhibitors of inflammation.
LGALS1 activates TNFAIP3.
| 1
| 1

reach
Thus, our data demonstrate that absence of Gal1 causes an aberrant response of the Tnfaip3 gene encoding A20 protein on PHx : up-regulation at 6 and down-regulation at 24 hours post-operation, suggesting a decreased NF-kappaB signaling which promotes LR at this stage.
KLF6 affects TNFAIP3
| 2
KLF6 inhibits TNFAIP3.
| 1
KLF6 inhibits TNFAIP3. 1 / 1
| 1

reach
As shown in XREF_FIG, NFKBIA knockdown completely or partially rescued KLF6-wt effect on the majority of the tested genes; furthermore, although not always statistically significant, it seemed to prevent KLF6 mediated upregulation of the other NF-kappaB-negative regulators (TNIP1, TNIP2 and TNFAIP3, XREF_SUPPLEMENTARY), suggesting that NF-kappaB could mediate a positive feedback loop by downregulating its negative regulators as previously described.
KLF6 increases the amount of TNFAIP3.
| 1
KLF6 increases the amount of TNFAIP3. 1 / 1
| 1

reach
RT-PCR confirmed that KLF6-wt, but not KLF6-sv1, induced expression of NFKBIA and TNFAIP3, and to a less extent, of TNIP1 and TNIP2, in all the cell lines tested (XREF_FIG).
GINS2 affects TNFAIP3
| 1 1
GINS2 inhibits TNFAIP3.
| 1
| 1

eidos
Our results showed that GINS2 knockdown increased TNFAIP3 protein expression , suggesting that TNFAIP3 may be involved in the effects of GINS2 on NSCLC proliferation and migration .
GINS2 decreases the amount of TNFAIP3.
| 1
GINS2 decreases the amount of TNFAIP3. 1 / 1
| 1

reach
Our results showed that GINS2 knockdown increased TNFAIP3 protein expression, suggesting that TNFAIP3 may be involved in the effects of GINS2 on NSCLC proliferation and migration.
Antirheumatic Agents increases the amount of TNFAIP3.
1 |
Antirheumatic Agents increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Antirheumatic Agents decreases the amount of TNFAIP3.
1 |
Antirheumatic Agents decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
8-Br-cAMP affects TNFAIP3
2 |
8-Br-cAMP increases the amount of TNFAIP3.
1 |
8-Br-cAMP increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
8-Br-cAMP decreases the amount of TNFAIP3.
1 |
8-Br-cAMP decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
2 |
2-nitrofluorene increases the amount of TNFAIP3.
1 |
2-nitrofluorene increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
2-nitrofluorene decreases the amount of TNFAIP3.
1 |
2-nitrofluorene decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
2 |
2-butoxyethanol increases the amount of TNFAIP3.
1 |
2-butoxyethanol increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
2-butoxyethanol decreases the amount of TNFAIP3.
1 |
2-butoxyethanol decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available

eidos
Consistent with our results , the latter study also demonstrated that zinc oxide nanoparticles induce the expression of A20 , a negative regulator of NF-kappaB .
1 |
Withaferin A increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Vincristine increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Vanadyl sulfate increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Vanadium oxoanion decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
VFLIP affects TNFAIP3
| 1
VFLIP increases the amount of TNFAIP3. 1 / 1
| 1

reach
On the basis of a microarray analysis, we previously reported that vFLIP enhances the expression of A20 and TNFAIP3 (TNFalpha induced protein 3) and ABIN-3 (A20 binding NF-kappaB inhibitor 3), and moderately enhances the expression of ABIN-1 in endothelial cells.
Ursodeoxycholic acid increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Urethane affects TNFAIP3
1 |
Urethane decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Tungsten carbide increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available

reach
A second DUB, A20 (also known as tumour necrosis factor‐α‐induced protein 3, TNFAIP3) negatively regulates NF‐κB signalling.

reach
Transcripts encoding two zinc finger proteins, ZFP36 and ZNF161, and the tumour necrosis factor alpha induced protein TNFAIP3, were also overexpressed after wounding.
1 |
Troglitazone increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Trimethyltin increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Triclosan affects TNFAIP3
1 |
Triclosan increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Trichloroethene increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Tributylstannane decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Toll-like receptor increases the amount of TNFAIP3. 1 / 1
| 1

reach
A broad spectrum of toll like receptor ligands induced TNFAIP3 expression, as did live Cutibacterium acnes, which is involved in the pathogenesis of acne.
1 |
Tolbutamide decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Testosterone increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Tert-butyl hydroperoxide increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Terbufos affects TNFAIP3
1 |
Terbufos increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Sunitinib affects TNFAIP3
1 |
Sunitinib increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Sulforaphane decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Succimer affects TNFAIP3
1 |
Succimer increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Strain affects TNFAIP3
| 1
| 1

eidos
In addition , both L. salivarius strains reduced the expression of A20 at hours 3 and 6 while they up-regulated this negative regulator at hour 12 .
Silver(0) affects TNFAIP3
1 |
Silver(0) decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Silver molecular entity increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Raloxifene hydrochloride decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Quinolin-8-ol increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Quercetin affects TNFAIP3
1 |
Quercetin increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Pyranone affects TNFAIP3
1 |
Pyranone increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Protein kinase inhibitor decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available

reach
A 2A R engagement, PGE 2 or cAMP elevating agents each increased mRNA expression of immunomodulatory transcription factors NR4A3, ATF3, TNFAIP3 and IER2, of the enzyme COX-2, of dual-specificity phosphatases 1 and 2 and of the regulatory element SOCS3.
1 |
Propiconazole increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Propanal affects TNFAIP3
1 |
Propanal increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Progesterone increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Potassium dichromate increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Polycyclic arene increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Poly(styrene) increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Piperonyl butoxide increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Phenylephrine increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Phenol affects TNFAIP3
1 |
Phenol increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Phenformin decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Pesticide affects TNFAIP3
1 |
Pesticide increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Pentanal affects TNFAIP3
1 |
Pentanal increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
| 1
Parthenolide decreases the amount of TNFAIP3. 1 / 1
| 1

reach
Significantly, concurrent application of parthenolide prevented the induction of IGFBP3 and TNFAIP3 gene expression by PPI-m DS G4 glycodendrimers in the same conditions as those in which the induction was demonstrated previously.
Paraquat affects TNFAIP3
1 |
Paraquat increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Palmitelaidic acid decreases the amount of TNFAIP3. 1 / 1
| 1

reach
Trans-palmitoleic acid and eicosapentaenoic acid (TPA and EPA) increased the phosphorylation level of MAPK/ERK1/2 and downregulated ROS generation and Tnfaip3 expression.
1 |
Paclitaxel increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Ozone affects TNFAIP3
1 |
Ozone increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
| 1

sparser
In addition, we evaluated the same proteins and the effect of an oligonucleotide antisense (ASO) inhibition of A20 in the adipose tissue of an animal model of obesity.
O-xylene affects TNFAIP3
1 |
O-xylene increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Nifedipine decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Nickel dichloride increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Nickel atom increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Monomethylarsonous acid decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |

ctd
No evidence text available
Methylmercury chloride decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Methotrexate decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Methapyrilene increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Mercury(0) increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Melatonin affects TNFAIP3
1 |
Melatonin increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Mechanical strain affects TNFAIP3
1 |
Mechanical strain increases the amount of TNFAIP3. 1 / 1
1 |

bel
Mesenchymal stem cells (MSCs) are a potential source for the construction of tissue-engineered vascular grafts. However, how vascular mechanical forces regulate the genetic reprogramming in MSCs is not well understood. Mechanical strain in the vascular wall is anisotropic and mainly in the circumferential direction. We have shown that cyclic uniaxial strain on elastic substrates causes the cells to align perpendicularly to the strain axis, which is different from that in the vascular wall. To simulate the vascular cell alignment and investigate the anisotropic mechanical sensing by MSCs, we used soft lithography to create elastomeric membranes with parallel microgrooves. This topographic pattern kept MSCs aligned parallel to the strain axis, and the cells were subjected to 5% cyclic uniaxial strain (1 Hz) for 2-4 days. DNA microarray analysis revealed global gene expression changes, including an increase in the smooth muscle marker calponin 1, decreases in cartilage matrix markers, and alterations in cell signaling (e.g., down-regulation of the Jagged1 signaling pathway). In addition, uniaxial strain increased MSC proliferation. However, when micropatterning was used to align cells perpendicularly to the axis of mechanical strain, the changes of some genes were diminished, and MSC proliferation was not affected. This study suggests that mechanical strain plays an important role in MSC differentiation and proliferation, and that the effects of mechanotransduction depend on the orientation of cells with respect to the strain axis. The differential cellular responses to the anisotropic mechanical environment have important implications in cardiovascular development, tissue remodeling, and tissue engineering.
Maneb affects TNFAIP3
1 |
Maneb increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Maduramicin increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Luteolin affects TNFAIP3
1 |
Luteolin increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
1 |
Levofloxacin increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Leflunomide increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Kaempferol increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
| 1
Isocyanic acid increases the amount of TNFAIP3. 1 / 1
| 1

reach
However, ICA treatment on its own did not upregulate expression of the NF-kappaB response gene Tnfaip3 (XREF_FIG) or induce the production of NO (XREF_FIG).
1 |
Isobutanol increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Hydroperoxide increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Hsa-miR-6887-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-6875-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-6837-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-6826-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-6795-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-6754-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-6507-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-586 decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-580-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-573 decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-5700 decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-5692a decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-5582-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-548x-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-548j-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
Hsa-miR-548aq-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
Hsa-miR-548am-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
Hsa-miR-548aj-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
Hsa-miR-548ah-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
Hsa-miR-548ae-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-526a decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-523-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-522-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-520g-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-520c-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-519c-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-519b-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-519a-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-518f-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-518e-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-518d-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-5096 decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-5093 decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-505-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-4777-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-4729 decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-4709-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-4670-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-4667-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
Hsa-miR-4659b-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
Hsa-miR-4659a-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-4635 decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-412-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-374a-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-3688-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-3679-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-3658 decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-3653-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-3616-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-335-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-3185 decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-29b-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-29a-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-26b-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-24-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-23c decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-23b-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-23a-3p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-2278 decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-21-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-19a-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-18a-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-141-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-130a-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-let-7e-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-let-7a-5p decreases the amount of TNFAIP3. 1 / 1
1 |

biopax:mirtarbase
No evidence text available

eidos
Kdm5a promotes B cell activation in systemic lupus erythematosus via downregulation of A20 by histone modification .
Hdac1-a affects TNFAIP3
| 1
Hdac1-a decreases the amount of TNFAIP3. 1 / 1
| 1

reach
To further explore the cytokine and chemokine responses in epithelial cells, we instilled HDM i.n. and then sorted CD45 - CD326 + lung epithelial cells and found that HDM exposed epithelial cells from Aoah -/- mice had decreased CCL20, GM-CSF, MCP-1, and IL-33 mRNA expression and elevated Tnfaip3 and SHIP compared with their counterparts in Aoah +/+ mice (XREF_FIG).
Gold molecular entity increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Gold atom affects TNFAIP3
1 |
Gold atom increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Gliclazide increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Gemcitabine increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Formaldehyde increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Folic acid increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Fluoranthene increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Fenthion affects TNFAIP3
1 |
Fenthion increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Eugenol affects TNFAIP3
1 |
Eugenol increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Ethylene glycol increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Ethylbenzene increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Ethyl methanesulfonate increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Ethanol affects TNFAIP3
1 |
Ethanol increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Erythromycin estolate decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available

ctd
No evidence text available
1 |
Eriodictyol increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Endosulfan decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
| 1
| 1

reach
Also, Emodin impaired TNFAIP3 and A20, ICAM-1 and VCAM-1 expression after TNFalpha stimulation (XREF_SUPPLEMENTARY), but again to a lesser extent than iNUB.

ctd
No evidence text available
Dioxygen affects TNFAIP3
1 |
Dioxygen increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Diclofenac decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Dichloromethane increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Deletion affects TNFAIP3
| 1
| 1

eidos
The authors also found that these deletions lead to reduced TNFAIP3 expression , but in contrast to the results from primary T-helper cells , they also saw a reduction in IL20RA and OLIG3 expression ( 53 ) .
Cytokine affects TNFAIP3
| 1
| 1

sparser
For these studies, we used quantitative real time PCR to analyze the expression of the NF-κB inducible gene A20, which is strongly activated by these cytokines.
1 |
Cytarabine decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Cyclophosphamide hydrate increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Cycloheximide increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Crotonaldehyde decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Copper(II) sulfate increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Cocoa butter increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Cobalt(2+) sulfate increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Cobalt atom increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Clonidine (imino form) increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Chromium atom increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Choline affects TNFAIP3
1 |
Choline increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
| 1

reach
Similarly CO also suppressed TNFAIP3, a proapoptotic protein that terminates TLR induced NF-kappaB activition and inflammatory gene induction in macrophages XREF_BIBR.
1 |
Calcitriol increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Cadmium dichloride increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Butanal affects TNFAIP3
1 |
Butanal increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Butan-1-ol increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Bortezomib increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Boron nitride increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Bis(tri-n-butyltin)oxide increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |

ctd
No evidence text available
Arsenic disulfide increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Arsenic atom decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Aripiprazole increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Antimony(0) increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Amiodarone increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Allergen affects TNFAIP3
1 |
Allergen decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available

reach
Trans-palmitoleic acid and eicosapentaenoic acid (TPA and EPA) increased the phosphorylation level of MAPK/ERK1/2 and downregulated ROS generation and Tnfaip3 expression.
Aldehyde affects TNFAIP3
1 |
Aldehyde increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Afimoxifene increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Acrylamide decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
| 1
| 1

reach
SOCS2 was modulated by both interferon beta and glatiramer acetate, TNFAIP3 was modulated by glatiramer acetate, and NR4A2 was not altered at all.
Abrine affects TNFAIP3
1 |
Abrine increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Abacavir affects TNFAIP3
| 1
| 1

reach
A20 is frequently inactivated in B-cell lymphomas : ~ 45% of classical Hodgkin 's lymphomas, 25% of ABC DLBCLs, and 20% of MALT lymphomas harbor inactivating mutations of at least one allele of TNFAIP3.
1 |
Zoledronic Acid increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
ZNF823 affects TNFAIP3
| 1
| 1

reach
Characterization of the functional roles of ZFP36 during IBV infection demonstrated that ZFP36 promoted the degradation of transcripts coding for IL-6, IL-8, dual-specificity phosphatase 1 (DUSP1), prostaglandin-endoperoxide synthase 2 (PTGS2) and TNF-α-induced protein 3 (TNFAIP3), through binding to AREs in these transcripts.
ZNF711 affects TNFAIP3
| 1
| 1

reach
Then, they constructed tissue-specific ZnF4 and ZnF7 domain double inactivated mice, Tnfaip3 LysM-Cre (Myeloid-specific), Tnfaip3 Vil1-Cre (IEC-specific).
| PMC
ZNF7 affects TNFAIP3
| 1
ZNF7 inhibits TNFAIP3. 1 / 1
| 1

reach
Then, they constructed tissue-specific ZnF4 and ZnF7 domain double inactivated mice, Tnfaip3 LysM-Cre (Myeloid-specific), Tnfaip3 Vil1-Cre (IEC-specific).
| PMC
Vehicle Emissions decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
| 1

eidos
In conclusion , RNF31 degrades A20 by ubiquitination and activates the TLR4 / MyD88 / NF-kappaB signaling pathway to aggravate acute liver injury .
Ubiquitin affects TNFAIP3
| 1
| 1

reach
Accordingly, the RIPK1 deubiquitinating enzyme cylindromatosis (CYLD) is required for optimal necroptotic responses following TNFR1 ligation, whereas the ubiquitin modifying TNF alpha induced protein 3 (TNFAIP3; best known as A20) and LUBAC limit TNFR1 driven necroptosis by favoring RIPK1 ubiquitination.
TYMS affects TNFAIP3
| 1
TYMS decreases the amount of TNFAIP3. 1 / 1
| 1

reach
Moreover, knockdown of TS sufficed to increase TNFAIP3 mRNA expression in GM-MO, an effect that was prevented in the presence of the p53 inhibitor pifithrin-alpha (XREF_FIG).
TRIM5 affects TNFAIP3
| 1
TRIM5 increases the amount of TNFAIP3. 1 / 1
| 1

reach
Transgenic TRIM5alpha did not modulate the kinetics of IkappaBalpha, JunB, and TNFAIP3 expression following TNF-alpha treatment.
TRAF6 affects TNFAIP3
| 1
TRAF6 increases the amount of TNFAIP3. 1 / 1
| 1

sparser
However, in these series of studies, TRAF6-induced A20 expression resulted in diminished canonical NF-κB activation and contributed to increased non-canonical NF-κB activation.
TRAF1 affects TNFAIP3
| 1
TRAF1 activates TNFAIP3. 1 / 1
| 1

reach
In turn, TRAF1 signalling has been reported to activate TNFAIP3 (A20)-induced apoptosis and activation of NF-kappaB.

reach
Of note, in a study of human coronavirus 229E-(HCoV-229E-) infected A549 and HuH7 cells, TNFAIP3 was typically upregulated in order to guarantee efficient viral replication [84] .
TNFAIP3 affects sulfate
| 1
| 1

reach
Intestinal epithelial cell (IEC) expression of TNFAIP3 improves barrier function and tight junction integrity and prevents dextran sulfate sodium (DSS)-induced IEC death and colitis.
| 1
| 1

reach
Intestinal epithelial cell (IEC) expression of TNFAIP3 improves barrier function and tight junction integrity and prevents dextran sulfate sodium (DSS)-induced IEC death and colitis.
| 1
| 1

reach
Though Nfkbia and Tnfaip3 mRNA production was increased in wt vs. Lyn-/- BMMCs in response to 20ng/ml Ag in several experiments (Additional file 6 : Figure S7), combined differences did not yield statistical significance.
TNFAIP3 affects protein 2
| 1
| 1

sparser
A20 also inhibits nucleotide-binding oligomerization domain-containing protein 2 (NOD2), antigen receptor, and cluster of differentiation 40 (CD40)-induced signals [ xref – xref ].
| 1

reach
However, ICA treatment on its own did not upregulate expression of the NF-kappaB response gene Tnfaip3 (XREF_FIG) or induce the production of NO (XREF_FIG).

reach
These findings phenocopy the T cell necrosis induced by Casp8, Fadd, Cflar or Tnfaip3 deletion.

eidos
Previous study suggests that upregulation of A20 / ABIN1 leads to macrophage polarization during infection [ 20 ] .

reach
Moreover, TNFAIP3 has been reported to control NF-kappa B activity and promote liver regeneration by activating the inflammatory IL-6/STAT3 signaling pathway.
| PMC

reach
Tnfaip3 CD11c-KO mice had perturbed splenic DC homeostasis as cDC1s, cDC2s, and pDCs were drastically reduced, while moDCs were increased.

reach
Furthermore, by knocking down TNFAIP3, the osteogenic effect of GABA was antagonized, which suggests that TNFAIP3 mediates the effects of GABA in hMSCs.

sparser
Although our results showed that A20 inhibited the EMT, FAK activation and RAC1 activity, the inhibitory effect of A20 was modest.
| 1

reach
This indicates that TNFAIP3 may limit the endocytosis of occludin caused by cytokine exposure and mediated by polyubiquitination XREF_BIBR.
TNFAIP3 affects dioxygen
| 1
| 1

reach
However, TNFAIP3 overexpression increased oxygen free radical generation and enhanced ferroptosis induced by erastin.
| PMC
TNFAIP3 affects cytokine
| 1
| 1

eidos
We speculated that NFKBIA and TNFAIP3 were significantly induced by ALV-J infection in MDM to down-regulate cytokines in macrophages , resulting in viral persistence in the host .
| 1

sparser
A20 significantly inhibited cell migration under these conditions ( xref F).

eidos
This study reveals a mechanism by which A20 prevents autoimmune uveitis .
TNFAIP3 affects abacavir
| 1
| 1

reach
Aberrant expression and genetic disorders of CD79b, CARD11, MYD88, TNFAIP3, BCL-10, TRAF3, TRAF2, NFKBIA, and NFKBIE (IkBepsilon), in concordance with the prevalence of chronic-active B cell receptor (BCR) signaling, JAK-STAT3 signaling, and canonical NF-kappaB signaling, were believed to underlie the inferior outcomes of ABC DLBCL [XREF_BIBR].
TNFAIP3 affects Wnt
| 1
TNFAIP3 inhibits Wnt. 1 / 1
| 1

eidos
While the mechanism by which A20 restricts Wnt signaling remains to be determined , this finding amplifies A20 's tumor suppressor potential , and dovetails with the clinical observation that A20 expression is reduced in adenomatous intestinal tissues , and further reduced in intestinal carcinomas .
TNFAIP3 affects VEGFA
| 1
| 1

reach
IL-6 activated the STAT3 and vascular endothelial growth factor A (VEGFA) pathway directly, and elevated TNFAIP3 suppressed SOCS3 (suppressor of cytokine signaling 3)-activated STAT3 and VEGFA indirectly.
| 1

eidos
A20 has been shown to reverse this ubiquitination , thereby reducing the ability of activated inflammasomes to generate active IL-1beta [ 169,170 ] .
TNFAIP3 affects UL83
| 1
TNFAIP3 inhibits UL83. 1 / 1
| 1

reach
Besides that, downregulation of TNFAIP3 increased HAND2-AS1-evoked decrease of p-p65.

eidos
Yokota et al. recently reported that measles virus P protein upregulates A20 to repress Toll-like receptors , inhibiting activation of NF-kappaB [ 82 ] .
TNFAIP3 affects TWIST1
| 1
| 1

eidos
Chen et al.13 also demonstrate that inhibition of Twist1 expression by A20 can suppresses hepatocellular carcinoma proliferation and metastasis .
TNFAIP3 affects TP53
| 1
TNFAIP3 inhibits TP53. 1 / 1
| 1

sparser
Based on the above results, we wondered if A20 inhibited the p53 protein in colon cancer cells.
TNFAIP3 affects TNFRSF10B
| 1
| 1

eidos
A20 is also reported to mediate TRAIL-R2 signalling , which is being studied as a therapeutic target due to the cancer cell-specific death induced by its activation [ 138 , 139 ] .
TNFAIP3 affects TJP1
| 1
TNFAIP3 activates TJP1. 1 / 1
| 1

eidos
Blocking A20 resulted in a significantly increased production of IL-6 , IL-8 , and MCP-1 and reduced tight junction protein ZO-1 and occludin expression by hRPE cells ( Figures 4E , I ) .
TNFAIP3 affects TCA
| 1
TNFAIP3 inhibits TCA. 1 / 1
| 1

sparser
Moreover we demonstrated that A20 could inhibit RIP- and TRAF2- but not NIK-induced NF-κB–dependent reporter gene activation, suggesting that A20 interferes with NF-κB activation upstream of NIK.
TNFAIP3 affects TBL1X
| 1
| 1

eidos
Herein , we tested the hypothesis that A20 attenuates EBI by establishing NF-kappaB-associated negative feedback after experimental SAH .
TNFAIP3 affects Spi1
| 1
TNFAIP3 activates Spi1. 1 / 1
| 1

sparser
Consistent with these studies, ligation of antigen receptors in A20 B cells mimics AKT activation of PU.1.
TNFAIP3 affects SUV39H1
| 1
| 1

reach
Of note, miR-125b is shown to repress SUV39h1 54 and TNFAIP3 55 as well as induces apoptosis in cancer cells by targeting anti-apoptotic Bcl-2, Bcl-W, and Mcl-1proteins 56.
TNFAIP3 affects SPI1
| 1
TNFAIP3 activates SPI1. 1 / 1
| 1

sparser
Consistent with these studies, ligation of antigen receptors in A20 B cells mimics AKT activation of PU.1.
TNFAIP3 affects SMAD7
| 1
| 1

reach
Therefore, we demonstrate that a pathological reduction in TNFAIP3 levels induced NF-kappaB and SMAD7 pathway activation, causing a deficiency in MSCs in ITP patients.
TNFAIP3 affects SETBP1
| 1
| 1

reach
A novel phenomenon was noted in the present study; in TNFAIP3 deficient HT-29 cells, a large number of SEB carrying endosomes were observed in HT-29 cells, but few SEB + endosome and lysosome were observed; the phenomenon indicates the lacking TNFAIP3 prevents the SEB carrying endosome from fusing the lysosome in the HT-29 cells since TNFAIP3 can tether endosomes to lysosomes XREF_BIBR; or in other words, TNFAIP3 is required in the endosome and lysosome fusion.
TNFAIP3 affects Relaxin-2
| 1
| 1

eidos
However , it is unknown whether TNFAIP3 is a downstream mediator of relaxin-2 in exerting its stabilizing effect on mast cells after GMH .

reach
83 In ABC DLBCL, biallelic inactivation of TNFAIP3 (by mutations, deletions or both) occurs in 30% of cases and can coexist with mutations in both MYD88 and CD79B, suggesting that inactivation of TNFAIP3 can enhance both BCR and TLR signalling pathways.
TNFAIP3 affects RNF168
| 1
| 1

sparser
Specifically, we report that the ubiquitin-editing enzyme A20 binds and inhibits the E3 ubiquitin ligase RNF168, which is responsible for regulating histone H2A turnover critical for proper DNA repair.
TNFAIP3 affects RELA
1 |
TNFAIP3 decreases the amount of RELA. 1 / 1
1 |

trrust
No evidence text available
| 1
TNFAIP3 decreases the amount of Proteasome. 1 / 1
| 1

reach
For instance, while it is known that NF-kappaB activates the expression of deubiquitinating enzymes CYLD and A20 (TNFAIP3) that negatively regulate NF-kappaB signaling [XREF_BIBR - XREF_BIBR] as well as expression of the proteasome subunit LMP2 (PSMB9) and proteasome activators PA28-alpha and PA28-beta [XREF_BIBR - XREF_BIBR], OHMM identified the E2 ubiquitin conjugating enzymes UBE2H, UBE2D3 and UBE2M that promote protein ubiquitination, as putative NF-kappaB targets.
| 1

reach
TNFAIP3-upregulated RIP3 exacerbates acute pancreatitis via activating NLRP3 inflammasome.
TNFAIP3 affects PSMA7
| 1
| 1

reach
More recently, two groups showed that activation of the canonical pathway by deletion of Tnfaip3 (A20), an inhibitor of the canonical pathway, also impairs HSPC self-renewal, indicating that there is a fine balance between positive and negative control of canonical NF-kappaB signaling for HSPC homeostasis [XREF_BIBR, XREF_BIBR].
TNFAIP3 affects PSEN2
| 1
| 1

sparser
A20 significantly inhibited both Ad5.
TNFAIP3 affects PSEN1
| 1
| 1

sparser
A20 significantly inhibited both Ad5.
TNFAIP3 affects PADI4
| 1
TNFAIP3 increases the amount of PADI4. 1 / 1
| 1

reach
Recently, genetic variations in the TNFAIP3 de-ubiquitinase domain, which is known to be associated with an increased risk of SLE, upregulates PADI4 expression.
TNFAIP3 affects OTUB1
| 1
| 1

eidos
Similar to OTUB1 , A20 suppresses NF-kappaB signaling by conjugating to E3 Ub-ligase [ 88 ] .
TNFAIP3 affects Neoplasms
| 1
| 1

eidos
Loss of A20 expression also leads to malignancies , especially B cell lymphomas .
TNFAIP3 affects NOS3
| 1
TNFAIP3 activates NOS3. 1 / 1
| 1

eidos
Overexpression of A20 in human coronary artery endothelial cells ( HCAEC ) increases endothelial nitric oxide synthase ( eNOS ) expression and prevents its downregulation by TNF , while A20 knockdown decreases eNOS levels .
TNFAIP3 affects NFKBIZ
| 1
| 1

reach
Analysis of target gene expression showed an overall attenuated transcriptional response in KMT2D mutant cell lines for important KMT2D targets such as the tumor suppressors genes TNFAIP3 and A20, NFKBIZ, FAS, and DUSP1 (XREF_FIG, XREF_SUPPLEMENTARY).
TNFAIP3 affects NFKBIA
| 1
| 1

eidos
The simulations furthermore show that the absence of A20 leads to a decrease in IkappaBalpha concentration in all three models .
TNFAIP3 affects NAD
| 1
TNFAIP3 activates NAD. 1 / 1
| 1

reach
In addition to IFN pathway genes, the higher anti-viral activity of hub genes related to TNF signaling and NAD metabolisms such as TNFAIP3, PARP9, and DTX3L would be able to characterize patients with a high viral load, indicating a clear association of their expression to the presence of the virus and the phase of the disease.

reach
In conclusion, our work has strengthened the case for the AHI1 gene candidate but also identified other potential MS gene targets, such as SGK1, BCLAF1 IL20RA, IL22RA2, IFNGR1 and TNFAIP3.
TNFAIP3 affects MYDGF
| 1
| 1

reach
Small intestine ILC2s constitutively express the IL-25 receptor, which is negatively regulated by A20 (Tnfaip3).
TNFAIP3 affects MS4A1
| 1
TNFAIP3 increases the amount of MS4A1. 1 / 1
| 1

reach
Overexpression of TNFAIP3 in DLBCL cells enhanced the inhibitory effect of rituximab and increased CD20 expression.
TNFAIP3 affects MAPK
| 1
TNFAIP3 inhibits MAPK. 1 / 1
| 1

eidos
Moreover , A20 can restrict MAPK activation .
| PMC
TNFAIP3 affects MAP3K7
| 1
| 1

reach
A20 (TNFAIP3), TNF alpha inducible protein 3; IkappaBalpha, inhibitor of kappaB alpha subunit; IKK, IkappaB kinase; IKKK, IKK kinase; IRAK1 interleukin-1 receptor associated kinase 1; MEKK3, mitogen activated protein kinase kinase kinase 3; NF-kappaB, nuclear factor-kappaB; RIP, receptor interacting protein; TAK1, transforming growth factor-beta-activated kinase 1; TNFalpha, tumor necrosis factor alpha; TNFR, TNF receptor; TRAF2, tumor necrosis factor receptor associated factor 2.
TNFAIP3 affects KMT2D
| 1
TNFAIP3 activates KMT2D. 1 / 1
| 1

reach
Analysis of target gene expression showed an overall attenuated transcriptional response in KMT2D mutant cell lines for important KMT2D targets such as the tumor suppressors genes TNFAIP3 and A20, NFKBIZ, FAS, and DUSP1 (XREF_FIG, XREF_SUPPLEMENTARY).
1 |
TNFAIP3 decreases the amount of JUN_family. 1 / 1
1 |

trrust
No evidence text available
TNFAIP3 affects ITP
| 1
TNFAIP3 inhibits ITP. 1 / 1
| 1

reach
We found that the heterozygous genotypes of FCRL3 rs11264799 and TNFAIP3 rs10499194 significantly decreased the risk of ITP compared with homozygous major alleles (p = 0.029 and p = 0.001, respectively, Table XREF_TABLE).
TNFAIP3 affects IL5
| 1
TNFAIP3 activates IL5. 1 / 1
| 1

reach
Compared with control siRNA, Tnfaip3 and Socs1 siRNAs increased both IL-13 and IL-5 cytokine production and mRNA expression in ILC2s (XREF_FIG).
TNFAIP3 affects IL2
| 1
TNFAIP3 activates IL2. 1 / 1
| 1

reach
CD11c specific TNFAIP3 deficient mice produce excess IL-2, IL-10, IL-12, IFN-gamma, and TNF-alpha in response to LPS.
TNFAIP3 affects IL1R1
| 1
TNFAIP3 activates IL1R1. 1 / 1
| 1

reach
One group found, upon overexpression of TNFAIP3 in an HEK293 cell line that also overexpressed the IL-1R, that TNFR1 complexes still contained polyubiquitinated RIP1 upon TNFalpha binding even though NF-kappaB was strongly inhibited.
TNFAIP3 affects IL17RA
| 1
| 1

sparser
A20 also directly binds to and inhibits the IL-17 receptor, an additional mechanism for inhibiting IL-17 induced NFκB and MAPK activation ( xref ).
TNFAIP3 affects IL13
| 1
TNFAIP3 activates IL13. 1 / 1
| 1

reach
Compared with control siRNA, Tnfaip3 and Socs1 siRNAs increased both IL-13 and IL-5 cytokine production and mRNA expression in ILC2s (XREF_FIG).
TNFAIP3 affects IKB
| 1
TNFAIP3 activates IKB. 1 / 1
| 1

sparser
The signaling pathway also has several levels of autoregulation, one of which includes the activation and association of the RIP1 and IκB kinases by the A20 ubiquitin-editing protein complex [ xref ].
TNFAIP3 affects IFNB1
| 1
TNFAIP3 activates IFNB1. 1 / 1
| 1

reach
Moreover, virus infection-induced TNFAIP3 can block the phosphorylation and dimerization of IRF3 and inhibit the TLR3-induced activation of NF-κB and IFN-β (72, 73).
TNFAIP3 affects IFNB
| 1
TNFAIP3 activates IFNB. 1 / 1
| 1

reach
Moreover, virus infection-induced TNFAIP3 can block the phosphorylation and dimerization of IRF3 and inhibit the TLR3-induced activation of NF-k B and IFN-b (72, 73) .
TNFAIP3 affects GOLM1
| 1
| 1

sparser
Conclusion: A20 inhibits apoptosis of hepatocytes and promotes the proliferation through the NF-κB signaling pathway in ALF rats, potentially providing new insight into the treatment of ALF.
TNFAIP3 affects FAS
| 1
TNFAIP3 activates FAS. 1 / 1
| 1

reach
Analysis of target gene expression showed an overall attenuated transcriptional response in KMT2D mutant cell lines for important KMT2D targets such as the tumor suppressors genes TNFAIP3 and A20, NFKBIZ, FAS, and DUSP1 (XREF_FIG, XREF_SUPPLEMENTARY).

eidos
The results demonstrated that SFE suppresses ESCC progression by down-regulating TNFAIP3 and PLAU expression in a p65-dependent manner .
TNFAIP3 affects ESR1
| 1
TNFAIP3 inhibits ESR1. 1 / 1
| 1

reach
It means that NFkappaB signaling is inhibited by TNFAIP3 expression in breast cancer patients expressing ESR1.
TNFAIP3 affects EGR1
| 1
TNFAIP3 activates EGR1. 1 / 1
| 1

reach
Using TRANSFAC, TSGene and TAG databases, the functional annotation analysis screened 1 transcription factor (upregulated EGR1) and 9 TAGs, including 1 oncogene (upregulated EGFR), 5 TSGs (downregulated TNFAIP3, ras association domain family member 5 and carcinoembryonic antigen related cell adhesion molecule 7; upregulated GLI pathogenesis related 1 and EGR1) and 3 other TAGs (downregulated breast carcinoma amplified sequence 1 and activin membrane bound inhibitor; upregulated PTHLH).
| 1

eidos
They also include cellular apoptosis inhibitor genes , namely c-IAP , c-IAP2 , TRAF1 , TRAF2 , zinc-finger protein A20 , and c-FLIP , which inhibit TNF-alpha-induced apoptosis , death receptor , and chemotherapy agents .

eidos
Formononetin attenuates atopic dermatitis by upregulating A20 expression via activation of G protein-coupled estrogen receptor .
| 1

eidos
They also include cellular apoptosis inhibitor genes , namely c-IAP , c-IAP2 , TRAF1 , TRAF2 , zinc-finger protein A20 , and c-FLIP , which inhibit TNF-alpha-induced apoptosis , death receptor , and chemotherapy agents .
TNFAIP3 affects DUSP1
| 1
TNFAIP3 activates DUSP1. 1 / 1
| 1

reach
Analysis of target gene expression showed an overall attenuated transcriptional response in KMT2D mutant cell lines for important KMT2D targets such as the tumor suppressors genes TNFAIP3 and A20, NFKBIZ, FAS, and DUSP1 (XREF_FIG, XREF_SUPPLEMENTARY).
TNFAIP3 affects Culture
| 1
| 1

eidos
Under standard ( no cytokine stimulation ) culture conditions , expression of relatively few inflammatory genes , or genes overall , were repressed by A20 or ABIN1 overexpression in NHEK cells ( Figure 1 ) .
TNFAIP3 affects Collagen
| 1
Modified TNFAIP3 decreases the amount of Collagen. 1 / 1
| 1

reach
We found that over-expression and knockdown of TNFAIP3 respectively increased and decreased the expression of both aggrecan and type II collagen (XREF_FIG - XREF_FIG), indicating TNFAIP3 maintains the NPCs function.
TNFAIP3 affects CXCL8
| 1
| 1

reach
Furthermore, when compared with TNFAIP3 non knockdown and UBE2L3 knockdown in human HeLa cells, TNFAIP3 knockdown and UBE2L3 non knockdown synergistically increase three cytokines, CCL2, CXCL8 (IL8), and IL6, all regulated by NF-kappaB in the human TNFR signaling pathway.
TNFAIP3 affects COL9A3
| 1
| 1

eidos
Therefore , we speculated that A20 can regulate inflammation and ameliorate IDD through autophagy mediated by NF-kappaB in human NPCs .
TNFAIP3 affects CHUK
| 1
TNFAIP3 inhibits CHUK. 1 / 1
| 1

reach
Also, TNFAIP3 acts to deactivate IKK1 and IKK2.
TNFAIP3 affects CEBPB
| 1
TNFAIP3 decreases the amount of CEBPB. 1 / 1
| 1

reach
The upregulated expression of C/EBP beta LAP could be caused by reduced TNFAIP3 and TNIP1 expression.
TNFAIP3 affects CDKN2B
| 1
TNFAIP3 decreases the amount of CDKN2B. 1 / 1
| 1

reach
Whereas ABC DLBCL is characterized by frequent mutations in nuclear factor-kappaB (NF-kappaB) pathway drivers and intermediates, including TNFAIP3, MYD88, CARD11 and CD79B, as well as loss of cell cycle regulators CDKN2A and CDKN2B, GCB DLBCL carry frequent mutations in epigenetic modifiers, such as CREBBP, KMT2D and EZH2.
| PMC
TNFAIP3 affects CDKN2A
| 1
TNFAIP3 decreases the amount of CDKN2A. 1 / 1
| 1

reach
Whereas ABC DLBCL is characterized by frequent mutations in nuclear factor-kappaB (NF-kappaB) pathway drivers and intermediates, including TNFAIP3, MYD88, CARD11 and CD79B, as well as loss of cell cycle regulators CDKN2A and CDKN2B, GCB DLBCL carry frequent mutations in epigenetic modifiers, such as CREBBP, KMT2D and EZH2.
| PMC
TNFAIP3 affects CDH1
| 1
Modified TNFAIP3 increases the amount of CDH1. 1 / 1
| 1

reach
Western blot analysis was used to examine protein changes from TNFAIP3 overexpression and knockdown, in which TNFAIP3 promoted the protein expression of E-cadherin and suppressed vimentin expression.
TNFAIP3 affects CD40
| 1
TNFAIP3 activates CD40. 1 / 1
| 1

reach
Both TRAF1 and TNFAIP3 function to modulate CD40 signaling.
TNFAIP3 affects CCL2
| 1
TNFAIP3 inhibits CCL2. 1 / 1
| 1

reach
Furthermore, when compared with TNFAIP3 non knockdown and UBE2L3 knockdown in human HeLa cells, TNFAIP3 knockdown and UBE2L3 non knockdown synergistically increase three cytokines, CCL2, CXCL8 (IL8), and IL6, all regulated by NF-kappaB in the human TNFR signaling pathway.
TNFAIP3 affects CBX4
| 1
TNFAIP3 inhibits CBX4. 1 / 1
| 1

reach
Therefore, high expression of TNF and/or IL8 in any individual subject would result in a high score for PC2, which could be lowered somewhat by high expression of TNFAIP3 and to a lesser extent RELA or PIGR.
TNFAIP3 affects CASP8
| 1
| 1

reach
Upregulation of TNFAIP3, TNFAIP8, TNFRSF12A, FAIM3, and CFLAR are important to inhibit caspase-8 activation, and may be direct targets of Shigella T3SS effector proteins or result from NF-kappaB activation.
TNFAIP3 affects BIRC2
| 1
| 1

reach
Tnfaip3 OTU and OTU and Tnfaip3 ZF4 and ZF4 cells produced less of the NF-kappaB dependent mRNAs IL-6 and cellular inhibitor of apoptosis protein 2 (cIAP2), and exhibited less NF-kappaB signaling than Tnfaip3 -/- cells, suggesting that neither A20 's C103 motif nor its ZF4 motif are singly responsible for all of A20 's functions during TNF signaling (XREF_SUPPLEMENTARY).
| 1

eidos
According with this view , we can assume that the A20 upregulation observed in sciatic nerve of 4 months old SOD1-G93A mice can be ascribed to an activation of the non-canonical pathway , fitting with the idea that A20 ( 62 ) , when aberrantly activated , in different cell types , can promote autoimmunity and inflammation .
| 1

eidos
In additional experiments , Lu and colleagues crossed mice with DC specific heterozygous deletion of A20 with lymphocyte-deficient recombination activating gene ( Rag-1 ) knock out mice and found that this abrogated the hypertensive response to low dose angiotensin II , suggesting that loss of A20 in DCs contributes to angiotensin II induced hypertension in a T cell-dependent manner .
TNFAIP3 affects Ala-Pro
| 1
| 1

reach
A study of the Han Chinese population found that the rs5029924 polymorphism of TNF-alpha-induced protein 3 (TNFAIP3) could increase the susceptibility of AP patients to SIRS by elevating the serum level of A20 protein [XREF_BIBR].
TNFAIP3 affects AGFG1
| 1
| 1

sparser
Moreover we demonstrated that A20 could inhibit RIP- and TRAF2- but not NIK-induced NF-κB–dependent reporter gene activation, suggesting that A20 interferes with NF-κB activation upstream of NIK.

reach
Briefly, each TNFAIP3 variant system was minimized with relaxed restraints using either Steepest Descent or Conjugate Gradient PR and then allowed to undergo the MC search criteria, as shown in the literature [XREF_BIBR - XREF_BIBR].

reach
Intestinal epithelial cell (IEC) expression of TNFAIP3 improves barrier function and tight junction integrity and prevents dextran sulfate sodium (DSS)-induced IEC death and colitis.
TCR affects TNFAIP3
| 1
TCR increases the amount of TNFAIP3. 1 / 1
| 1

reach
Ligation of the TCR has been shown to induce TNFAIP3 expression 21 and corticosteroids are commonly used as treatment for MOG-AAD which can aid in the resolution of relapses and potentially prevent new relapses XREF_BIBR, XREF_BIBR.
TAX1BP1 affects TNFAIP3
1 |
1 |

signor
Tx1bp1 appears to be a novel a20-binding protein which mediate the anti-apoptotic activity of a20; tax1bp1 phosphorylation was pivotal for cytokine-dependent interactions among tax1bp1, a20, itch and rnf11 and downregulation of signaling by the transcription factor nf-Kb.
Serpina1a affects TNFAIP3
| 1
| 1

sparser
Since A20 is not only anti-autophagic but also anti-apoptotic ( xref ), AAT inhibition of A20 may be, in part, responsible for the increased apoptosis seen with post-AAT infused plasma of M. intracellulare -infected macrophages.
STAT2 affects TNFAIP3
| 1
STAT2 activates TNFAIP3. 1 / 1
| 1

reach
In addition, increased expression of IFN inducible transcription factors STAT1 and STAT2, TNF-alpha induced protein TNFAIP3, apoptosis related proteins caspase3 and caspase4, suppressors of cytokine signaling Socs1 and Socs3, pro inflammatory cytokines IL-1 and IL-6, TLR7, as well as IFN response antiviral genes of OAS family were also observed in microarray analysis.
STAT1 affects TNFAIP3
| 1
STAT1 activates TNFAIP3. 1 / 1
| 1

reach
In addition, increased expression of IFN inducible transcription factors STAT1 and STAT2, TNF-alpha induced protein TNFAIP3, apoptosis related proteins caspase3 and caspase4, suppressors of cytokine signaling Socs1 and Socs3, pro inflammatory cytokines IL-1 and IL-6, TLR7, as well as IFN response antiviral genes of OAS family were also observed in microarray analysis.
SLURP1 affects TNFAIP3
| 1
| 1

reach
We speculated that NFKBIA and TNFAIP3 were significantly induced by ALV-J infection in MDM to down-regulate cytokines in macrophages, resulting in viral persistence in the host.
SLC27A5 affects TNFAIP3
| 1
| 1

reach
All three BACs rescue the perinatal lethal phenotype of Tnfaip3 global KO mice, but only deletion of downstream sequences compromised human A20 (hA20) expression, in lymphocytes, macrophages, and synovial fibroblasts (SFs).
SERPINA1 affects TNFAIP3
| 1
| 1

sparser
Since A20 is not only anti-autophagic but also anti-apoptotic ( xref ), AAT inhibition of A20 may be, in part, responsible for the increased apoptosis seen with post-AAT infused plasma of M. intracellulare -infected macrophages.
| 1
| 1

eidos
In both cell lines , SARS-CoV up-regulated A20 which may protect different cell types against tumour necrosis factor ( TNF ) - mediated programmed cell death and is critical for limiting inflammation by terminating TNF-induced nuclear factor ( NF ) - kB responses in the intestine and other organs [ 20 ] .
Ricin affects TNFAIP3
| 1
Ricin increases the amount of TNFAIP3. 1 / 1
| 1

reach
Ricin did increase the expression of HIST2H2AA and TNFAIP3, which were observed to be upregulated by b-SO6 in our studies, but only in IM-9 cells.
RIPK3 affects TNFAIP3
| 1
RIPK3 activates TNFAIP3. 1 / 1
| 1

reach
T cell specific RIPK3 deficiency restored cell survival in A20 deficient T cells, and global RIPK3 deficiency partially rescued the perinatal lethal phenotype of Tnfaip3 -/- (called A20 -/- here) mice.
REL affects TNFAIP3
1 |
REL increases the amount of TNFAIP3. 1 / 1
1 |

trrust
No evidence text available
RCA affects TNFAIP3
| 1
RCA inhibits TNFAIP3. 1 / 1
| 1

sparser
UCHL1, UCHL3, USP2 and USP8 were found to be inhibited by AM146, RA-9, and RA-14, which did not inhibit Ataxin-3, A20, BAP1, Otubain 1 or USP7 ( xref ).

reach
Upon DTMUV infection, key PRRs (RIG-I and MDA5) in the immune system were activated, inducing increased production of cytokines (IFN-α2, IL-6, IL-8L, IL-12B, CCR7, CCL19, and CCL20), transcription factors or signaling molecules (IRF7, NF-κB, STAT1, TMEM173/STING and TNFAIP3), and antigen-presenting proteins (CD44 and CD70).
Poly I:C affects TNFAIP3
| 1
| 1

reach
However, in LPS exposed Tnfaip3 DNGR1-KO mice, the RV was larger than in Tnfaip3 DNGR1-KO mice treated with saline, Poly I : C or CpG, or in LPS- or saline treated WT mice (XREF_FIG c).
1 |
Plant Extracts increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
| 1
| 1

reach
Independent of immune-mediated destruction, SNPs tagged to genes involved in the regulation of apoptosis (protein tyrosine phosphatase non-receptor 2 (PTPN2): rs1893217 and tumor necrosis factor, alpha-induced protein 3 (TNFAIP3): rs2327832) have been associated with T1D, with the risk variants resulting in increased apoptosis of β-cells (88, 89).
| PMC
Palm Oil affects TNFAIP3
1 |
Palm Oil increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
PTPN2 affects TNFAIP3
| 1
PTPN2 activates TNFAIP3. 1 / 1
| 1

reach
Independent of immune-mediated destruction, SNPs tagged to genes involved in the regulation of apoptosis (protein tyrosine phosphatase non-receptor 2 (PTPN2): rs1893217 and tumor necrosis factor, alpha-induced protein 3 (TNFAIP3): rs2327832) have been associated with T1D, with the risk variants resulting in increased apoptosis of β-cells (88, 89).
| PMC
PRKCA affects TNFAIP3
| 1
PRKCA activates TNFAIP3. 1 / 1
| 1

reach
Silencing of PKCalpha reduced TNFAIP3 and A20 production, whereas PKCgamma siRNA (but not PKCbeta or delta siRNA) significantly increased TNFAIP3 and A20.
PML affects TNFAIP3
1 |
PML decreases the amount of TNFAIP3. 1 / 1
1 |

trrust
No evidence text available
PMAIP1 affects TNFAIP3
| 1
| 1

sparser
Analysis of individual A20 kappa B sites revealed that both kappa B sites were required for TNF or PMA activation of the A20 promoter; however, Tax activation required only one kappa B site.
PCI 32765 affects TNFAIP3
1 |
PCI 32765 decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Ovalbumin affects TNFAIP3
1 |
Ovalbumin increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
OXT affects TNFAIP3
| 1
OXT activates TNFAIP3. 1 / 1
| 1

sparser
OT selectively activates dsRNA-activated kinase (PKR), X-box binding protein 1 (XBP1), immunoglobulin binding protein (BiP), A20 (TNFα-induced protein 3) and inositol requiring enzyme 1a (IRE1a).
NPPA affects TNFAIP3
| 1
NPPA activates TNFAIP3. 1 / 1
| 1

sparser
We analyze the network by means of the model combining a deterministic description for molecular species with large cellular concentrations with two classes of stochastic switches: cell-surface receptor activation by TNF α ligand, and I κ B α and A20 genes activation by NF- κ B molecules.
NLRP3 affects TNFAIP3
| 1
NLRP3 activates TNFAIP3. 1 / 1
| 1

reach
As in IAP triple deficient cells, RIPK3 may drive NLRP3 inflammasome activation in Tnfaip3 -/- cells via ROS generation (not shown).
N-acetyl-L-cysteine increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Mutation affects TNFAIP3
| 1
| 1

eidos
This mutation causes decreased A20 expression and results in immune dysregulation with increased NF-kappaB activity in response to TNF-alpha ( 10 ) ; it is also proposed as a risk factor for autoimmune disorders ( 11 , 12 ) .
Mice affects TNFAIP3
| 1
Mice activates TNFAIP3. 1 / 1
| 1

reach
Trib3 Tnfaip3 Lyz2 mice were produced by intercrossing Tnfaip3 Lyz2 mice with Trib3 mice.
| PMC
Menthol affects TNFAIP3
1 |
Menthol decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
MOG affects TNFAIP3
| 1
MOG increases the amount of TNFAIP3. 1 / 1
| 1

reach
Addition of MOG peptide did not increase TNFAIP3 expression in relapse or non relapse samples but in the presence of both, MOG antigen and dexamethasone, which is a synthetic glucocorticoid, TNFAIP3 expression was comparable at 4, 8 and 16h, however expression increased after 24h of stimulation in the relapse sample as compared to non relapse sample thereby partially rescuing the expression of TNFAIP3 in the relapse sample.
MIR125A affects TNFAIP3
| 1
| 1

eidos
Additionally , expression of miR-125a / b inhibits TNFAIP3 , leading to activation of the NF-kappaB pathway ( 45 ) .
MEOX2 affects TNFAIP3
1 |
Transcriptionally active MEOX2 decreases the amount of TNFAIP3. 1 / 1
1 |

bel
downregulated
MEFV affects TNFAIP3
| 1
MEFV activates TNFAIP3. 1 / 1
| 1

reach
Sanger sequence targeting TNFAIP3 exon 5 and MEFV exon 10 was carried out.
| 1
| 1

reach
Thus, it is noteworthy that both NFkappaB transcription factors (NFKB1 (p105), NFKB2 (p100), and RELA) and antiapoptotic target genes (IL1B, TRAF1, SOD2, GADD45B, CFLAR, TNFAIP3, BIRC4, and BIRC3) were rapidly induced by LVS.
LY294002 affects TNFAIP3
1 |
LY294002 decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
L-methionine increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
KDM5A affects TNFAIP3
| 1
| 1

eidos
Further , Kdm5a knockdown increased the H3K4me3 level and A20 expression .
| 1
| 1

reach
In addition, increased expression of IFN inducible transcription factors STAT1 and STAT2, TNF-alpha induced protein TNFAIP3, apoptosis related proteins caspase3 and caspase4, suppressors of cytokine signaling Socs1 and Socs3, pro inflammatory cytokines IL-1 and IL-6, TLR7, as well as IFN response antiviral genes of OAS family were also observed in microarray analysis.
IRF3 affects TNFAIP3
| 1
IRF3 activates TNFAIP3. 1 / 1
| 1

sparser
We show that A20 deficient BMDM display enhanced NF-κB and IRF3 activation in response to RIG-I stimulation by synthetic LMW double stranded RNA.
IL23A affects TNFAIP3
| 1
| 1

reach
TNF-alpha blockade improves symptoms in a mouse model of psoriasis induced by administration of IL-23 XREF_BIBR and a region of mouse chromosome 10 encompassing Tnfaip3 promotes psoriasis in a TNF-alpha dependent manner in another mouse model XREF_BIBR.
IL1A affects TNFAIP3
| 1
IL1A inhibits TNFAIP3. 1 / 1
| 1

reach
TNFAIP3 (TNF-alpha-induced protein-3) was down-regulated by IL-1alpha, in contrast to genes discussed above.
| 1
| 1

sparser
All these activities of TNFAIP3 disable IKK activation in the cytoplasm to reduce NF-κB activity in the nucleus.
Histone affects TNFAIP3
| 1
| 1

reach
TNFAIP3 downregulation mediated by histone modification contributes to T-cell dysfunction in systemic lupus erythematosus.
Heptachlor epoxide decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Helicobacter pylori infection affects TNFAIP3
1 |
Helicobacter pylori infection increases the amount of TNFAIP3. 1 / 1
1 |

bel
Table 2. Differentially expressed genes in spiral and coccoid H. pylori-infected GES-1 cells
Gasoline affects TNFAIP3
1 |
Gasoline increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
GYS affects TNFAIP3
| 1
GYS activates TNFAIP3. 1 / 1
| 1

sparser
Indeed, adiponectin was found to suppress primary macrophage responses to lipopolysaccharide and proinflammatory fatty acids, and this suppression depended on glycogen synthase kinase 3β activation and induction of A20.
GSK-J4 affects TNFAIP3
1 |
GSK-J4 increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
GPR39 affects TNFAIP3
| 1
GPR39 activates TNFAIP3. 1 / 1
| 1

reach
Conclusions Zinc supplementation ameliorates phosphate induced osteo- and chondrogenic transdifferentiation of VSMCs and vascular calcification through an active cellular mechanism resulting from GPR39 dependent induction of TNFAIP3 and subsequent suppression of the NF- kappa B pathway.
GIT2 affects TNFAIP3
| 1
GIT2 activates TNFAIP3. 1 / 1
| 1

reach
The overexpression of GIT2 enhanced the deubiquitination activity of TNFAIP3 toward IKBKG, and siRNA targeted at GIT2 abrogated the TNFAIP3 dependent deubiquitination of IKBKG and impaired the ability of TNFAIP3 to inhibit NF-kappaB activation (XREF_FIG).
GATA2 affects TNFAIP3
| 1
GATA2 bound to GATA1 decreases the amount of TNFAIP3. 1 / 1
| 1

reach
As predicted by bioinformatics analysis, the T allele of rs5029924 affects the binding of GATA-1 and GATA-2, which could reduce TNFAIP3 expression by changing promoter activity XREF_BIBR.
GAL affects TNFAIP3
| 1
GAL inhibits TNFAIP3. 1 / 1
| 1

eidos
Co-administration of the hepatocyte specific transcriptional inhibitor d-galactosamine ( GalN ) together with TNF significantly reduced A20 , but not A1 expression , showing that NO , but not Al , was expressed by hepatocytes .
| PMC
FMN1 affects TNFAIP3
| 1
FMN1 inhibits TNFAIP3. 1 / 1
| 1

reach
To assess whether differences in the LD structure between EA and Korean populations (see XREF_SUPPLEMENTARY) could reduce the size of the TNFAIP3 risk segment, we compared haplotypes (frequency> = 1%) formed by the SNPs in XREF_TABLE.
FGFR1 affects TNFAIP3
| 1
FGFR1 activates TNFAIP3. 1 / 1
| 1

reach
TNFAIP3, a ubiquitin editing enzyme, is upregulated by iFGFR1 signaling in a FGFR1 kinase activity and in an ERK2 dependent manner.

eidos
Furthermore , ES up-regulated A20 and suppressed the phosphorylation of p38 and ERK1 / 2 in hind paw joints , as well as inhibiting the activation of spinal p38 in CIA rats .
EIF2AK2 affects TNFAIP3
| 1
EIF2AK2 increases the amount of TNFAIP3. 1 / 1
| 1

reach
To monitor PKR activity, we analysis the expression of Tnfaip3 (A20) which could be induced by PKR activation through NF-kappaB pathway.
Dust affects TNFAIP3
1 |
Dust increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
Dietary Fats increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Death affects TNFAIP3
| 1
Death activates TNFAIP3. 1 / 1
| 1

reach
A conceptual mathematical model informed us how these death rate dynamics can be interpreted, leading us to identify TNF induced and NFkappaB responsive TNFAIP3 and A20 as a key regulator of necroptotic fate decisions.
DNMT3B affects TNFAIP3
| 1
DNMT3B increases the amount of TNFAIP3. 1 / 1
| 1

reach
For example, tumor suppressor Tnfaip3 which showed promoter hypermethylation, DNMT3B KD decreased peak enrichment (XREF_FIG) and increased Tnfaip3 expression (XREF_FIG).
DDX58 affects TNFAIP3
| 1
| 1

reach
Although RIG-I silencing produced a greater induction of TNFAIP3 and A20 in response to dsRNA, the expression of ISG56, a IRF3 dependent gene, was significantly inhibited (XREF_FIG).
DCS affects TNFAIP3
| 1
DCS activates TNFAIP3. 1 / 1
| 1

reach
In addition, DC-S overexpress TNFAIP3, which produces A20, which has been shown to have an important role in maintaining tolerance in the steady state [XREF_BIBR].
1 |
D-mannitol increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available

eidos
Additionally , HCoV-229E was found to induce the expression of TNFAIP3 ( A20 ) ( mean fold 1.6 + / - 0.60 s.d .
Cholesterol, Dietary increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Cholates affects TNFAIP3
1 |
Cholates increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
CXCL10 affects TNFAIP3
| 1
| 1

reach
Coupled with the expression profile data from the GSE20347 and GSE75241 datasets, we narrowed the set to 8 genes, 4 of which (C-X-C motif chemokine ligand 10 (CXCL10), TNF alpha induced protein 3 (TNFAIP3), inhibin subunit beta A (INHBA), and plasminogen activator, urokinase (PLAU)) were verified as the targets of SFE.
CNTN2 affects TNFAIP3
| 1
| 1

sparser
Since it has been shown that Tax1 inactivates A20 by disrupting the TAX1BP1/Itch/A20 complex, thus counteracting its negative function xref , we speculate that NRP also is involved in this process.
CERS2 affects TNFAIP3
| 1
CERS2 activates TNFAIP3. 1 / 1
| 1

reach
Herein, we first report that Lass2 deficiency caused the downregulation of miR-694 and the upregulation of its target gene Tnfaip3 in vivo in mice, which may be related to a high risk of occurrence of HCC.
CEBPB affects TNFAIP3
| 1
CEBPB increases the amount of TNFAIP3. 1 / 1
| 1

reach
Together these data indicate that NF-kappaB p65 and C/EBPbeta were mediators of LPS induced Tnfaip3 expression in macrophages.
CD8 affects TNFAIP3
| 1
CD8 activates TNFAIP3. 1 / 1
| 1

reach
Differences in T-cell-specific Tnfaip3 deletion between the two mouse strains could indicate that either CD8 + T-cells drive inflammation in Tnfaip3 maT-KO mice or CD4 + T-cells have increased regulatory function in Tnfaip3 CD4-KO mice.
CD40 affects TNFAIP3
| 1
CD40 activates TNFAIP3. 1 / 1
| 1

sparser
A second possibility is A20, which is activated by both LMP1 ( Laherty et al. 1992 ) and CD40 ( Sarma et al. 1995 ).
CASP8 affects TNFAIP3
| 1
CASP8 decreases the amount of TNFAIP3. 1 / 1
| 1

reach
Mechanistically, Casp8 induced PD-L1 degradation by upregulating TNFAIP3 (A20) expression, a ubiquitin editing enzyme that results in PD-L1 ubiquitination.
Berbamine affects TNFAIP3
1 |
Berbamine increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
BMPR2 affects TNFAIP3
| 1
| 1

reach
Reduced BMPRII signaling as an additional trigger in an inflammatory based 31-week-old Tnfaip3 DNGR1-KO mouse model did not result in an enhanced PH phenotype.
BCL6 affects TNFAIP3
| 1
BCL6 activates TNFAIP3. 1 / 1
| 1

reach
Two mutations (B-cell chronic lymphocytic leukemia/lymphoma 6 [BCL6] leucine to serine change at position 677 [L677S] in patient 1 and tumor necrosis factor, alpha induced protein 3 [TNFAIP3] proline to serine change at position 481 [P481S] in patient 5) were called in all 3 samples that were sequenced.
BCL10 affects TNFAIP3
| 1
BCL10 activates TNFAIP3. 1 / 1
| 1

sparser
Transient transfection assays in HEK 293 cells indicate that Bcl10 can activate the A20 promoter, which contains NF-κB-binding sites.
BCKDHA affects TNFAIP3
| 1
| 1

sparser
At the cellular level, MSU inhibited the deubiquitinases A20 and UCHL2 and increased 20s proteasomal activity, leading to a global decrease in K 63 -linked ubiquitination and increase in K 48 -linked ubiquitination in THP-1 macrophages.
1 |
Antimycin A increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available

ctd
No evidence text available
Antigens, Bacterial increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
Allergens affects TNFAIP3
1 |
Allergens increases the amount of TNFAIP3. 1 / 1
1 |

bel
See table 2: Highly differentially expressed genes sorted by ontology in functional groups. All fold changes are greater than or equal to 5 p<0.01.
ATP affects TNFAIP3
| 1
ATP activates TNFAIP3. 1 / 1
| 1

reach
On the other hand, pCX-TRI-2A-transfected cells significantly up-regulated the expression of the anti-apoptotic Tnfaip3 gene, as compared to control cells, when treated with TNF-alpha plus ATP or with TNF-alpha plus ATP and hemin (XREF_FIG).
ATG16L1 affects TNFAIP3
| 1
| 1

reach
The WDD mediates lysosomal degradation of TNFAIP3 promoted by ATG16L1, and also regulates the NFKB and NF-kappaB response.
ASH1L affects TNFAIP3
| 1
ASH1L activates TNFAIP3. 1 / 1
| 1

eidos
ERRalpha directly binds to the A20 promoter region to promote expression [ 70 ] , and Ash1l upregulates A20 through H3K4 methylation of the A20 promoter in macrophages [ 71 ] .
| PMC
AGO2 affects TNFAIP3
| 1
AGO2 decreases the amount of TNFAIP3. 1 / 1
| 1

reach
In this study, we found that miRNAs was essential to control the expression of TNFAIP3, as evidenced by the observations that knockdown of AGO2 up-regulated the expression of TNFAIP3.
ADM affects TNFAIP3
| 1
ADM inhibits TNFAIP3. 1 / 1
| 1

sparser
UCHL1, UCHL3, USP2 and USP8 were found to be inhibited by AM146, RA-9, and RA-14, which did not inhibit Ataxin-3, A20, BAP1, Otubain 1 or USP7 ( xref ).
ACAD8 affects TNFAIP3
| 1
ACAD8 activates TNFAIP3. 1 / 1
| 1

reach
The inflammation and inflammatory bowel disease (IBD) disorders had many commonly modulated genes that were also found in the String analysis that were common with the disorders which included IL-8, ICAM1, RELB, NFkappaBIA, TNFAIP3, LIF, CXCL1, CXCL2, CXCL3, CXCL10, and TNF-alpha.
7-ketocholesterol increases the amount of TNFAIP3. 1 / 1
| 1

reach
The results indicate that miR-98-5p interference and 3beta-hydroxycholest-5-en-7-one treatment significantly upregulated the low TNFAIP3 expression induced by LPS stimulation, thereby inhibiting TRAF6, RIP, NF-kappaB, IL-1beta, and TNF-alpha secretion.
1 |
5-fluorouracil increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
4-nitroquinoline N-oxide increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
4-hydroxynon-2-enal decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available

ctd
No evidence text available
1 |

ctd
No evidence text available

ctd
No evidence text available
2-hydroxypropanoic acid increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
1-phenylpropan-2-amine decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1-naphthyl isothiocyanate increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1-methylanthracene increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |

ctd
No evidence text available
1,4-phenylenediamine increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1,1-dichloroethene increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
(S)-amphetamine decreases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available
1 |
(-)-demecolcine increases the amount of TNFAIP3. 1 / 1
1 |

ctd
No evidence text available

ctd
No evidence text available

reach
A 2A R engagement, PGE 2 or cAMP elevating agents each increased mRNA expression of immunomodulatory transcription factors NR4A3, ATF3, TNFAIP3 and IER2, of the enzyme COX-2, of dual-specificity phosphatases 1 and 2 and of the regulatory element SOCS3.